90	DR	A novel approach for high-quality microarray processing using third-dye array visualization technology.	15376909	IEEE Trans Nanobioscience	2003
90	PR	Computational strategies for analyzing data in gene expression microarray experiments.	15290769	J Bioinform Comput Biol	2003
90	NR	Strategies for microarray analysis of limiting amounts of RNA.	15239941	Brief Funct Genomic Proteomic	2003
90	NR	Comment in:     Brief Funct Genomic Proteomic. 2003 Apr;2(1):4-6.	15239939	Brief Funct Genomic Proteomic	2003
90	PR	MicroPreP: a cDNA microarray data pre-processing framework.	15130795	Appl Bioinformatics	2003
90	PR	Clinically validated benchmarking of normalisation techniques for two-colour oligonucleotide spotted microarray slides.	15130793	Appl Bioinformatics	2003
90	NR	Overcoming confounded controls in the analysis of gene expression data from microarray experiments.	15130791	Appl Bioinformatics	2003
90	PR	Profound normalisation challenges remain in the analysis of data from microarray experiments.	15130790	Appl Bioinformatics	2003
90	DR	Maintaining data integrity in microarray data management.	14708120	Biotechnol Bioeng	2003
90	DR	The design of a gene chip for functional immunological studies on a high-quality control platform.	14679077	Ann N Y Acad Sci	2003
90	NR	Effects of atmospheric ozone on microarray data quality.	14632079	Anal Chem	2003
90	NR	A Bayesian missing value estimation method for gene expression profile data.	14594714	Bioinformatics	2003
90	DR	A novel strategy for microarray quality control using Bayesian networks.	14594707	Bioinformatics	2003
90	PR	A software package for cDNA microarray data normalization and assessing confidence intervals.	14583113	OMICS	2003
90	NR	Optimizing stringency for expression microarrays.	14579749	Biotechniques	2003
90	NR	Transcriptome profiling of a Saccharomyces cerevisiae mutant with a constitutively activated Ras/cAMP pathway.	14570984	Physiol Genomics	2003
90	PR	A tool-kit for cDNA microarray and promoter analysis.	14512358	Bioinformatics	2003
90	PR	Controlling false-negative errors in microarray differential expression analysis: a PRIM approach.	14512352	Bioinformatics	2003
90	NR	Designing, testing, and validating a focused stem cell microarray for characterization of neural stem cells and progenitor cells.	12968112	Stem Cells	2003
90	NR	The effect of replication on gene expression microarray experiments.	12967957	Bioinformatics	2003
90	DR	Probabilistic estimation of microarray data reliability and underlying gene expression.	12967349	BMC Bioinformatics	2003
90	DR	Sex genes for genomic analysis in human brain: internal controls for comparison of probe level data extraction.	12962547	BMC Bioinformatics	2003
90	PR	Assessing the variability in GeneChip data.	12930160	Am J Pharmacogenomics	2003
90	DR	The design and analysis of microarray experiments: applications in parasitology.	12906732	DNA Cell Biol	2003
90	NR	Demystified...tissue microarray technology.	12890740	Mol Pathol	2003
90	PR	Noise sampling method: an ANOVA approach allowing robust selection of differentially regulated genes measured by DNA microarrays.	12874046	Bioinformatics	2003
90	DR	Quantitative quality control in microarray experiments and the application in data filtering, normalization and false positive rate prediction.	12874045	Bioinformatics	2003
90	PR	New normalization methods for cDNA microarray data.	12874043	Bioinformatics	2003
90	NR	Automated evaluation and normalization of immunohistochemistry on tissue microarrays with a DNA microarray scanner.	12866417	Biotechniques	2003
90	PR	Identification and correction of spurious spatial correlations in microarray data.	12866403	Biotechniques	2003
90	NR	Estimating the occurrence of false positives and false negatives in microarray studies by approximating and partitioning the empirical distribution of p-values.	12835267	Bioinformatics	2003
90	NR	Real-time polymerase chain reaction quantitation of relative expression of genes modulated by p53 using SYBR Green I.	12824526	Methods Mol Biol	2003
90	NR	ExpressYourself: A modular platform for processing and visualizing microarray data.	12824348	Nucleic Acids Res	2003
90	DR	Bagging to improve the accuracy of a clustering procedure.	12801869	Bioinformatics	2003
90	PR	Modified nonparametric approaches to detecting differentially expressed genes in replicated microarray experiments.	12801864	Bioinformatics	2003
90	DR	Use of a three-color cDNA microarray platform to measure and control support-bound probe for improved data quality and reproducibility.	12771224	Nucleic Acids Res	2003
90	NR	Fuzzy C-means method for clustering microarray data.	12761060	Bioinformatics	2003
90	PR	Microarray standard data set and figures of merit for comparing data processing methods and experiment designs.	12761058	Bioinformatics	2003
90	NR	Corrected small-sample estimation of the Bayes error.	12761056	Bioinformatics	2003
90	NR	Microarray analysis: a novel research tool for cardiovascular scientists and physicians.	12748210	Heart	2003
90	PR	Non-linear normalization and background correction in one-channel cDNA microarray studies.	12724292	Bioinformatics	2003
90	NR	Robust cluster analysis of microarray gene expression data with the number of clusters determined biologically.	12724291	Bioinformatics	2003
90	NR	Statistical design of reverse dye microarrays.	12724289	Bioinformatics	2003
90	PR	Microarray databases: storage and retrieval of microarray data.	12710676	Methods Mol Biol	2003
90	PR	Statistical issues in cDNA microarray data analysis.	12710670	Methods Mol Biol	2003
90	PR	QA/QC as a pressing need for microarray analysis: meeting report from CAMDA'02.	12664687	Biotechniques	2003
90	NR	Assessing the functional bias of commercial microarrays using the onto-compare database.	12664686	Biotechniques	2003
90	PR	Experimental design of DNA microarray experiments.	12664680	Biotechniques	2003
90	NR	[Recent advances in molecular diagnostic tests]	12652786	Rinsho Byori	2002
90	NR	Biomedical informatics for proteomics.	12634797	Nature	2003
90	NR	Automated high-throughput probe production for DNA microarray analysis.	12613263	Biotechniques	2003
90	NR	RNA amplification strategies for cDNA microarray experiments.	12613262	Biotechniques	2003
90	NR	Probe generation directly from small numbers of cells for DNA microarray studies.	12613261	Biotechniques	2003
90	NR	QuickLIMS: facilitating the data management for DNA-microarray fabrication.	12538251	Bioinformatics	2003
90	DR	Combinatorial image analysis of DNA microarray features.	12538239	Bioinformatics	2003
90	NR	TRANSPATH: an integrated database on signal transduction and a tool for array analysis.	12519957	Nucleic Acids Res	2003
90	PR	The Stanford Microarray Database: data access and quality assessment tools.	12519956	Nucleic Acids Res	2003
90	NR	Analysis of whole-genome microarray replicates using mixed models.	12499293	Bioinformatics	2003
90	NR	Evolutionary algorithms for finding optimal gene sets in microarray prediction.	12499292	Bioinformatics	2003
90	NR	Calculation of the minimum number of replicate spots required for detection of significant gene expression fold change in microarray experiments.	12490445	Bioinformatics	2002
90	NR	Between-group analysis of microarray data.	12490444	Bioinformatics	2002
90	NR	Tissue microarrays are an effective quality assurance tool for diagnostic immunohistochemistry.	12481020	Mod Pathol	2002
90	PR	Post-analysis follow-up and validation of microarray experiments.	12454646	Nat Genet	2002
90	NR	Options available--from start to finish--for obtaining data from DNA microarrays II.	12454642	Nat Genet	2002
90	NR	Medical applications of microarray technologies: a regulatory science perspective.	12454641	Nat Genet	2002
90	NR	Microarray databases: standards and ontologies.	12454640	Nat Genet	2002
90	NR	Analytical reproducibility in (1)H NMR-based metabonomic urinalysis.	12437328	Chem Res Toxicol	2002
90	NR	Comment in:     Am J Clin Pathol. 2002 Nov;118(5):669-71.	12428786	Am J Clin Pathol	2002
90	NR	Methods for assessing reproducibility of clustering patterns observed in analyses of microarray data.	12424117	Bioinformatics	2002
90	NR	Comparison of microarray designs for class comparison and class discovery.	12424114	Bioinformatics	2002
90	NR	PRIMEGENS: robust and efficient design of gene-specific probes for microarray analysis.	12424113	Bioinformatics	2002
90	NR	A common reference for cDNA microarray hybridizations.	12409475	Nucleic Acids Res	2002
90	NR	Picoliter-scale protein microarrays by laser direct write.	12363367	Biotechnol Prog	2002
90	DR	A method for evaluation of the quality of DNA microarray spots.	12359098	J Biochem Mol Biol	2002
90	NR	Sequence diversity of Jeryl Lynn strain of mumps virus: quantitative mutant analysis for vaccine quality control.	12350348	Virology	2002
90	NR	Bacterial discrimination by means of a universal array approach mediated by LDR (ligase detection reaction).	12243651	BMC Microbiol	2002
90	NR	Linear amplification of catalyzed reporter deposition technology on nylon membrane microarray.	12238767	Biotechniques	2002
90	NR	Microarray data representation, annotation and storage.	12227734	Adv Biochem Eng Biotechnol	2002
90	NR	Identification of Schistosoma mansoni gender-associated gene transcripts by cDNA microarray profiling.	12186648	Genome Biol	2002
90	NR	Challenges in applying microarrays to environmental studies.	12180093	Curr Opin Biotechnol	2002
90	DR	MArray: analysing single, replicated or reversed microarray experiments.	12176840	Bioinformatics	2002
90	NR	Mapping physiological states from microarray expression measurements.	12176828	Bioinformatics	2002
90	NR	Representation is faithfully preserved in global cDNA amplified exponentially from sub-picogram quantities of mRNA.	12172558	Nat Biotechnol	2002
90	DR	Statistical process control for large scale microarray experiments.	12169543	Bioinformatics	2002
90	PR	Comment in:     J Clin Pathol. 2002 Aug;55(8):575-6.	12147657	J Clin Pathol	2002
90	NR	High-quality RNA from cells isolated by laser capture microdissection.	12139243	Biotechniques	2002
90	DR	Defining signal thresholds in DNA microarrays: exemplary application for invasive cancer.	12123529	BMC Genomics	2002
90	NR	Quantitative assessment of filter-based cDNA microarrays: gene expression profiles of human T-lymphoma cell lines.	12117793	Bioinformatics	2002
90	PR	Local mean normalization of microarray element signal intensities across an array surface: quality control and correction of spatially systematic artifacts.	12074162	Biotechniques	2002
90	NR	Microarray technology GEM microarrays and drug discovery.	12074093	J Ind Microbiol Biotechnol	2002
90	PR	Microarray optimizations: increasing spot accuracy and automated identification of true microarray signals.	12060692	Nucleic Acids Res	2002
90	DR	Statistical issues with microarrays: processing and analysis.	12047952	Trends Genet	2002
90	DR	Nondestructive quality control for microarray production.	12019778	Biotechniques	2002
90	NR	Microarray data warehouse allowing for inclusion of experiment annotations in statistical analysis.	11934741	Bioinformatics	2002
90	DR	Quality control in manufacturing oligo arrays: a combinatorial design approach.	11911792	J Comput Biol	2002
90	NR	The feasibility of using fine needle aspiration from primary breast cancers for cDNA microarray analyses.	11895911	Clin Cancer Res	2002
90	NR	What the clinician needs from the pathologist: evidence-based reporting in breast cancer.	11888005	Eur J Cancer	2001
90	PR	Correcting for signal saturation errors in the analysis of microarray data.	11848410	Biotechniques	2002
90	NR	Microgel assessment of nucleic acid integrity and labeling quality in microarray experiments.	11848407	Biotechniques	2002
90	NR	Sources of nonlinearity in cDNA microarray expression measurements.	11737946	Genome Biol	2001
90	PR	RNA expression analysis using an antisense Bacillus subtilis genome array.	11717296	J Bacteriol	2001
90	NR	Comparative evaluation of laser-based microarray scanners.	11570499	Biotechniques	2001
90	NR	Tissue microarray (TMA) technology: miniaturized pathology archives for high-throughput in situ studies.	11568893	J Pathol	2001
90	DR	Quantitative quality control in microarray image processing and data acquisition.	11470890	Nucleic Acids Res	2001
90	PR	Sequence verification as quality-control step for production of cDNA microarrays.	11464521	Biotechniques	2001
90	DR	A novel method using edge detection for signal extraction from cDNA microarray image analysis.	11460886	Exp Mol Med	2001
90	NR	[Clinical trials: prerequisite of evidence-based oncology: reality, perspectives and a new tool recruited--the Internet]	11441309	Onkologie	2001
90	NR	Issues in cDNA microarray analysis: quality filtering, channel normalization, models of variations and assessment of gene effects.	11410663	Nucleic Acids Res	2001
90	NR	[The present status and future prospect of the molecular diagnostic tests]	11307306	Rinsho Byori	2001
90	NR	An evaluation of the performance of cDNA microarrays for detecting changes in global mRNA expression.	11292855	Nucleic Acids Res	2001
90	DR	Quality control in manufacturing oligo arrays: a combinatorial design approach.	11262954	Pac Symp Biocomput	2001
90	NR	Applications of biochip and microarray systems in pharmacogenomics.	11256580	Pharmacogenomics	2000
90	PR	Tissue microarrays: what will they bring to molecular and anatomic pathology?	11152090	Adv Anat Pathol	2001
90	DR	Analysis of DNA microarrays by non-destructive fluorescent staining using SYBR green II.	10907080	Biotechniques	2000
90	NR	Electrospray ionization mass spectrometry of synthetic oligonucleotides using 2-propanol and spermidine	0010669883	Rapid Commun Mass Spectrom	2000
91	NR	Phage display of functional human TNF-alpha converting enzyme catalytic domain: a rapid method for the production of stabilized proteolytic proteins for assay development and high-throughput screening.	14599359	J Biomol Screen	2002
91	NR	Drosophila S3 ribosomal protein accelerates repair of 8-oxoguanine performed by human and mouse cell extracts.	12874813	Environ Mol Mutagen	2003
91	DR	[Molecular cloning and expression of E2 gene of the Chinese classical swine fever virus(shimen strain) and preliminary studies of its DNA vaccine]	12548987	Wei Sheng Wu Xue Bao	2000
91	NR	Interaction of casein kinase II with ribosomal protein L22 of Drosophila melanogaster.	12379220	Biochem Biophys Res Commun	2002
91	NR	Temporal expression profile of late gene expression factor 4 from Bombyx mori nucleopolyhedrovirus.	12234668	Gene	2002
91	PR	Characterization of the in vitro kinase activity of a partially purified soluble GST/JAK2 fusion protein.	12190118	Mol Cell Biochem	2002
91	DR	A approximately 35 kDa polypeptide from insect cells binds to yeast ACS like elements in the presence of ATP.	12186657	BMC Biochem	2002
91	DR	Cloning of Etp28 Gene of Eimeria tenella (Guangdong Strain) Sporozoites and Its Expression in Baculovirus Expression System.	12174264	Sheng Wu Hua Xue Yu Sheng Wu Wu Li Xue Bao (Shanghai)	1998
91	DR	Production of recombinant human calcitonin from silkworm (B. mori) larvae infected by baculovirus.	12144509	Protein Pept Lett	2002
91	NR	The ubiquitin-interacting motifs target the endocytic adaptor protein epsin for ubiquitination.	12121618	Curr Biol	2002
91	NR	Expression and functional analysis of an inhibitor of apoptosis protein from Trichoplusia ni.	12054521	Biochem Biophys Res Commun	2002
91	NR	Measurement of HCV RdRp activity with C-terminal 21 aa truncated NS5b protein: optimization of assay conditions.	12048062	Hepatol Res	2002
91	NR	Expression and characterization of a novel class of glutathione S-transferase from Anopheles dirus.	11886777	Insect Biochem Mol Biol	2002
91	DR	The endothelial receptor tyrosine kinase Tie1 activates phosphatidylinositol 3-kinase and Akt to inhibit apoptosis.	11865050	Mol Cell Biol	2002
91	NR	Analysis of beta3-endonexin mutants for their ability to interact with cyclin A.	11810239	Mol Genet Genomics	2001
91	NR	Expression of ecdysteroid receptor and ultraspiracle from Chironomus tentans (Insecta, Diptera) in E. coli and purification in a functional state.	11755059	Insect Biochem Mol Biol	2002
91	DR	Characterization of human taurine transporter expressed in insect cells using a recombinant baculovirus.	11722175	Protein Expr Purif	2001
91	DR	Dimerization-induced activation of soluble insulin/IGF-1 receptor kinases: an alternative mechanism of activation.	11714281	Biochemistry	2001
91	NR	Cingulin interacts with F-actin in vitro.	11682052	FEBS Lett	2001
91	NR	A conserved domain in arthropod cuticular proteins binds chitin.	11520687	Insect Biochem Mol Biol	2001
91	NR	Ostip2, a novel oncoprotein that associates with the Rho exchange factor Ost.	11506702	DNA Cell Biol	2001
91	NR	A bacterially produced virus enhancing factor from an entomopoxvirus enhances nucleopolyhedrovirus infection in armyworm larvae.	11500090	J Invertebr Pathol	2001
91	NR	Heterologous expression and characterization of alternatively spliced glutathione S-transferases from a single Anopheles gene.	11439246	Insect Biochem Mol Biol	2001
91	DR	Epstein-Barr virus-encoded protein kinase BGLF4 mediates hyperphosphorylation of cellular elongation factor 1delta (EF-1delta): EF-1delta is universally modified by conserved protein kinases of herpesviruses in mammalian cells.	11369891	J Gen Virol	2001
91	NR	Suramin and the suramin analogue NF307 discriminate among calmodulin-binding sites.	11311147	Biochem J	2001
91	DR	Expression and purification of human recombinant GST-FGF receptor-1.	11223144	J Biotechnol	2001
91	NR	Identification and characterization of a novel protein inhibitor of type 1 protein phosphatase.	11076525	Biochemistry	2000
91	NR	Expression of porcine interleukin-2 in Escherichia coli.	11073083	J Vet Med Sci	2000
91	DR	Hepatitis C virus glycoprotein E2 binding to CD81: the role of E1E2 cleavage and protein glycosylation in bioactivity.	10891408	Virology	2000
91	DR	Human Cdc7-related kinase complex. In vitro phosphorylation of MCM by concerted actions of Cdks and Cdc7 and that of a criticial threonine residue of Cdc7 bY Cdks.	10846177	J Biol Chem	2000
91	DR	Endogenous glutathione-binding proteins of insect cell lines: characterization and removal from glutathione S-transferase (GST) fusion proteins.	10833407	Protein Expr Purif	2000
91	NR	Antigenic properties and diagnostic potential of recombinant dobrava virus nucleocapsid protein.	10797384	J Med Virol	2000
91	DR	N-Glycan processing by a lepidopteran insect alpha1,2-mannosidase.	10764822	Glycobiology	2000
91	NR	Molecular cloning of a cDNA for a small GTP binding protein, BRho, from the embryo of Bombyx mori and its characterization after expression and purification.	10737920	Arch Insect Biochem Physiol	2000
91	NR	Cloning of three novel neuronal Cdk5 activator binding proteins.	10721722	Gene	2000
91	DR	Identification of oxidized protein hydrolase of human erythrocytes as acylpeptide hydrolase.	10719179	Biochim Biophys Acta	2000
91	NR	Preliminary study on the cleavage of fusion protein GST-CMIV with palladium(II) complex.	10701454	Prep Biochem Biotechnol	2000
91	NR	Formation of the Ras dimer is essential for Raf-1 activation.	10660519	J Biol Chem	2000
91	DR	Involvement of multiple subunit-subunit contacts in the assembly of RNA polymerase II.	10648788	Nucleic Acids Res	2000
91	NR	MSL1 plays a central role in assembly of the MSL complex, essential for dosage compensation in Drosophila.	10619853	EMBO J	2000
91	NR	Transcription factors of the Sp1 family: interaction with E2F and regulation of the murine thymidine kinase promoter.	10547281	J Mol Biol	1999
91	NR	c-Jun transactivates the promoter of the human p21(WAF1/Cip1) gene by acting as a superactivator of the ubiquitous transcription factor Sp1.	10506225	J Biol Chem	1999
91	DR	Homogeneous purification of human recombinant GST-Akt/PKB from Sf9 cells.	10497072	Protein Expr Purif	1999
91	PR	c-Src association with and phosphorylation of p58gag, a membrane- and microfilament-associated retroviral Gag-like protein in a xenotransplantable rat mammary tumor.	10435591	Oncogene	1999
91	NR	Activation process of dipteran-specific insecticidal protein produced by Bacillus thuringiensis subsp. israelensis.	10427035	Appl Environ Microbiol	1999
91	NR	BCR binds to the xeroderma pigmentosum group B protein.	10403766	Biochem Biophys Res Commun	1999
91	NR	Epstein-Barr virus nuclear antigen 3C interacts with histone deacetylase to repress transcription.	10364319	J Virol	1999
91	NR	Expression of elongation factor 1 beta' in Escherichia coli and its interaction with elongation factor 1 alpha from silk gland.	10361679	Biosci Biotechnol Biochem	1999
91	DR	Transcriptional analysis of the PTEN/MMAC1 pseudogene, psiPTEN.	10208437	Oncogene	1999
91	DR	Comparison of human sera reactivities in immunoblots with recombinant human herpesvirus (HHV)-8 proteins associated with the latent (ORF73) and lytic (ORFs 65, K8.1A, and K8.1B) replicative cycles and in immunofluorescence assays with HHV-8-infected BCBL-1 cells.	10191203	Virology	1999
91	DR	Chemotaxin-dependent translocation of immunoreactive ADP-ribosyltransferase-1 to the surface of human neutrophil polymorphs.	10092875	Eur J Biochem	1999
91	DR	A cellular protein which binds hepatitis B virus but not hepatitis B surface antigen.	10091999	J Gen Virol	1999
91	NR	A scintillation proximity assay for the Raf/MEK/ERK kinase cascade: high-throughput screening and identification of selective enzyme inhibitors.	10075822	Anal Biochem	1999
91	NR	A gene located at 56F1-2 in Drosophila melanogaster encodes a novel metazoan beta-like subunit of casein kinase II.	10329473	Mol Cell Biol Res Commun	1999
91	DR	Overcoming expression and purification problems of RhoGDI using a family of "parallel" expression vectors.	10024467	Protein Expr Purif	1999
91	PR	Cyclin D1 associates with the TBP-associated factor TAF(II)250 to regulate Sp1-mediated transcription.	9926939	Oncogene	1999
91	NR	Identification and characterization of baxepsilon, a novel bax variant missing the BH2 and the transmembrane domains.	9920818	Biochem Biophys Res Commun	1999
91	NR	Varicella-zoster virus Fc receptor component gI is phosphorylated on its endodomain by a cyclin-dependent kinase.	9882337	J Virol	1999
91	NR	Molecular cloning of cDNA for BRab from the brain of Bombyx mori and biochemical properties of BRab expressed in Escherichia coli.	9836423	Biosci Biotechnol Biochem	1998
91	DR	Amino acids 16-275 of minute virus of mice NS1 include a domain that specifically binds (ACCA)2-3-containing DNA.	9813208	Virology	1998
91	NR	Reduction of MTT by glutathione S-transferase.	9793644	Biotechniques	1998
91	PR	Interaction of insulin receptor substrate-1 with the sigma3A subunit of the adaptor protein complex-3 in cultured adipocytes.	9792713	J Biol Chem	1998
91	NR	GST-Induced dimerization of DNA-binding domains alters characteristics of their interaction with DNA.	9790883	Protein Expr Purif	1998
91	DR	Secretion and purification of HCV E1 protein forms as glutathione-S-transferase fusion in the baculovirus insect cell system.	9725668	Virus Res	1998
91	NR	Serological characterization of the 3'-proximal encoded proteins of beet yellows closterovirus.	9722879	Arch Virol	1998
91	PR	Insulin stimulates pp120 endocytosis in cells co-expressing insulin receptors.	9712832	J Biol Chem	1998
91	NR	Hypoderma lineatum: expression of enzymatically active hypodermin C in Escherichia coli and its use for the immunodiagnosis of hypodermosis.	9709025	Exp Parasitol	1998
91	DR	Use of GST-fusion and related constructs for the identification of interacting proteins.	9664300	Methods Mol Biol	1998
91	DR	Eukaryotic virus display: engineering the major surface glycoprotein of the Autographa californica nuclear polyhedrosis virus (AcNPV) for the presentation of foreign proteins on the virus surface.	9636281	Biotechnology (N Y)	1995
91	DR	Development and characterization of monoclonal antibodies specific to the serotonin 5-HT2A receptor.	9632740	J Histochem Cytochem	1998
91	NR	Functional expression and enzymatic properties of two Sitophilus zeamais cysteine proteinases showing different autolytic processing profiles in vitro.	9538263	J Biochem (Tokyo)	1998
91	NR	TNF-alpha convertase enzyme from human arthritis-affected cartilage: isolation of cDNA by differential display, expression of the active enzyme, and regulation of TNF-alpha.	9574564	J Immunol	1998
91	NR	Interaction of troponin-H and glutathione S-transferase-2 in the indirect flight muscles of Drosophila melanogaster.	9536439	J Muscle Res Cell Motil	1998
91	PR	Regulation of the p85/p110 phosphatidylinositol 3'-kinase: stabilization and inhibition of the p110alpha catalytic subunit by the p85 regulatory subunit.	9488453	Mol Cell Biol	1998
91	PR	Interaction between the herpes simplex virus type 1 origin-binding and DNA polymerase accessory proteins.	9454723	Virology	1998
91	NR	A complex glutathione transferase gene family in the housefly Musca domestica.	9349710	Mol Gen Genet	1997
91	PR	Kinetics of trkA tyrosine kinase activity and inhibition by K-252a.	9448714	Arch Biochem Biophys	1998
91	PR	The immunophilin FKBP65 forms an association with the serine/threonine kinase c-Raf-1.	9438387	Cell Growth Differ	1998
91	NR	Identification of endogenous substrates for Drosophila calpain from a salt-extracted fraction of Drosophila ovaries.	9399593	J Biochem (Tokyo)	1997
91	DR	Production of recombinant herpes simplex virus protease in 10-L stirred vessels using a baculovirus-insect cell expression system.	9366090	J Ind Microbiol Biotechnol	1997
91	PR	Protein-protein interactions are implied in glucocorticoid receptor mutant 465*-mediated cell death.	9325319	J Biol Chem	1997
91	NR	Distinct roles of E2F recognition sites as positive or negative elements in regulation of the DNA polymerase alpha 180 kDa catalytic subunit gene promoter during Drosophila development.	9380507	Nucleic Acids Res	1997
91	NR	Herpes simplex virus 1 alpha regulatory protein ICP0 interacts with and stabilizes the cell cycle regulator cyclin D3.	9311810	J Virol	1997
91	NR	Role of histone tails in nucleosome remodeling by Drosophila NURF.	9303316	EMBO J	1997
91	NR	Direct interaction of endothelial nitric-oxide synthase and caveolin-1 inhibits synthase activity.	9228013	J Biol Chem	1997
91	DR	Expression, purification, and characterization of an activated cytokine-suppressive anti-inflammatory drug-binding protein 2 (CSBP2) kinase from baculovirus-infected insect cells.	9226723	Protein Expr Purif	1997
91	NR	Carbon regulation of the cuticle-degrading enzyme PR1 from Metarhizium anisopliae may involve a trans-acting DNA-binding protein CRR1, a functional equivalent of the Aspergillus nidulans CREA protein.	9211795	Curr Genet	1997
91	NR	Identification of a p130 domain mediating interactions with cyclin A/cdk 2 and cyclin E/cdk 2 complexes.	9188854	Oncogene	1997
91	NR	Interactions of Drosophila Cbl with epidermal growth factor receptors and role of Cbl in R7 photoreceptor cell development.	9121472	Mol Cell Biol	1997
91	DR	Tpl-2 is an oncogenic kinase that is activated by carboxy-terminal truncation.	9087424	Genes Dev	1997
91	NR	Conformation-dependent phosphorylation of p53.	9050839	Proc Natl Acad Sci U S A	1997
91	PR	Identification of the major sites of autophosphorylation of the murine protein-tyrosine kinase Syk.	9042338	Biochim Biophys Acta	1997
91	PR	Real-time assay of the interaction of a GST fusion protein with a protein ligate using resonant mirror technique.	9043696	Biotechniques	1997
91	NR	A domain of TEL conserved in a subset of ETS proteins defines a specific oligomerization interface essential to the mitogenic properties of the TEL-PDGFR beta oncoprotein.	9009269	EMBO J	1997
91	NR	Expression of EcR and USP in Escherichia coli: purification and functional studies.	9131781	Arch Insect Biochem Physiol	1997
91	NR	Drosophila ribosomal protein PO contains apurinic/apyrimidinic endonuclease activity.	8932386	Nucleic Acids Res	1996
91	DR	Regulation mechanism of ERM (ezrin/radixin/moesin) protein/plasma membrane association: possible involvement of phosphatidylinositol turnover and Rho-dependent signaling pathway.	8858161	J Cell Biol	1996
91	NR	Interactions between geminivirus replication proteins.	8794317	J Virol	1996
91	DR	Ligand activation of ELK receptor tyrosine kinase promotes its association with Grb10 and Grb2 in vascular endothelial cells.	8798570	J Biol Chem	1996
91	DR	Expression and purification of the seven nonstructural proteins of the flavivirus Kunjin in the E. coli and the baculovirus expression systems.	8882936	J Virol Methods	1996
91	NR	Wiskott-Aldrich syndrome protein (WASp) is a binding partner for c-Src family protein-tyrosine kinases.	8805332	Curr Biol	1996
91	NR	Human homolog of Drosophila heterochromatin-associated protein 1 (HP1) is a DNA-binding protein which possesses a DNA-binding motif with weak similarity to that of human centromere protein C (CENP-C).	8864858	J Biochem (Tokyo)	1996
91	NR	A 27 amino acid coding region of JE virus E protein expressed in E. coli as fusion protein with glutathione-S-transferase elicit neutralizing antibody in mice.	8822638	Virus Res	1996
91	NR	A point mutation in the microtubule binding region of the Ncd motor protein reduces motor velocity.	8670831	EMBO J	1996
91	DR	Reconstitution of a pentameric complex of dimeric transforming growth factor beta ligand and a type I, II, III receptor in baculoviral-infected insect cells.	8842749	In Vitro Cell Dev Biol Anim	1996
91	DR	Production, purification and characterization of non-myristylated human T-cell protein tyrosine kinase in a baculovirus expression system.	8647461	Gene	1996
91	PR	Characterization of novel vascular endothelial growth factor (VEGF) receptors on tumor cells that bind VEGF165 via its exon 7-encoded domain.	8621443	J Biol Chem	1996
91	PR	The hepatitis delta virus large antigen is farnesylated both in vitro and in animal cells.	8617711	J Biol Chem	1996
91	NR	Isolation and characterization of cDNA for DREF, a promoter-activating factor for Drosophila DNA replication-related genes.	8632015	J Biol Chem	1996
91	DR	Recombinant prion protein rPrP27-30 from Syrian golden hamster reveals proteinase K sensitivity.	8619803	Biochem Biophys Res Commun	1996
91	NR	cDNA cloning of a murine homologue of Drosophila single-minded, its mRNA expression in mouse development, and chromosome localization.	8561800	Biochem Biophys Res Commun	1996
91	NR	Essential role of E2F recognition sites in regulation of the proliferating cell nuclear antigen gene promoter during Drosophila development.	7559650	J Biol Chem	1995
91	NR	Carboxy-terminal truncation of oryzacystatin II by oryzacystatin-insensitive insect digestive proteinases.	7574723	Arch Biochem Biophys	1995
91	PR	Identification of Lck-binding elements in tip of herpesvirus saimiri.	7544793	J Biol Chem	1995
91	DR	Overexpression of active Syrian golden hamster prion protein PrPc as a glutathione S-transferase fusion in heterologous systems.	7609044	J Virol	1995
91	PR	The Ras GTPase-activating protein (GAP) is an SH3 domain-binding protein and substrate for the Src-related tyrosine kinase, Hck.	7782336	J Biol Chem	1995
91	NR	The Epstein-Barr virus open reading frame BDLF3 codes for a 100-150 kDa glycoprotein.	7782767	J Gen Virol	1995
91	NR	Molecular cloning and characterization of a conserved nuclear serine(threonine) protein kinase.	7761441	Proc Natl Acad Sci U S A	1995
91	DR	The human immunodeficiency virus type 1 Nef protein functions as a protein kinase C substrate in vitro.	9049329	J Gen Virol	1995
91	PR	Lipid-mediated regulation of G protein-coupled receptor kinases 2 and 3.	7890702	J Biol Chem	1995
91	PR	Tyrosine phosphorylation of p95Vav in myeloid cells is regulated by GM-CSF, IL-3 and steel factor and is constitutively increased by p210BCR/ABL.	7530656	EMBO J	1995
91	NR	Identifying a transcription factor interaction site on RNA polymerase II.	7488860	Gene Expr	1995
91	NR	Direct binding to and tyrosine phosphorylation of the alpha subunit of the type I interferon receptor by p135tyk2 tyrosine kinase.	7526154	Mol Cell Biol	1994
91	DR	A rapid one-step method to purify baculovirus-expressed human estrogen receptor to be used in the analysis of the oxytocin promoter.	8076833	Gene	1994
91	DR	Insect cell-expressed p180erbB3 possesses an impaired tyrosine kinase activity.	8058768	Proc Natl Acad Sci U S A	1994
91	DR	Myristoylation-dependent binding of HIV-1 Nef to CD4.	8057354	J Mol Biol	1994
91	NR	The regulatory region of protein kinase C gamma. Studies of phorbol ester binding to individual and combined functional segments expressed as glutathione S-transferase fusion proteins indicate a complex mechanism of regulation by phospholipids, phorbol esters, and divalent cations.	8051084	J Biol Chem	1994
91	NR	Inhibition of p53 DNA binding by human papillomavirus E6 proteins.	8207801	J Virol	1994
91	NR	A complex of GRB2-dynamin binds to tyrosine-phosphorylated insulin receptor substrate-1 after insulin treatment.	8039498	EMBO J	1994
91	NR	RNA- and single-stranded DNA-binding (SSB) proteins expressed during Drosophila melanogaster oogenesis: a homolog of bacterial and eukaryotic mitochondrial SSBs.	8206370	Gene	1994
91	NR	PI 3-kinase: structural and functional analysis of intersubunit interactions.	8313896	EMBO J	1994
91	NR	Trypanosoma cruzi cDNA encodes a tandemly repeated domain structure characteristic of small stress proteins and glutathione S-transferases.	8054880	Biol Cell	1994
92	DR	Ribosomal protein L11 negatively regulates oncoprotein MDM2 and mediates a p53-dependent ribosomal-stress checkpoint pathway.	14612427	Mol Cell Biol	2003
92	NR	Ascaris suum: cDNA microarray analysis of 4th stage larvae (L4) during self-cure from the intestine.	14552858	Exp Parasitol	2003
92	NR	Characterization and analysis of posttranslational modifications of the human large cytoplasmic ribosomal subunit proteins by mass spectrometry and Edman sequencing.	12962325	J Protein Chem	2003
92	NR	Structural basis for contrasting activities of ribosome binding thiazole antibiotics.	12954336	Chem Biol	2003
92	NR	Structure-based design of agents targeting the bacterial ribosome.	12852942	Bioorg Med Chem Lett	2003
92	DR	Regulation of HDM2 activity by the ribosomal protein L11.	12842086	Cancer Cell	2003
92	NR	Specific binding of ribosome recycling factor (RRF) with the Escherichia coli ribosomes by BIACORE.	12841582	Mol Biol Rep	2003
92	NR	Site of functional interaction of release factor 1 with the ribosome.	12818198	J Mol Biol	2003
92	NR	[Structural and functional analysis of the human ribosomal protein L11 gene]	12815950	Mol Biol (Mosk)	2003
92	NR	Crystallization and preliminary X-ray diffraction analysis of ribosomal protein L11 methyltransferase from Thermus thermophilus HB8.	12777815	Acta Crystallogr D Biol Crystallogr	2003
92	NR	NMR assignment of the full-length ribosomal protein L11 from Thermotoga maritima.	12652127	J Biomol NMR	2003
92	NR	Mechanism of Tet(O)-mediated tetracycline resistance.	12574130	EMBO J	2003
92	NR	Genetic and physiological characterization of rpoB mutations that activate antibiotic production in Streptomyces lividans.	12427928	Microbiology	2002
92	NR	Dissection of the mechanism for the stringent factor RelA.	12419222	Mol Cell	2002
92	NR	Dissociation of intact Escherichia coli ribosomes in a mass spectrometer. Evidence for conformational change in a ribosome elongation factor G complex.	12409297	J Biol Chem	2003
92	NR	Large-scale motions within ribosomal 50S subunits as demonstrated using photolabile oligonucleotides.	12406702	Bioorg Chem	2002
92	NR	Proteins released by Helicobacter pylori in vitro.	12399485	J Bacteriol	2002
92	NR	Ribosome interactions of aminoacyl-tRNA and elongation factor Tu in the codon-recognition complex.	12379845	Nat Struct Biol	2002
92	NR	GTPase activation of elongation factors Tu and G on the ribosome.	12369843	Biochemistry	2002
92	NR	A Drosophila fragile X protein interacts with components of RNAi and ribosomal proteins.	12368261	Genes Dev	2002
92	NR	Ribosomal proteins at the stalk region modulate functional rRNA structures in the GTPase center.	12198134	J Biol Chem	2002
92	NR	Modeling a minimal ribosome based on comparative sequence analysis.	12144780	J Mol Biol	2002
92	NR	Interaction among silkworm ribosomal proteins P1, P2 and P0 required for functional protein binding to the GTPase-associated domain of 28S rRNA.	12060678	Nucleic Acids Res	2002
92	NR	A compact RNA tertiary structure contains a buried backbone-K+ complex.	12054794	J Mol Biol	2002
92	NR	Initiation factor IF2, thiostrepton and micrococcin prevent the binding of elongation factor G to the Escherichia coli ribosome.	12051934	J Mol Biol	2002
92	NR	Limitation of ribosomal protein L11 availability in vivo affects translation termination.	12051910	J Mol Biol	2002
92	NR	Rpf2p, an evolutionarily conserved protein, interacts with ribosomal protein L11 and is essential for the processing of 27 SB Pre-rRNA to 25 S rRNA and the 60 S ribosomal subunit assembly in Saccharomyces cerevisiae.	12048200	J Biol Chem	2002
92	NR	Normal assembly of 60 S ribosomal subunits is required for the signaling in response to a secretory defect in Saccharomyces cerevisiae.	11893754	J Biol Chem	2002
92	NR	Translation elongation by a hybrid ribosome in which proteins at the GTPase center of the Escherichia coli ribosome are replaced with rat counterparts.	11729183	J Biol Chem	2002
92	NR	Involvement of the N terminus of ribosomal protein L11 in regulation of the RelA protein of Escherichia coli.	11673421	J Bacteriol	2001
92	NR	Two C or not two C: recurrent disruption of Zn-ribbons, gene duplication, lineage-specific gene loss, and horizontal gene transfer in evolution of bacterial ribosomal proteins.	11574053	Genome Biol	2001
92	NR	The large subunit of the mammalian mitochondrial ribosome. Analysis of the complement of ribosomal proteins present.	11551941	J Biol Chem	2001
92	NR	Knock-out of the plastid ribosomal protein L11 in Arabidopsis: effects on mRNA translation and photosynthesis.	11532164	Plant J	2001
92	NR	1H, 15N, and 13C assignments and secondary structure identification for full-length ribosomal protein L11 from Thermus thermophilus.	11519754	J Biomol NMR	2001
92	NR	Localization of L11 protein on the ribosome and elucidation of its involvement in EF-G-dependent translocation.	11518530	J Mol Biol	2001
92	NR	Characterization of a wheat cDNA encoding mitochondrial ribosomal protein L11: qualitative and quantitative tissue-specific differences in its expression.	11459176	Mol Genet Genomics	2001
92	NR	Transcription of essential cell division genes is linked to chromosome replication in Escherichia coli.	11401698	Mol Microbiol	2001
92	NR	Quantitative analysis of nucleic acid three-dimensional structures.	11352582	J Mol Biol	2001
92	NR	Organization and transcriptional analysis of a six-gene cluster around the rplK-rplA operon of Corynebacterium glutamicum encoding the ribosomal proteins L11 and L1.	11319098	Appl Environ Microbiol	2001
92	NR	Cryo-electron microscopic localization of protein L7/L12 within the Escherichia coli 70 S ribosome by difference mapping and Nanogold labeling.	11278411	J Biol Chem	2001
92	NR	A universal mode of helix packing in RNA.	11276255	Nat Struct Biol	2001
92	PR	The immunoprotective MHC II epitope of a chemically induced tumor harbors a unique mutation in a ribosomal protein.	11274422	Proc Natl Acad Sci U S A	2001
92	NR	Loss of ribosomal protein L11 blocks stress activation of the Bacillus subtilis transcription factor sigma(B).	11244072	J Bacteriol	2001
92	NR	Identification of the 50S ribosomal proteins from the Eubacterium Thermus thermophilus.	11154066	Biol Chem	2000
92	NR	Down regulation of ribosomal protein mRNAs during neuronal differentiation of human NTERA2 cells.	11100899	Differentiation	2000
92	NR	Conformational changes induced in the Saccharomyces cerevisiae GTPase-associated rRNA by ribosomal stalk components and a translocation inhibitor.	11071938	Nucleic Acids Res	2000
92	NR	Factors affecting nuclear export of the 60S ribosomal subunit in vivo.	11071906	Mol Biol Cell	2000
92	NR	Sequence, structural, and evolutionary analysis of prokaryotic ribosomal protein L11 methyltransferases.	10997488	Acta Microbiol Pol	2000
92	NR	A covariant change of the two highly conserved bases in the GTPase-associated center of 28 S rRNA in silkworms and other moths.	10960474	J Biol Chem	2000
92	NR	RNA-protein interactions in ribosomes: in vitro selection from randomly fragmented rRNA.	10889993	Methods Enzymol	2000
92	NR	The plastid ribosomal proteins. Identification of all the proteins in the 50 S subunit of an organelle ribosome (chloroplast).	10874046	J Biol Chem	2000
92	NR	Crystal structure of the ffh and EF-G binding sites in the conserved domain IV of Escherichia coli 4.5S RNA.	10801497	Structure Fold Des	2000
92	NR	The 3D arrangement of the 23 S and 5 S rRNA in the Escherichia coli 50 S ribosomal subunit based on a cryo-electron microscopic reconstruction at 7.5 A resolution.	10756104	J Mol Biol	2000
92	NR	The RNA-binding domain of ribosomal protein L11 recognizes an rRNA tertiary structure stabilized by both thiostrepton and magnesium ion.	10734197	Nucleic Acids Res	2000
92	NR	Contributions of basic residues to ribosomal protein L11 recognition of RNA.	10623547	J Mol Biol	2000
92	NR	Ribosomal protein gene expression is cell type specific during development in Dictyostelium discoideum.	10550541	Differentiation	1999
92	NR	[Computer analysis of regulatory signals in complete bacterial genomes. Translation initiation of ribosomal protein operons]	10544808	Biofizika	1999
92	NR	Molecular cloning of the dnaK gene region from Bacillus sphaericus in the context of genomic comparisons.	10518301	Microb Comp Genomics	1999
92	NR	Comment in:     Nature. 1999 Aug 26;400(6747):811-2.	10476961	Nature	1999
92	NR	Control of ribosomal protein L1 synthesis in mesophilic and thermophilic archaea.	10430567	Genetics	1999
92	NR	Resistance of ribosomal protein mRNA translation to protein synthesis shutoff induced by poliovirus.	10400812	J Virol	1999
92	NR	Mapping the ribosomal RNA neighborhood of protein L11 by directed hydroxyl radical probing.	10366501	J Mol Biol	1999
92	DR	Human bleomycin hydrolase binds ribosomal proteins.	10353821	Biochemistry	1999
92	NR	Assignment of the L11 ribosomal protein gene (RPL11) to human chromosome 1p36.1-->p35 by in situ hybridization.	10343117	Cytogenet Cell Genet	1999
92	NR	Comment in:     Cell. 1999 May 14;97(4):423-6.	10338213	Cell	1999
92	NR	Comment on:     Cell. 1999 May 14;97(4):491-502.	10338205	Cell	1999
92	NR	Structural and functional studies on the overproduced L11 protein from Thermus thermophilus.	10333296	J Protein Chem	1999
92	NR	Crystal structure of a conserved ribosomal protein-RNA complex.	10325228	Science	1999
92	NR	Protein-RNA sequence covariation in a ribosomal protein-rRNA complex.	10090750	Biochemistry	1999
92	NR	The antibiotic micrococcin acts on protein L11 at the ribosomal GTPase centre.	10074405	J Mol Biol	1999
92	NR	Sequence analysis of the ribosomal L11 protein gene (rplK=relC) in Streptomyces lavendulae using a deletion allele.	9917010	J Antibiot (Tokyo)	1998
92	NR	Green fluorescent proteins with short half-lives as reporters in Dictyostelium discoideum.	9914420	Dev Genes Evol	1999
92	NR	RNA binding strategies of ribosomal proteins.	9862955	Nucleic Acids Res	1999
92	NR	Comment in:     Int J Syst Evol Microbiol. 2003 Sep;53(Pt 5):1697-8.	9828420	Int J Syst Bacteriol	1998
92	NR	Comparative ribosomal protein (L11 and L30) sequence analyses of several Streptomyces spp. commonly used in genetic studies.	9731302	Int J Syst Bacteriol	1998
92	NR	Thermus thermophilus L11 ribosomal protein: cloning, overproduction, structural, and functional studies--in vivo methylation of the overproduced protein.	9723724	J Protein Chem	1998
92	NR	A functional ribosomal RNA tertiary structure involves a base triple interaction.	9718323	Biochemistry	1998
92	NR	The solution structure of ribosomal protein S4 delta41 reveals two subdomains and a positively charged surface that may interact with RNA.	9707416	EMBO J	1998
92	NR	Efficient in vitro translational termination in Escherichia coli is constrained by the orientations of the release factor, stop signal and peptidyl-tRNA within the termination complex.	9705149	Biol Chem	1998
92	NR	A novel cell-free system for peptide synthesis driven by pyridine.	9705145	Biol Chem	1998
92	NR	Structure and dynamics of ribosomal RNA.	9666324	Curr Opin Struct Biol	1998
92	NR	A ribosomal protein gene cluster is encoded in the mitochondrial DNA of Dictyostelium discoideum: UGA termination codons and similarity of gene order to Acanthamoeba castellanii.	9560439	Curr Genet	1998
92	NR	The antibiotic thiostrepton inhibits a functional transition within protein L11 at the ribosomal GTPase centre.	9512711	J Mol Biol	1998
92	NR	Cloning and transcriptional analysis of the rplKA-or f31-rplJL gene cluster of Streptomyces griseus.	9491081	Mol Gen Genet	1998
92	NR	MvaL1 autoregulates the synthesis of the three ribosomal proteins encoded on the MvaL1 operon of the archaeon Methanococcus vannielii by inhibiting its own translation before or at the formation of the first peptide bond.	9484899	Mol Microbiol	1998
92	NR	Cross-linking of selected residues in the N- and C-terminal domains of Escherichia coli protein L7/L12 to other ribosomal proteins and the effect of elongation factor Tu.	9430711	J Biol Chem	1998
92	NR	The RNA binding domain of ribosomal protein L11: three-dimensional structure of the RNA-bound form of the protein and its interaction with 23 S rRNA.	9398519	J Mol Biol	1997
92	NR	Affinities and selectivities of divalent cation binding sites within an RNA tertiary structure.	9367788	J Mol Biol	1997
92	NR	Molecular and functional analysis of the ribosomal L11 and S12 protein genes (rplK and rpsL) of Streptomyces coelicolor A3(2).	9413432	Mol Gen Genet	1997
92	NR	Proteins on ribosome surface: measurements of protein exposure by hot tritium bombardment technique.	9371771	Proc Natl Acad Sci U S A	1997
92	NR	Molecular analysis of the ribosomal L11 protein gene (rplK = relC) of Streptomyces griseus and identification of a deletion allele.	9323358	Mol Gen Genet	1997
92	NR	Identification and characterization of an operon of Helicobacter pylori that is involved in motility and stress adaptation.	9244252	J Bacteriol	1997
92	NR	Nucleotide sequence of a gene cluster encoding NusG and the L11-L1-L10-L12 ribosomal proteins from the thermophilic archaeon Sulfolobus solfataricus.	9252104	Biochim Biophys Acta	1997
92	NR	The eukaryotic translation initiation factor 5, eIF-5, a protein from Zea mays, containing a zinc-finger structure, binds nucleic acids in a zinc-dependent manner.	9240471	Biochem Biophys Res Commun	1997
92	NR	The yeast ORF YDL202w codes for the mitochondrial ribosomal protein YmL11.	9162110	Curr Genet	1997
92	NR	Evolutionary divergence and salinity-mediated selection in halophilic archaea.	9106366	Microbiol Mol Biol Rev	1997
92	NR	Molecular characterization of the prokaryotic efp gene product involved in a peptidyltransferase reaction.	9195040	Biochimie	1997
92	NR	High resolution solution structure of ribosomal protein L11-C76, a helical protein with a flexible loop that becomes structured upon binding to RNA.	8989327	Nat Struct Biol	1997
92	NR	The RNA binding domain of ribosomal protein L11 is structurally similar to homeodomains.	8989317	Nat Struct Biol	1997
92	NR	Structure of a U.U pair within a conserved ribosomal RNA hairpin.	8758993	Nucleic Acids Res	1996
92	NR	The unique organization of the rpoB region of Spiroplasma citri: a restriction and modification system gene is adjacent to rpoB.	8675039	Gene	1996
92	NR	Gene organization in the ada-rplL region of Streptomyces virginiae.	8675024	Gene	1996
92	NR	Cooperative interactions of RNA and thiostrepton antibiotic with two domains of ribosomal protein L11.	8634289	Biochemistry	1996
92	NR	UGA suppression by a mutant RNA of the large ribosomal subunit.	8618891	Proc Natl Acad Sci U S A	1995
92	NR	A base substitution within the GTPase-associated domain of mammalian 28 S ribosomal RNA causes high thiostrepton accessibility.	8530386	J Biol Chem	1995
92	NR	Recognition determinants for proteins and antibiotics within 23S rRNA.	8722035	Biochem Cell Biol	1995
92	NR	Proteins P1, P2, and P0, components of the eukaryotic ribosome stalk. New structural and functional aspects.	8722011	Biochem Cell Biol	1995
92	NR	Variety of nonsense suppressor phenotypes associated with mutational changes at conserved sites in Escherichia coli ribosomal RNA.	8722008	Biochem Cell Biol	1995
92	NR	On the role of rRNA tertiary structure in recognition of ribosomal protein L11 and thiostrepton.	7567452	Nucleic Acids Res	1995
92	NR	Cooperative assembly of proteins in the ribosomal GTPase centre demonstrated by their interactions with mutant 23S rRNAs.	7630717	Nucleic Acids Res	1995
92	NR	Mitochondrial ribosomal protein L11 gene of Dictyostelium discoideum resides not in the nuclear genome but in the mitochondrial genome.	8581739	DNA Res	1995
92	NR	Stabilization of a ribosomal RNA tertiary structure by ribosomal protein L11.	7783196	J Mol Biol	1995
92	NR	Cloning and characterization of the ribosomal l11 gene from Leishmania spp.	7477109	Mol Biochem Parasitol	1995
92	NR	Cloning, nucleotide sequence, and transcriptional analysis of the nusG gene of Streptomyces coelicolor A3(2), which encodes a putative transcriptional antiterminator.	7715599	Mol Gen Genet	1995
92	NR	Molecular cloning of the Drosophila homologue of the rat ribosomal protein L11 gene.	7893752	Biochim Biophys Acta	1995
92	NR	[Cloning and determination of the primary structure of DNA complementary to the mRNA of human ribosomal protein L11]	7748210	Bioorg Khim	1995
92	NR	Mutations at three sites in the Escherichia coli 23S ribosomal RNA binding region for protein L11 cause UGA-specific suppression and conditional lethality.	8643403	Nucleic Acids Symp Ser	1995
92	NR	Protein recognition of a ribosomal RNA tertiary structure.	8643396	Nucleic Acids Symp Ser	1995
92	NR	Ribosomal protein methylation in Escherichia coli: the gene prmA, encoding the ribosomal protein L11 methyltransferase, is dispensable.	7715456	Mol Microbiol	1994
92	NR	Structure and transcription of the L11-L1-L10-L12 ribosomal protein gene operon from the extreme thermophilic archaeon Sulfolobus acidocaldarius.	7966335	J Mol Biol	1994
92	NR	Overexpression of the thiostrepton-resistance gene from Streptomyces azureus in Escherichia coli and characterization of recognition sites of the 23S rRNA A1067 2'-methyltransferase in the guanosine triphosphatase center of 23S ribosomal RNA.	7925357	Eur J Biochem	1994
92	NR	Synthesis of ribosomal proteins during growth of Streptomyces coelicolor.	7545948	Mol Microbiol	1994
92	NR	Molecular phylogenies based on ribosomal protein L11, L1, L10, and L12 sequences.	8007008	J Mol Evol	1994
92	NR	Location of the streptomycin ribosomal binding site explains its pleiotropic effects on protein biosynthesis.	7508514	J Mol Biol	1994
92	NR	Autogenous translational regulation of the ribosomal MvaL1 operon in the archaebacterium Methanococcus vannielii.	8288536	J Bacteriol	1994
92	NR	[Study of segments of 23S RNA, important for interaction with elongation factors Tu and G using complementary DNA-oligonucleotides]	8145758	Mol Biol (Mosk)	1994
93	PR	D2 and D4 dopamine receptor gene polymorphisms and personality traits in a young Korean population.	12898574	Am J Med Genet B Neuropsychiatr Genet	2003
93	DR	Olanzapine reduces craving for alcohol: a DRD4 VNTR polymorphism by pharmacotherapy interaction.	12888781	Neuropsychopharmacology	2003
93	NR	Population genetics. Seeking the signs of selection.	12434033	Science	2002
93	DR	Dopamine D 4 receptor gene polymorphism and extraversion revisited: results from the Munich gene bank project for alcoholism.	12393313	J Psychiatr Res	2002
93	DR	The DRD4 VNTR polymorphism moderates craving after alcohol consumption.	11950104	Health Psychol	2002
93	DR	Absence of dopamine D4 receptors results in enhanced reactivity to unconditioned, but not conditioned, fear.	11860516	Eur J Neurosci	2002
93	PR	The discovery of PD 89211 and related compounds: selective dopamine D4 receptor antagonists.	11817497	Prog Neuropsychopharmacol Biol Psychiatry	2002
93	PR	Effects of morphine withdrawal on catecholaminergic neurons on heart right ventricle; implication of dopamine receptors.	11697748	Can J Physiol Pharmacol	2001
93	NR	The activation of dopamine D4 receptors inhibits oxidative stress-induced nerve cell death.	11487630	J Neurosci	2001
93	DR	[Genetics of addictive disorders]	11347517	Rev Med Chil	2000
93	NR	An in-frame deletion in the alpha(2C) adrenergic receptor is common in African--Americans.	11317218	Mol Psychiatry	2001
93	DR	DRD4 and DAT1 as modifying genes in alcoholism: interaction with novelty seeking on level of alcohol consumption.	11244477	Mol Psychiatry	2001
93	DR	Extraversion. Interaction between D2 dopamine receptor polymorphisms and parental alcoholism.	11163121	Alcohol	2000
93	DR	Reward deficiency syndrome: genetic aspects of behavioral disorders.	11105655	Prog Brain Res	2000
93	PR	The dopamine D(4) receptor gene and novelty seeking.	11058499	Am J Psychiatry	2000
93	NR	Pharmacological characterization of dopamine receptors in the corpus allatum of Manduca sexta larvae.	10876119	Insect Biochem Mol Biol	2000
93	PR	Cloning, expression, functional coupling and pharmacological characterization of the rat dopamine D4 receptor.	10832611	Naunyn Schmiedebergs Arch Pharmacol	2000
93	DR	Association study between genetic polymorphisms in the 14-3-3 eta chain and dopamine D4 receptor genes and alcoholism.	10776673	Alcohol Clin Exp Res	2000
93	PR	Comparative pharmacological and functional analysis of the human dopamine D4.2 and D4.10 receptor variants.	10591536	Pharmacogenetics	1999
93	DR	Linkage studies of D2 and D4 receptor genes and alcoholism.	10581489	Am J Med Genet	1999
93	DR	Personality traits and dopamine receptors (D2 and D4): linkage studies in families of alcoholics.	10581482	Am J Med Genet	1999
93	DR	Dopamine D4 receptor gene and personality dimensions in Brazilian male alcoholics.	10551544	Psychiatr Genet	1999
93	DR	Human chromosomes 11p15 and 4p12 and alcohol dependence: possible association with the GABRB1 gene.	10490712	Am J Med Genet	1999
93	DR	Clozapine's effects on ethanol's motivational properties.	10470981	Alcohol Clin Exp Res	1999
93	DR	[Hereditary alcoholism: some neurochemical and genetic mechanisms]	10432864	Vestn Ross Akad Med Nauk	1999
93	DR	Dopamine D4 receptor gene: novelty or nonsense?	10379515	Neuropsychopharmacology	1999
93	NR	Dopamine activation of endogenous cannabinoid signaling in dorsal striatum.	10204543	Nat Neurosci	1999
93	NR	Dopamine D4-like binding sites labeled by [3H]nemonapride include substantial serotonin 5-HT2A receptors in primate cerebral cortex.	10049714	Biochem Biophys Res Commun	1999
93	NR	Isoindolinone enantiomers having affinity for the dopamine D4 receptor.	9873377	Bioorg Med Chem Lett	1998
93	DR	Dopamine receptors and dopamine transporter in brain function and addictive behaviors: insights from targeted mouse mutants.	9691193	Dev Neurosci	1998
93	NR	Dopamine inhibits vasopressin-dependent cAMP production in the rat cortical collecting duct.	9689005	Am J Physiol	1998
93	PR	D2 and D4 dopamine receptor polymorphisms and personality.	9603615	Am J Med Genet	1998
93	PR	Evidence for genetic linkage to alcohol dependence on chromosomes 4 and 11 from an autosome-wide scan in an American Indian population.	9603607	Am J Med Genet	1998
93	NR	Mapping genes for personality: is the saga sagging?	9577832	Mol Psychiatry	1998
93	NR	Expression and characterization of a dopamine D4R variant associated with delusional disorder.	9489994	FEBS Lett	1998
93	DR	No association between novelty seeking and the type 4 dopamine receptor gene (DRD4) in two New Zealand samples.	9433345	Am J Psychiatry	1998
93	DR	Dopamine receptor gene expression in an animal model of 'behavioral dependence' on ethanol.	9406938	Brain Res Mol Brain Res	1997
93	NR	Structural and functional characteristics of the dopamine D4 receptor.	9327945	Adv Pharmacol	1998
93	DR	Dopamine D4 receptor exon III alleles and variation of novelty seeking in alcoholics.	9342196	Am J Med Genet	1997
93	DR	Mice lacking dopamine D4 receptors are supersensitive to ethanol, cocaine, and methamphetamine.	9323127	Cell	1997
93	NR	[Neurochemistry of Parkinson's disease and parkinsonism plus]	9280680	Rev Neurol	1997
93	NR	Activation of type II adenylate cyclase by D2 and D4 but not D3 dopamine receptors.	9271339	Mol Pharmacol	1997
93	DR	Alcoholism and gene polymorphisms related to central dopaminergic transmission in the Japanese population.	9285967	Psychiatr Genet	1997
93	NR	In vitro and in vivo characterization of the dopamine D4 receptor, serotonin 5-HT2A receptor and alpha-1 adrenoceptor antagonist (R)-(+)-2-amino-4-(4-fluorophenyl)-5-[1-[4-(4-fluorophenyl)-4-oxobutyl] pyrrolidin-3-yl]thiazole (NRA0045).	9223539	J Pharmacol Exp Ther	1997
93	NR	The effects of a selective D4 dopamine receptor antagonist (L-745,870) in acutely psychotic inpatients with schizophrenia. D4 Dopamine Antagonist Group.	9193198	Arch Gen Psychiatry	1997
93	DR	No association between polymorphisms in the human dopamine D3 and D4 receptors genes and alcoholism.	9184311	Am J Med Genet	1997
93	PR	Excess dopamine D4 receptor (D4DR) exon III seven repeat allele in opioid-dependent subjects.	9152990	Mol Psychiatry	1997
93	DR	The dopamine D4 receptor gene (DRD4) is not associated with alcoholism in three Taiwanese populations: six polymorphisms tested separately and as haplotypes.	9034534	Biol Psychiatry	1997
93	DR	Tyrosine hydroxylase and dopamine D4 receptor allelic distribution in Scandinavian chronic alcoholics.	9046370	Alcohol Clin Exp Res	1997
93	NR	Epinephrine and norepinephrine act as potent agonists at the recombinant human dopamine D4 receptor.	9003072	J Neurochem	1997
93	NR	Noradrenaline and adrenaline are high affinity agonists at dopamine D4 receptors.	9042615	Eur J Pharmacol	1997
93	NR	Dopamine-related genes and their relationships to monoamine metabolites in CSF.	8915563	Biol Psychiatry	1996
93	DR	The association between the dopamine D4 receptor (D4DR) 16 amino acid repeat polymorphism and novelty seeking.	9154232	Mol Psychiatry	1996
93	DR	Association between alcoholism and the dopamine D4 receptor gene.	8929946	J Med Genet	1996
93	DR	DRD4 dopamine receptor genotype and CSF monoamine metabolites in Finnish alcoholics and controls.	7573171	Am J Med Genet	1995
93	NR	Receptor mechanisms mediating clozapine-induced c-fos expression in the forebrain.	7609873	Neuroscience	1995
93	NR	Candidate genes in alcoholism.	8612062	Clin Neurosci	1995
93	NR	Pharmacological and functional characterization of D2, D3 and D4 dopamine receptors in fibroblast and dopaminergic cell lines.	8301592	J Pharmacol Exp Ther	1994
93	NR	The role of dopamine in the regulation of melatonin biosynthesis in vertebrate retina.	7801792	Acta Neurobiol Exp (Wars)	1994
94	DR	Pluripotential mechanisms of cardioprotection with HMG-CoA reductase inhibitor therapy.	14728000	Am J Cardiovasc Drugs	2001
94	PR	Lovastatin inhibits Rho-regulated expression of E-selectin by TNFalpha and attenuates tumor cell adhesion.	14630701	FASEB J	2004
94	NR	Molecular regulation of cholesterol biosynthesis: implications in carcinogenesis.	14533871	J Environ Pathol Toxicol Oncol	2003
94	PR	The beta-catenin/VegT-regulated early zygotic gene Xnr5 is a direct target of SOX3 regulation.	14522872	Development	2003
94	PR	Pneumocystis carinii STE11, an HMG-box protein, is phosphorylated by the mitogen activated protein kinase PCM.	12909353	Gene	2003
94	DR	Parallel analysis of tagged deletion mutants efficiently identifies genes involved in endoplasmic reticulum biogenesis.	12868057	Yeast	2003
94	DR	HMG-CoA reductase inhibitors inhibit inducible nitric oxide synthase gene expression in macrophages.	12824699	J Biomed Sci	2003
94	PR	HMG box transcription factor TCF-4's interaction with CtBP1 controls the expression of the Wnt target Axin2/Conductin in human embryonic kidney cells.	12711682	Nucleic Acids Res	2003
94	NR	Pax6 autoregulation mediated by direct interaction of Pax6 protein with the head surface ectoderm-specific enhancer of the mouse Pax6 gene.	12710953	Dev Biol	2003
94	PR	Induction of the Sry-related factor SOX6 contributes to bone morphogenetic protein-2-induced chondroblastic differentiation of C3H10T1/2 cells.	12677004	Mol Endocrinol	2003
94	DR	Histone deacetylase inhibitors stimulate mitochondrial HMG-CoA synthase gene expression via a promoter proximal Sp1 site.	12626711	Nucleic Acids Res	2003
94	PR	Atorvastatin inhibits expression of minichromosome maintenance proteins in vascular smooth muscle cells.	12591091	Eur J Pharmacol	2003
94	PR	Expression pattern and transcriptional control of SoxB1 in embryos of the ascidian Halocynthia roretzi.	12560602	Zoolog Sci	2003
94	NR	Neural crest patterning: autoregulatory and crest-specific elements co-operate for Krox20 transcriptional control.	12538520	Development	2003
94	PR	HMG-CoA reductase inhibitors regulate inflammatory transcription factors in human endothelial and vascular smooth muscle cells.	12524225	Arterioscler Thromb Vasc Biol	2003
94	PR	Mouse mu opioid receptor distal promoter transcriptional regulation by SOX proteins.	12446692	J Biol Chem	2003
94	NR	New insights in the transcriptional activity and coregulator molecules in the arterial wall.	12419552	Int J Cardiol	2002
94	NR	Molecular regulation of vertebrate early endoderm development.	12221001	Dev Biol	2002
94	PR	3-Hydroxy-3-methylglutaryl coenzyme A reductase inhibitors increase the binding activity and nuclear level of Oct-1 in mononuclear cells.	12144930	Eur J Pharmacol	2002
94	DR	Proteolysis and sterol regulation.	12142284	Annu Rev Cell Dev Biol	2002
94	NR	Dynamics of a developmental switch: recursive intracellular and intranuclear redistribution of Caenorhabditis elegans POP-1 parallels Wnt-inhibited transcriptional repression.	12142026	Dev Biol	2002
94	NR	Erratum in:     Atherosclerosis. 2003 Jun;167(2):371.	12119189	Atherosclerosis	2002
94	DR	Specificity of the stimulatory interaction between chromosomal HMGB proteins and the transcription factor Dof2 and its negative regulation by protein kinase CK2-mediated phosphorylation.	12065590	J Biol Chem	2002
94	DR	A core-BRAF35 complex containing histone deacetylase mediates repression of neuronal-specific genes.	12032298	Proc Natl Acad Sci U S A	2002
94	NR	Differences in the regulation of the classical and the alternative pathway for bile acid synthesis in human liver. No coordinate regulation of CYP7A1 and CYP27A1.	12011083	J Biol Chem	2002
94	DR	HMG-1 as regulatory trans-acting protein in the acute phase-induced expression of the rat liver haptoglobin gene.	11989650	Gen Physiol Biophys	2001
94	NR	TCF: Lady Justice casting the final verdict on the outcome of Wnt signalling.	11934263	Biol Chem	2002
94	DR	High-mobility group-I/Y proteins: Potential role in the pathophysiology of critical illnesses.	11891405	Crit Care Med	2002
94	NR	EGFR signalling inhibits Capicua-dependent repression during specification of Drosophila wing veins.	11861482	Development	2002
94	NR	Enhanced antitumor activities of TZT-1027 against TNF-alpha or IL-6 secreting Lewis lung carcinoma in vivo.	11855751	Cancer Chemother Pharmacol	2002
94	NR	Transcriptional profiling of cell lines derived from an orthotopic pancreatic tumor model reveals metastasis-associated genes.	11848476	Anticancer Res	2001
94	NR	Tissue-specific transcriptional regulation of the cholesterol biosynthetic pathway leads to accumulation of testis meiosis-activating sterol (T-MAS).	11792726	J Lipid Res	2002
94	DR	High-mobility group-I/Y proteins: potential role in the pathophysiology of critical illnesses.	11782559	Crit Care Med	2002
94	NR	Effects of plant stanol esters on LDL receptor protein expression and on LDL receptor and HMG-CoA reductase mRNA expression in mononuclear blood cells of healthy men and women.	11772951	FASEB J	2002
94	DR	HMGB1 and HMGB2 cell-specifically down-regulate the p53- and p73-dependent sequence-specific transactivation from the human Bax gene promoter.	11748232	J Biol Chem	2002
94	PR	A POP-1 repressor complex restricts inappropriate cell type-specific gene transcription during Caenorhabditis elegans embryogenesis.	11742996	EMBO J	2001
94	NR	Downregulation of angiotensin II type 1 receptor by hydrophobic 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors in vascular smooth muscle cells.	11742861	Arterioscler Thromb Vasc Biol	2001
94	DR	Comment in:     Mol Cell. 2001 Nov;8(5):932-3.	11741541	Mol Cell	2001
94	NR	Regulation of lipid metabolism and gene expression by fenofibrate in hamsters.	11731332	Biochim Biophys Acta	2001
94	NR	Novel human HALR (MLL3) gene encodes a protein homologous to ALR and to ALL-1 involved in leukemia, and maps to chromosome 7q36 associated with leukemia and developmental defects.	11718452	Cancer Detect Prev	2001
94	NR	Diverse effects of inhibition of 3-hydroxy-3-methylglutaryl-CoA reductase on the expression of VCAM-1 and E-selectin in endothelial cells.	11716764	Biochem J	2001
94	PR	3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors upregulate inducible NO synthase expression and activity in vascular smooth muscle cells.	11711492	Hypertension	2001
94	NR	Lovastatin-induced E2F-1 modulation and its effect on prostate cancer cell death.	11577016	Carcinogenesis	2001
94	PR	SOX18 directly interacts with MEF2C in endothelial cells.	11554755	Biochem Biophys Res Commun	2001
94	NR	Quantitative effects on gene silencing by allelic variation at a tetranucleotide microsatellite.	11532988	Hum Mol Genet	2001
94	PR	Negative regulation of the Wnt-beta-catenin pathway by the transcriptional repressor HBP1.	11500377	EMBO J	2001
94	NR	Characterization of an SRY-like gene, DSox14, from Drosophila.	11470517	Gene	2001
94	NR	Simvastatin reduces reperfusion injury by modulating nitric oxide synthase expression: an ex vivo study in isolated working rat hearts.	11470468	Cardiovasc Res	2001
94	NR	Spt16-Pob3 and the HMG protein Nhp6 combine to form the nucleosome-binding factor SPN.	11432837	EMBO J	2001
94	NR	Statin-induced inhibition of the Rho-signaling pathway activates PPARalpha and induces HDL apoA-I.	11390424	J Clin Invest	2001
94	PR	Requirement for high mobility group protein HMGI-C interaction with STAT3 inhibitor PIAS3 in repression of alpha-subunit of epithelial Na+ channel (alpha-ENaC) transcription by Ras activation in salivary epithelial cells.	11390395	J Biol Chem	2001
94	NR	Low activity of mitochondrial HMG-CoA synthase in liver of starved piglets is due to low levels of protein despite high mRNA levels.	11368018	Arch Biochem Biophys	2001
94	PR	Interaction of FACT, SSRP1, and the high mobility group (HMG) domain of SSRP1 with DNA damaged by the anticancer drug cisplatin.	11344167	J Biol Chem	2001
94	NR	3-Hydroxy-3-methylglutaryl coenzyme A synthase-1 of Blattella germanica has structural and functional features of an active retrogene.	11222952	Insect Biochem Mol Biol	2001
94	NR	SRYand architectural gene regulation: the kinetic stability of a bent protein-DNA complex can regulate its transcriptional potency.	11222738	Mol Endocrinol	2001
94	NR	The HMG-CoA reductase inhibitor simvastatin inhibits IFN-gamma induced MHC class II expression in human vascular endothelial cells.	11219190	Swiss Med Wkly	2001
94	DR	Coevolution of HMG domains and homeodomains and the generation of transcriptional regulation by Sox/POU complexes.	11169970	J Cell Physiol	2001
94	NR	Induction and repression of DAN1 and the family of anaerobic mannoprotein genes in Saccharomyces cerevisiae occurs through a complex array of regulatory sites.	11160904	Nucleic Acids Res	2001
94	NR	dTcf antagonises Wingless signalling during the development and patterning of the wing in Drosophila.	11128568	Int J Dev Biol	2000
94	PR	Chromatin-mediated transcriptional regulation by the yeast architectural factors NHP6A and NHP6B.	11118215	EMBO J	2000
94	PR	The oncogenic potential of the high mobility group box protein Sox3.	11103788	Cancer Res	2000
94	PR	High-mobility-group protein I can modulate binding of transcription factors to the U5 region of the human immunodeficiency virus type 1 proviral promoter.	11044097	J Virol	2000
94	DR	Distinct organization of DNA complexes of various HMGI/Y family proteins and their modulation upon mitotic phosphorylation.	11034995	J Biol Chem	2001
94	NR	The architectural transcription factor high mobility group I(Y) participates in photoreceptor-specific gene expression.	11007889	J Neurosci	2000
94	NR	Contribution of steroidogenic factor 1 to the regulation of cholesterol synthesis.	10970793	Biochem J	2000
94	DR	HMG-I/Y, a new c-Myc target gene and potential oncogene.	10891489	Mol Cell Biol	2000
94	DR	HMG I/Y regulates long-range enhancer-dependent transcription on DNA and chromatin by changes in DNA topology.	10871404	Nucleic Acids Res	2000
94	NR	Characterization and regulation of Leishmania major 3-hydroxy-3-methylglutaryl-CoA reductase.	10861207	Biochem J	2000
94	PR	Binding of HMG-I(Y) imparts architectural specificity to a positioned nucleosome on the promoter of the human interleukin-2 receptor alpha gene.	10848593	Mol Cell Biol	2000
94	NR	Transcriptional regulation of the ATP citrate-lyase gene by sterol regulatory element-binding proteins.	10777536	J Biol Chem	2000
94	NR	New molecular targets for cholesterol-lowering therapy.	10772997	J Pharmacol Exp Ther	2000
94	NR	A beta-catenin/engrailed chimera selectively suppresses Wnt signaling.	10769207	J Cell Sci	2000
94	DR	The regulatory effects of thyroid hormone on the activity of 3-hydroxy-3-methylglutaryl coenzyme A reductase.	10711719	Endocr Res	2000
94	NR	NBP-45, a novel nucleosomal binding protein with a tissue-specific and developmentally regulated expression.	10692437	J Biol Chem	2000
94	PR	Sterol regulatory element binding protein-mediated effect of fluvastatin on cytosolic 3-hydroxy-3-methylglutaryl-coenzyme A synthase transcription.	10666309	Arch Biochem Biophys	2000
94	NR	Transcriptional control in myelinating glia: the basic recipe.	10625329	Glia	2000
94	NR	Modulation of rat liver apolipoprotein gene expression and serum lipid levels by tetradecylthioacetic acid (TTA) via PPARalpha activation.	10553013	J Lipid Res	1999
94	NR	Deoxycholic acid treatment in patients with cholesterol gallstones: failure to detect a suppression of cholesterol 7alpha-hydroxylase activity.	10583711	J Intern Med	1999
94	PR	The Yin-Yang of TCF/beta-catenin signaling.	10549354	Adv Cancer Res	2000
94	NR	Two distinct subgroups of Group B Sox genes for transcriptional activators and repressors: their expression during embryonic organogenesis of the chicken.	10473124	Mech Dev	1999
94	NR	Isoprenoid-mediated inhibition of mevalonate synthesis: potential application to cancer.	10460692	Proc Soc Exp Biol Med	1999
94	PR	XCtBP is a XTcf-3 co-repressor with roles throughout Xenopus development.	10375506	Development	1999
94	PR	Transcriptional regulation of T lymphocyte development and function.	10358756	Annu Rev Immunol	1999
94	DR	The role of HMG I(Y) in the assembly and function of the IFN-beta enhanceosome.	10357819	EMBO J	1999
94	NR	Regulation of the expression and activity by progestins of a member of the SOX gene family of transcriptional modulators.	10343288	J Mol Endocrinol	1999
94	NR	YY1 is a negative regulator of transcription of three sterol regulatory element-binding protein-responsive genes.	10318878	J Biol Chem	1999
94	NR	Plant chromosomal HMGI/Y proteins and histone H1 exhibit a protein domain of common origin.	10196467	Gene	1999
94	NR	Transcriptional arrest of the human E-selectin gene.	10090829	J Surg Res	1999
94	NR	Recruitment of TATA-binding protein-TAFI complex SL1 to the human ribosomal DNA promoter is mediated by the carboxy-terminal activation domain of upstream binding factor (UBF) and is regulated by UBF phosphorylation.	10082553	Mol Cell Biol	1999
94	NR	Multiple layers of cooperativity regulate enhanceosome-responsive RNA polymerase II transcription complex assembly.	10082527	Mol Cell Biol	1999
94	PR	Mitochondrial 3-hydroxy-3-methylglutaryl-CoA synthase: a control enzyme in ketogenesis.	10051425	Biochem J	1999
94	NR	Characterisation and mapping of the human SOX14 gene.	9925951	Cytogenet Cell Genet	1998
94	DR	Transcriptional regulation of mitochondrial HMG-CoA synthase in the control of ketogenesis.	9893938	Biochimie	1998
94	NR	DSP1 gene of Drosophila melanogaster encodes an HMG-domain protein that plays multiple roles in development.	9883584	Dev Genet	1998
94	DR	Induction of high mobility group-I(Y) protein by endotoxin and interleukin-1beta in vascular smooth muscle cells. Role in activation of inducible nitric oxide synthase.	9880529	J Biol Chem	1999
94	NR	The MSN1 and NHP6A genes suppress SWI6 defects in Saccharomyces cerevisiae.	9872947	Genetics	1999
94	NR	HMG-CoA reductase regulation: use of structurally diverse first half-reaction squalene synthetase inhibitors to characterize the site of mevalonate-derived nonsterol regulator production in cultured IM-9 cells.	9869647	J Lipid Res	1999
94	NR	Characterization of two Chinese hamster ovary cell lines expressing the COOH-terminal domains of sterol regulatory element-binding protein (SREBP)-1.	9855111	Cell Struct Funct	1998
94	NR	A mitochondrial ketogenic enzyme regulates its gene expression by association with the nuclear hormone receptor PPARalpha.	9843503	EMBO J	1998
94	NR	The mating-type proteins of fission yeast induce meiosis by directly activating mei3 transcription.	9819418	Mol Cell Biol	1998
94	PR	Acetylation of HMG I(Y) by CBP turns off IFN beta expression by disrupting the enhanceosome.	9809067	Mol Cell	1998
94	NR	Alx-4, a transcriptional activator whose expression is restricted to sites of epithelial-mesenchymal interactions.	9786416	Dev Dyn	1998
94	PR	Effects of differentiation on the transcriptional regulation of the FGF-4 gene: critical roles played by a distal enhancer.	9740330	Mol Reprod Dev	1998
94	NR	Post-transcriptional regulation of endothelial nitric oxide synthase mRNA stability by Rho GTPase.	9727051	J Biol Chem	1998
94	NR	The 5'-AMP-activated protein kinase inhibits the transcriptional stimulation by glucose in liver cells, acting through the glucose response complex.	9708898	FEBS Lett	1998
94	NR	Recruitment of CBP/p300 by the IFN beta enhanceosome is required for synergistic activation of transcription.	9659924	Mol Cell	1998
94	NR	The mechanism of transcriptional synergy of an in vitro assembled interferon-beta enhanceosome.	9659909	Mol Cell	1997
94	NR	CBP is required for sterol-regulated and sterol regulatory element-binding protein-regulated transcription.	9651391	J Biol Chem	1998
94	NR	Rainbow trout Sox24, a novel member of the Sox family, is a transcriptional regulator during oogenesis.	9602142	Gene	1998
94	NR	Gene regulatory functions of Drosophila fish-hook, a high mobility group domain Sox protein.	9622621	Mech Dev	1998
94	DR	Multiple DNA elements for sterol regulatory element-binding protein and NF-Y are responsible for sterol-regulated transcription of the genes for human 3-hydroxy-3-methylglutaryl coenzyme A synthase and squalene synthase.	9604010	J Biochem (Tokyo)	1998
94	PR	Inhibition of the 3-hydroxy-3-methylglutaryl-coenzyme A reductase pathway induces p53-independent transcriptional regulation of p21(WAF1/CIP1) in human prostate carcinoma cells.	9553123	J Biol Chem	1998
94	NR	Molecular approaches for production of pravastatin, a HMG-CoA reductase inhibitor: transcriptional regulation of the cytochrome p450sca gene from Streptomyces carbophilus by ML-236B sodium salt and phenobarbital.	9524240	Gene	1998
94	NR	Hypocholesterolemic effects of the LDL receptor gene transcriptional upregulator CP-230821.	9538248	J Biochem (Tokyo)	1998
94	NR	The HMG domain protein SSRP1/PREIIBF is involved in activation of the human embryonic beta-like globin gene.	9566881	Mol Cell Biol	1998
94	PR	Effect of a coffee lipid (cafestol) on cholesterol metabolism in human skin fibroblasts.	9555953	J Lipid Res	1998
94	PR	Compensatory responses to inhibition of hepatic squalene synthase.	9514656	Arch Biochem Biophys	1998
94	NR	Purification and characterization of the heteromeric transcriptional activator MvaT of the Pseudomonas mevalonii mvaAB operon.	9514272	Protein Sci	1998
94	NR	The hepatocyte nuclear factor 4 (HNF-4) represses the mitochondrial HMG-CoA synthase gene.	9464279	Biochem Biophys Res Commun	1998
94	NR	Sterol regulation of 3-hydroxy-3-methylglutaryl-coenzyme A synthase gene through a direct interaction between sterol regulatory element binding protein and the trimeric CCAAT-binding factor/nuclear factor Y.	9430668	J Biol Chem	1998
94	NR	TCF/LEF factor earn their wings.	9433138	Trends Genet	1997
94	NR	Synergistic activation of the fibroblast growth factor 4 enhancer by Sox2 and Oct-3 depends on protein-protein interactions facilitated by a specific spatial arrangement of factor binding sites.	9343393	Mol Cell Biol	1997
94	DR	Expression of the Sox11 gene in mouse embryos suggests roles in neuronal maturation and epithelio-mesenchymal induction.	9337129	Dev Dyn	1997
94	PR	A beta-catenin/XTcf-3 complex binds to the siamois promoter to regulate dorsal axis specification in Xenopus.	9308964	Genes Dev	1997
94	NR	Chicken ovalbumin upstream-promoter transcription factor (COUP-TF) could act as a transcriptional activator or repressor of the mitochondrial 3-hydroxy-3-methylglutaryl-CoA synthase gene.	9291136	Biochem J	1997
94	PR	Mechanism of repression of RNA polymerase I transcription by the retinoblastoma protein.	9234680	Mol Cell Biol	1997
94	DR	3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors unmask cryptic regulatory mechanisms.	9210653	Arch Biochem Biophys	1997
94	DR	Intra- and intermolecular cooperative binding of high-mobility-group protein I(Y) to the beta-interferon promoter.	9199299	Mol Cell Biol	1997
94	NR	Gene expression of mitochondrial 3-hydroxy-3-methylglutaryl-CoA synthase in a poorly ketogenic mammal: effect of starvation during the neonatal period of the piglet.	9164842	Biochem J	1997
94	NR	ESX: a structurally unique Ets overexpressed early during human breast tumorigenesis.	9129154	Oncogene	1997
94	NR	ALY, a context-dependent coactivator of LEF-1 and AML-1, is required for TCRalpha enhancer function.	9119228	Genes Dev	1997
94	DR	Distamycin prolongs E-selectin expression by interacting with a specific NF-kappaB-HMG-I(Y) binding site in the promoter.	9016563	Nucleic Acids Res	1997
94	DR	High-mobility-group proteins and cancer--an emerging link.	9119878	J Cancer Res Clin Oncol	1997
94	NR	Cloning of the human platelet endothelial cell adhesion molecule-1 promoter and its tissue-specific expression. Structural and functional characterization.	8955189	J Immunol	1996
94	DR	Molecular basis governing primary sex in mammals.	9088107	Jpn J Hum Genet	1996
94	NR	Erratum in:     Mol Cell Biol. 1997 Apr;17(4):2351.	8943338	Mol Cell Biol	1996
94	PR	Lovastatin inhibits gene expression of type-I scavenger receptor in THP-1 human macrophages.	8908154	Biochim Biophys Acta	1996
94	DR	HMG1 interacts with HOX proteins and enhances their DNA binding and transcriptional activation.	8890171	EMBO J	1996
94	NR	Repression of interleukin-2 and interleukin-4 promoters by tumor suppressor protein p53.	8877730	J Interferon Cytokine Res	1996
94	NR	Binding of transcription factors to widely-separated cis-regulatory elements of the murine FGF-4 gene.	8844688	Mol Reprod Dev	1996
94	DR	Analysis of the role of v-rel in transcriptional regulation of high mobility group 14.	8700510	Oncogene	1996
94	PR	Mechanisms of murine RANTES chemokine gene induction by Newcastle disease virus.	8662857	J Biol Chem	1996
94	NR	Identification of two Sox17 messenger RNA isoforms, with and without the high mobility group box region, and their differential expression in mouse spermatogenesis.	8636240	J Cell Biol	1996
94	NR	Transcriptional analysis of the mtA idiomorph of Neurospora crassa identifies two genes in addition to mtA-1.	8628238	Mol Gen Genet	1996
94	NR	Transcriptional regulation of squalene epoxidase by sterols and inhibitors in HeLa cells.	8626488	J Biol Chem	1996
94	PR	Progesterone receptor-induced bending of its target DNA: distinct effects of the A and B receptor forms.	8721984	Mol Endocrinol	1996
94	PR	Mechanisms of transcriptional synergism of eukaryotic genes. The interferon-beta paradigm.	8613258	Hypertension	1996
94	NR	Light suppresses 3-Hydroxy-3-methylglutaryl coenzyme A reductase gene expression in Arabidopsis thaliana.	8742338	Plant Physiol	1996
94	DR	Virus induction of human IFN beta gene expression requires the assembly of an enhanceosome.	8548797	Cell	1995
94	DR	Regulation of intracellular cholesterol metabolism.	8825062	Cell Struct Funct	1995
94	NR	pop-1 encodes an HMG box protein required for the specification of a mesoderm precursor in early C. elegans embryos.	7585963	Cell	1995
94	NR	The length of 5'-untranslated leader sequences influences distribution of 3-hydroxy-3-methylglutaryl-coenzyme A reductase mRNA in polysomes: effects of lovastatin, oxysterols, and mevalonate.	7574724	Arch Biochem Biophys	1995
94	NR	Azalanstat (RS-21607), a lanosterol 14 alpha-demethylase inhibitor with cholesterol-lowering activity.	7646560	Biochem Pharmacol	1995
94	NR	Functional interaction between the POU domain protein Tst-1/Oct-6 and the high-mobility-group protein HMG-I/Y.	7791781	Mol Cell Biol	1995
94	NR	In vivo LDL receptor and HMG-CoA reductase regulation in human lymphocytes and its alterations during aging.	7541292	Arterioscler Thromb Vasc Biol	1995
94	DR	Differential regulation of a multipromoter gene. Selective 12-O-tetradecanoylphorbol-13-acetate induction of a single transcription start site in the HMG-I/Y gene.	7775485	J Biol Chem	1995
94	NR	Regulation of cholesterol 7 alpha-hydroxylase expression by sterols in primary rat hepatocyte cultures.	7665995	J Lipid Res	1995
94	NR	Brefeldin A renders Chinese hamster ovary cells insensitive to transcriptional suppression by 25-hydroxycholesterol.	7713903	J Biol Chem	1995
94	DR	3'-untranslated sequences mediate post-transcriptional regulation of 3-hydroxy-3-methylglutaryl-CoA reductase mRNA by 25-hydroxycholesterol.	7717981	Biochem J	1995
94	NR	The high mobility group transcription factor, SOX4, transactivates the human CD2 enhancer.	7706298	J Biol Chem	1995
94	DR	High mobility group protein 2 functionally interacts with the POU domains of octamer transcription factors.	7720710	EMBO J	1995
94	NR	Post-transcriptional regulation of 3-hydroxy-3-methylglutaryl coenzyme A reductase by mevalonate.	7872789	Arch Biochem Biophys	1995
94	NR	Failure of intravenous infusion of taurocholate to down-regulate cholesterol 7 alpha-hydroxylase in rats with biliary fistulas.	7835596	Gastroenterology	1995
94	NR	Identification of novel cellular genes transcriptionally suppressed by v-src.	7832805	Biochem Biophys Res Commun	1995
94	DR	Stimulation of transcription in cultured cells by high mobility group protein 1: essential role of the acidic carboxyl-terminal region.	7993897	Biochemistry	1994
94	NR	Interaction between a novel F9-specific factor and octamer-binding proteins is required for cell-type-restricted activity of the fibroblast growth factor 4 enhancer.	7969117	Mol Cell Biol	1994
94	NR	[Regulation of gene expression by cholesterol and macrophage scavenger receptor]	7853709	Nippon Rinsho	1994
94	NR	Post-transcriptional regulation of 3-hydroxy-3-methylglutaryl coenzyme A reductase and cholesterol 7 alpha-hydroxylase in rats with subtotal nephrectomy.	7967347	Kidney Int	1994
94	NR	Peroxisome proliferator-activated receptor mediates induction of the mitochondrial 3-hydroxy-3-methylglutaryl-CoA synthase gene by fatty acids.	7913466	J Biol Chem	1994
94	NR	Regulation of cholesterol 7 alpha-hydroxylase gene expression in Hep-G2 cells. Effect of serum, bile salts, and coordinate and noncoordinate regulation with other sterol-responsive genes.	8144506	J Biol Chem	1994
94	NR	Effects of different bile salts on steady-state mRNA levels and transcriptional activity of cholesterol 7 alpha-hydroxylase.	8138269	Hepatology	1994
94	NR	Non-sterol compounds that regulate cholesterogenesis. Analogues of farnesyl pyrophosphate reduce 3-hydroxy-3-methylglutaryl-coenzyme A reductase levels.	8120018	J Biol Chem	1994
94	DR	Functional differences between the two splice variants of the nucleolar transcription factor UBF: the second HMG box determines specificity of DNA binding and transcriptional activity.	8313887	EMBO J	1994
95	NR	IRAS is an anti-apoptotic protein.	15028619	Ann N Y Acad Sci	2003
95	DR	Conjugated linoleic acid inhibits DNA synthesis and induces apoptosis in TSU-Pr1 human bladder cancer cells.	14981924	Anticancer Res	2003
95	DR	The insulin-like growth factors and insulin-signalling systems: an appealing target for breast cancer therapy?	14710369	Horm Metab Res	2003
95	DR	Development of molecular agents for IGF receptor targeting.	14710367	Horm Metab Res	2003
95	DR	Inducible expression of dominant negative insulin-like growth factor I receptor in MCF-7 breast cancer cells.	14709803	Endocrine	2003
95	DR	A fully human monoclonal antibody to the insulin-like growth factor I receptor blocks ligand-dependent signaling and inhibits human tumor growth in vivo.	14695208	Cancer Res	2003
95	DR	Enhanced insulin signaling via Shc in human breast cancer.	14669164	Metabolism	2003
95	NR	A highly conserved NTRK3 C-terminal sequence in the ETV6-NTRK3 oncoprotein binds the phosphotyrosine binding domain of insulin receptor substrate-1: an essential interaction for transformation.	14668342	J Biol Chem	2004
95	NR	Coexpression of insulin receptor-related receptor and insulin-like growth factor 1 receptor correlates with enhanced apoptosis and dedifferentiation in human neuroblastomas.	14654552	Clin Cancer Res	2003
95	DR	Interferons: mechanisms of action and clinical applications.	14624225	Curr Opin Oncol	2003
95	DR	A dominant negative type I insulin-like growth factor receptor inhibits metastasis of human cancer cells.	14615489	J Biol Chem	2004
95	NR	Role of insulin receptor substrates and protein kinase C-zeta in vascular permeability factor/vascular endothelial growth factor expression in pancreatic cancer cells.	14604996	J Biol Chem	2004
95	NR	Insulin down-regulates insulin receptor substrate-2 expression through the phosphatidylinositol 3-kinase/Akt pathway.	14596677	J Endocrinol	2003
95	DR	Selective ovary resistance to insulin signaling in women with polycystic ovary syndrome.	14556818	Fertil Steril	2003
95	NR	Progesterone crosstalks with insulin-like growth factor signaling in breast cancer cells via induction of insulin receptor substrate-2.	14534541	Oncogene	2003
95	NR	Polycystic ovary syndrome: syndrome XX?	14516934	Trends Endocrinol Metab	2003
95	NR	Insulin augmentation of 17alpha-hydroxylase activity is mediated by phosphatidyl inositol 3-kinase but not extracellular signal-regulated kinase-1/2 in human ovarian theca cells.	14512432	Endocrinology	2004
95	PR	The functions of insulin signaling: size isn't everything, even in Drosophila.	12969331	Differentiation	2003
95	DR	Alterations in the expression of MHC class I glycoproteins by B16BL6 melanoma cells modulate insulin receptor-regulated signal transduction and augment [correction of augments] resistance to apoptosis.	12960318	J Immunol	2003
95	NR	Growth factor-specific regulation of insulin receptor substrate-1 expression in MCF-7 breast carcinoma cells: effects on the insulin-like growth factor signaling pathway.	12960057	Endocrinology	2003
95	PR	C-peptide enhances insulin-mediated cell growth and protection against high glucose-induced apoptosis in SH-SY5Y cells.	12951645	Diabetes Metab Res Rev	2003
95	NR	An anti-insulin-like growth factor I receptor antibody that is a potent inhibitor of cancer cell proliferation.	12941837	Cancer Res	2003
95	DR	Gene expression and tyrosine kinase activity of insulin receptor in uterine leiomyoma and matched myometrium.	12937923	Arch Gynecol Obstet	2004
95	NR	T-antigen of human polyomavirus JC cooperates withIGF-IR signaling system in cerebellar tumors of the childhood-medulloblastomas.	12894576	Anticancer Res	2003
95	NR	Insulin attenuates leptin-induced STAT3 tyrosine-phosphorylation in a hepatoma cell line.	12890573	Mol Cell Endocrinol	2003
95	NR	Conjugated linoleic acid downregulates insulin-like growth factor-I receptor levels in HT-29 human colon cancer cells.	12888657	J Nutr	2003
95	NR	Development of new insulin-like growth factor-1 receptor kinase inhibitors using catechol mimics.	12869569	J Biol Chem	2003
95	PR	Vanadate regulates the insulin mitogenic effect by modulating SHP-2 association with insulin receptor substrate 1 in JAr human choriocarcinoma cells.	12857432	Gynecol Endocrinol	2003
95	NR	Tomato and soy polyphenols reduce insulin-like growth factor-I-stimulated rat prostate cancer cell proliferation and apoptotic resistance in vitro via inhibition of intracellular signaling pathways involving tyrosine kinase.	12840208	J Nutr	2003
95	NR	Estrogen receptor-alpha regulates the degradation of insulin receptor substrates 1 and 2 in breast cancer cells.	12821935	Oncogene	2003
95	NR	Oxidation state of the active-site cysteine in protein tyrosine phosphatase 1B.	12802339	Nature	2003
95	NR	Interactions between estrogen and insulin-like growth factor signaling pathways in human breast tumor cells.	12790794	Endocr Relat Cancer	2003
95	NR	The FRK/RAK-SHB signaling cascade: a versatile signal-transduction pathway that regulates cell survival, differentiation and proliferation.	12776987	Curr Mol Med	2003
95	NR	Retinoic acid-induced growth arrest of MCF-7 cells involves the selective regulation of the IRS-1/PI 3-kinase/AKT pathway.	12776186	Oncogene	2003
95	DR	The insulin-like growth factor system and cancer.	12767520	Cancer Lett	2003
95	NR	Constitutive over-expression of the insulin receptor substrate-1 causes functional up-regulation of Fas receptor.	12763374	J Hepatol	2003
95	DR	Signaling differences from the A and B isoforms of the insulin receptor (IR) in 32D cells in the presence or absence of IR substrate-1.	12746329	Endocrinology	2003
95	PR	Glucosamine induces resistance to insulin-like growth factor I (IGF-I) and insulin in Hep G2 cell cultures: biological significance of IGF-I/insulin hybrid receptors.	12746299	Endocrinology	2003
95	NR	The p38 mitogen-activated protein kinase pathway and its role in interferon signaling.	12725866	Pharmacol Ther	2003
95	PR	Chronic hyperinsulinism induced down-regulation of insulin post-receptor signaling transduction in Hep G2 cells.	12674767	J Huazhong Univ Sci Technolog Med Sci	2002
95	NR	A nucleoprotein complex containing Sp1, C/EBP beta, and HMGI-Y controls human insulin receptor gene transcription.	12665574	Mol Cell Biol	2003
95	NR	Leptin induces mitogenic effect on human choriocarcinoma cell line (JAr) via MAP kinase activation in a glucose-dependent fashion.	12657513	Placenta	2003
95	DR	The tyrphostin AG1024 accelerates the degradation of phosphorylated forms of retinoblastoma protein (pRb) and restores pRb tumor suppressive function in melanoma cells.	12649208	Cancer Res	2003
95	NR	p190-B RhoGAP regulates mammary ductal morphogenesis.	12637587	Mol Endocrinol	2003
95	NR	The polycystic ovary syndrome: what does insulin resistance have to do with it?	12626141	Reprod Biomed Online	2003
95	NR	Focal overexpression of insulin-like growth factor 2 by hepatocytes and cholangiocytes in viral liver cirrhosis.	12618883	Br J Cancer	2003
95	DR	IRS-4 mediated mitogenic signalling by insulin and growth hormone in LB cells, a murine T-cell lymphoma devoid of IGF-I receptors.	12618213	Cell Signal	2003
95	NR	The HIV protease inhibitor indinavir impairs glycogen synthesis in HepG2 hepatoma cells.	12605345	Exp Clin Endocrinol Diabetes	2003
95	NR	The efficacy of small interfering RNAs targeted to the type 1 insulin-like growth factor receptor (IGF1R) is influenced by secondary structure in the IGF1R transcript.	12604614	J Biol Chem	2003
95	NR	A chimeric humanized single-chain antibody against the type I insulin-like growth factor (IGF) receptor renders breast cancer cells refractory to the mitogenic effects of IGF-I.	12566306	Cancer Res	2003
95	NR	An inhibitory function for JNK in the regulation of IGF-I signaling in breast cancer.	12555073	Oncogene	2003
95	DR	Insulin can block apoptosis by decreasing oxidative stress via phosphatidylinositol 3-kinase- and extracellular signal-regulated protein kinase-dependent signaling pathways in HepG2 cells.	12534368	Eur J Endocrinol	2003
95	PR	Osmotic regulation of insulin-induced mitogen-activated protein kinase phosphatase (MKP-1) expression in H4IIE rat hepatoma cells.	12529177	Biochem J	2003
95	PR	Metformin modulates insulin post-receptor signaling transduction in chronically insulin-treated Hep G2 cells.	12511230	Acta Pharmacol Sin	2003
95	PR	Reduction of protein-tyrosine phosphatase-1B increases insulin signaling in FAO hepatoma cells.	12504077	Biochem Biophys Res Commun	2003
95	NR	Mono- or dual-phosphorylation of akt kinase is regulated by distinct receptors that involve the common insulin receptor substrate.	12503617	J Recept Signal Transduct Res	2002
95	DR	Differential responses of EGFR-/AGT-expressing cells to the "combi-triazene" SMA41.	12497201	Cancer Chemother Pharmacol	2003
95	NR	Insulin-like growth factor I receptor signaling system in JC virus T antigen-induced primitive neuroectodermal tumors--medulloblastomas.	12491166	J Neurovirol	2002
95	PR	Lubricating cell signaling pathways with gangliosides.	12464309	Curr Opin Struct Biol	2002
95	PR	Dual mechanism of signal transducer and activator of transcription 5 activation by the insulin receptor.	12456798	Mol Endocrinol	2002
95	DR	In IGF-I receptor-deficient leiomyosarcoma cells autocrine IGF-II induces cell invasion and protection from apoptosis via the insulin receptor isoform A.	12447687	Oncogene	2002
95	DR	Secretion of Annexin II via activation of insulin receptor and insulin-like growth factor receptor.	12431980	J Biol Chem	2003
95	PR	Constitutive activation of insulin receptor substrate 1 is a frequent event in human tumors: therapeutic implications.	12414625	Cancer Res	2002
95	NR	Molecular changes associated with the acquisition of oestrogen hypersensitivity in MCF-7 breast cancer cells on long-term oestrogen deprivation.	12361723	J Steroid Biochem Mol Biol	2002
95	NR	Protein-tyrosine phosphatase PTPL1/FAP-1 triggers apoptosis in human breast cancer cells.	12354757	J Biol Chem	2002
95	NR	[Chronic complications of polycystic ovary syndrome. Review]	12229282	Invest Clin	2002
95	NR	Decreased insulin receptor (IR) autophosphorylation in fibroblasts from patients with PCOS: effects of serine kinase inhibitors and IR activators.	12213853	J Clin Endocrinol Metab	2002
95	PR	Regulation of insulin receptor function by a small molecule insulin receptor activator.	12213804	J Biol Chem	2002
95	DR	Functional insulin receptors on human epithelial ovarian carcinoma cells: implications for IGF-II mitogenic signaling.	12193537	Endocrinology	2002
95	NR	Proinflammatory cytokines block growth of breast cancer cells by impairing signals from a growth factor receptor.	12183434	Cancer Res	2002
95	NR	ETV6-NTRK3 transformation requires insulin-like growth factor 1 receptor signaling and is associated with constitutive IRS-1 tyrosine phosphorylation.	12173038	Oncogene	2002
95	NR	Insulin-like growth factor binding protein-1 (IGFBP-1) inhibits breast cancer cell motility.	12154042	Cancer Res	2002
95	PR	Dichloroacetate stimulates glycogen accumulation in primary hepatocytes through an insulin-independent mechanism.	12151648	Toxicol Sci	2002
95	NR	Antiestrogen ICI 182,780 decreases proliferation of insulin-like growth factor I (IGF-I)-treated MCF-7 cells without inhibiting IGF-I signaling.	12124331	Cancer Res	2002
95	PR	Epigallocatechin gallate, a constituent of green tea, represses hepatic glucose production.	12118006	J Biol Chem	2002
95	PR	Sam68 associates with the SH3 domains of Grb2 recruiting GAP to the Grb2-SOS complex in insulin receptor signaling.	12112020	J Cell Biochem	2002
95	NR	[Genetics of the polycystic ovarian syndrome and therapeutic perspectives ]	12089937	Rev Med Chir Soc Med Nat Iasi	2000
95	NR	STAT6 mediates interleukin-4 growth inhibition in human breast cancer cells.	12082548	Neoplasia	2002
95	NR	Insulin-like growth factor I receptor activity in human medulloblastomas.	12060623	Clin Cancer Res	2002
95	NR	Prevention of cytokine-induced apoptosis by insulin-like growth factor-I is independent of cell adhesion molecules in HT29-D4 colon carcinoma cells-evidence for a NF-kappaB-dependent survival mechanism.	12058282	Cell Death Differ	2002
95	DR	Overexpression of insulin receptor substrate-1, but not insulin receptor substrate-2, protects a T cell hybridoma from activation-induced cell death.	12055235	J Immunol	2002
95	NR	Upper abdominal obesity, insulin resistance and breast cancer risk.	12037643	Int J Obes Relat Metab Disord	2002
95	DR	Insulin receptor-mediated organ overgrowth in Drosophila is not restricted by body size.	12012234	Dev Genes Evol	2002
95	NR	Nitric oxide regulates oestrogen-activated signalling pathways at multiple levels through cyclic GMP-dependent recruitment of insulin receptor substrate 1.	11978177	Biochem J	2002
95	DR	RACK1 is an insulin-like growth factor 1 (IGF-1) receptor-interacting protein that can regulate IGF-1-mediated Akt activation and protection from cell death.	11964397	J Biol Chem	2002
95	NR	RACK1, an insulin-like growth factor I (IGF-I) receptor-interacting protein, modulates IGF-I-dependent integrin signaling and promotes cell spreading and contact with extracellular matrix.	11884618	Mol Cell Biol	2002
95	NR	Aurintricarboxylic acid induces a distinct activation of the IGF-I receptor signaling within MDA-231 cells.	11861505	Endocrinology	2002
95	NR	Sex steroids and insulin resistance.	11834135	Clin Sci (Lond)	2002
95	NR	[Resistance to insulin and polycystic ovary syndrome]	11787441	Diabetes Metab	2001
95	NR	Dysregulation of IGF-I signaling in uterine leiomyoma.	11786376	J Endocrinol	2002
95	NR	Growth and characterization of N-methyl-N-nitrosourea-induced mammary tumors in intact and ovariectomized rats.	11751437	Carcinogenesis	2001
95	PR	Altered insulin receptor processing and function in scrapie-infected neuroblastoma cell lines.	11750072	Brain Res Mol Brain Res	2001
95	NR	Insulin-like growth factor I stimulates motility in human neuroblastoma cells.	11709726	Oncogene	2001
95	PR	Ghrelin modulates the downstream molecules of insulin signaling in hepatoma cells.	11724768	J Biol Chem	2002
95	PR	Phosphatidylinositol 3-kinase and Ras/mitogen-activated protein kinase signaling pathways are required for the regulation of 5-aminolevulinate synthase gene expression by insulin.	11716532	Exp Cell Res	2001
95	NR	Regulation of breast cancer cell motility by insulin receptor substrate-2 (IRS-2) in metastatic variants of human breast cancer cell lines.	11704861	Oncogene	2001
95	PR	Insulin inhibits leptin receptor signalling in HEK293 cells at the level of janus kinase-2: a potential mechanism for hyperinsulinaemia-associated leptin resistance.	11596667	Diabetologia	2001
95	NR	Differential insulin-like growth factor I receptor signaling and function in estrogen receptor (ER)-positive MCF-7 and ER-negative MDA-MB-231 breast cancer cells.	11559546	Cancer Res	2001
95	PR	Regulation of insulin/insulin-like growth factor-1 signaling by proteasome-mediated degradation of insulin receptor substrate-2.	11546773	J Biol Chem	2001
95	NR	Activation of preformed EGF receptor dimers by ligand-induced rotation of the transmembrane domain.	11531336	J Mol Biol	2001
95	NR	Regulation of the Akt/Glycogen synthase kinase-3 axis by insulin-like growth factor-II via activation of the human insulin receptor isoform-A.	11500939	J Cell Biochem	2001
95	NR	Re-expression of estrogen receptor alpha in estrogen receptor alpha-negative MCF-7 cells restores both estrogen and insulin-like growth factor-mediated signaling and growth.	11479214	Cancer Res	2001
95	NR	Mitogenic and metabolic effects of type I IGF receptor overexpression in insulin receptor-deficient hepatocytes.	11459778	Endocrinology	2001
95	NR	Effects of IGF-I and -II, IGF binding protein-3 (IGFBP-3), and transforming growth factor-beta (TGF-beta) on growth and apoptosis of human osteosarcoma Saos-2/B-10 cells: lack of IGF-independent IGFBP-3 effects.	11454519	Eur J Endocrinol	2001
95	NR	A PDZ domain protein interacts with the C-terminal tail of the insulin-like growth factor-1 receptor but not with the insulin receptor.	11445579	J Biol Chem	2001
95	NR	Phosphatidyl-inositol-3 kinase-independent insulin action pathway(s) in the human ovary.	11443175	J Clin Endocrinol Metab	2001
95	NR	Defects in insulin receptor signaling in vivo in the polycystic ovary syndrome (PCOS).	11440917	Am J Physiol Endocrinol Metab	2001
95	NR	Identification of insulin receptor substrate 1 (IRS-1) and IRS-2 as signaling intermediates in the alpha6beta4 integrin-dependent activation of phosphoinositide 3-OH kinase and promotion of invasion.	11438664	Mol Cell Biol	2001
95	NR	Transcriptional regulation of plasminogen activator inhibitor type 1 gene by insulin: insights into the signaling pathway.	11423472	Diabetes	2001
95	NR	Complexes formation between insulin receptor and extracellular signal-regulated kinases ERKs.	11409918	Mol Cell Biol Res Commun	2000
95	NR	Dual action of eicosapentaenoic acid in hepatoma cells: up-regulation of metabolic action of insulin and inhibition of cell proliferation.	11390373	J Biol Chem	2001
95	NR	Multiple signal transduction pathways mediate interleukin-4-induced 3beta-hydroxysteroid dehydrogenase/Delta5-Delta4 isomerase in normal and tumoral target tissues.	11384880	J Steroid Biochem Mol Biol	2001
95	NR	Insulin-like growth factor 1 and oestradiol promote cell proliferation of MCF-7 breast cancer cells: new insights into their synergistic effects.	11376126	Mol Pathol	2001
95	NR	The IGF axis and hepatocarcinogenesis.	11376124	Mol Pathol	2001
95	NR	IGF-I receptor signalling in transformation and differentiation.	11376123	Mol Pathol	2001
95	NR	The IGF system in thyroid cancer: new concepts.	11376121	Mol Pathol	2001
95	NR	Cloning, mapping, and characterization of the human sorbin and SH3 domain containing 1 (SORBS1) gene: a protein associated with c-Abl during insulin signaling in the hepatoma cell line Hep3B.	11374898	Genomics	2001
95	NR	PTEN expression causes feedback upregulation of insulin receptor substrate 2.	11359902	Mol Cell Biol	2001
95	NR	Insulin-stimulated hydrogen peroxide reversibly inhibits protein-tyrosine phosphatase 1b in vivo and enhances the early insulin action cascade.	11297536	J Biol Chem	2001
95	NR	Inhibition of endosomal insulin-like growth factor-I processing by cysteine proteinase inhibitors blocks receptor-mediated functions.	11278993	J Biol Chem	2001
95	NR	Insulin stimulates PKCzeta -mediated phosphorylation of insulin receptor substrate-1 (IRS-1). A self-attenuated mechanism to negatively regulate the function of IRS proteins.	11278339	J Biol Chem	2001
95	NR	Loss of insulin-like growth factor II receptor expression promotes growth in cancer by increasing intracellular signaling from both IGF-I and insulin receptors.	11262195	Exp Cell Res	2001
95	NR	Insulin resistance in polycystic ovary syndrome: progress and paradoxes.	11237218	Recent Prog Horm Res	2001
95	NR	PTEN inhibits insulin-stimulated MEK/MAPK activation and cell growth by blocking IRS-1 phosphorylation and IRS-1/Grb-2/Sos complex formation in a breast cancer model.	11230180	Hum Mol Genet	2001
95	NR	PS6K amplification characterizes a small subset of anaplastic meningiomas.	11211609	Am J Clin Pathol	2001
95	NR	Protein-tyrosine phosphatase-1B negatively regulates insulin signaling in l6 myocytes and Fao hepatoma cells.	11136729	J Biol Chem	2001
95	NR	Inhibition of mitogen-activated protein kinase kinase selectively inhibits cell proliferation in human breast cancer cells displaying enhanced insulin-like growth factor I-mediated mitogen-activated protein kinase activation.	11149601	Cell Growth Differ	2000
95	NR	Insulin-like growth factor (IGF) binding protein-3 inhibits type 1 IGF receptor activation independently of its IGF binding affinity.	11145572	Endocrinology	2001
95	NR	Effects of dichloroacetate (DCA) on serum insulin levels and insulin-controlled signaling proteins in livers of male B6C3F1 mice.	11134557	Toxicol Sci	2001
95	NR	Differential requirements of the MAP kinase and PI3 kinase signaling pathways in Src- versus insulin and IGF-1 receptors-induced growth and transformation of rat intestinal epithelial cells.	11103940	Oncogene	2000
95	NR	Down-regulation of insulin-like growth factor-I receptor and insulin receptor substrate-1 expression in advanced human breast cancer.	11102895	Int J Cancer	2000
95	NR	Vav3 mediates receptor protein tyrosine kinase signaling, regulates GTPase activity, modulates cell morphology, and induces cell transformation.	11094073	Mol Cell Biol	2000
95	NR	Regulation of the insulin and asialoglycoprotein receptors via cGMP-dependent protein kinase.	11078721	Am J Physiol Cell Physiol	2000
95	NR	Suppressor of cytokine signaling (SOCS)-3 protein interacts with the insulin-like growth factor-I receptor.	11071852	Biochem Biophys Res Commun	2000
95	NR	Differentially expressed genes in asbestos-induced tumorigenic human bronchial epithelial cells: implication for mechanism.	11062161	Carcinogenesis	2000
95	NR	Silibinin up-regulates insulin-like growth factor-binding protein 3 expression and inhibits proliferation of androgen-independent prostate cancer cells.	11059749	Cancer Res	2000
95	NR	The HIV-1 protease inhibitor indinavir impairs insulin signalling in HepG2 hepatoma cells.	11043860	Diabetologia	2000
95	NR	Tumor necrosis factor alpha-mediated insulin resistance, but not dedifferentiation, is abrogated by MEK1/2 inhibitors in 3T3-L1 adipocytes.	11043572	Mol Endocrinol	2000
95	NR	Insulin-like growth factor 1 regulates the location, stability, and transcriptional activity of beta-catenin.	11035789	Proc Natl Acad Sci U S A	2000
95	NR	Insulin-like growth factor I is a dual effector of multiple myeloma cell growth.	11023522	Blood	2000
95	NR	Expression of insulin-receptor substrate-1 and -2 in ovaries from women with insulin resistance and from controls.	10973656	Fertil Steril	2000
95	NR	Ret oncogene signal transduction via a IRS-2/PI 3-kinase/PKB and a SHC/Grb-2 dependent pathway: possible implication for transforming activity in NIH3T3 cells.	11000521	Mol Cell Endocrinol	2000
95	NR	[Insulin resistance: from clinical diagnosis to molecular genetics. Implications in diabetes mellitus]	10987057	Bull Acad Natl Med	1999
95	NR	Activation of insulin-like growth factor I receptor signaling pathway is critical for mouse plasma cell tumor growth.	10919668	Cancer Res	2000
95	NR	IL-4/IL-13 signaling beyond JAK/STAT.	10856136	J Allergy Clin Immunol	2000
95	NR	Characterization of pancreastatin receptor and signaling in rat HTC hepatoma cells.	10844119	Eur J Pharmacol	2000
95	NR	Insulin receptor substrate-1, p70S6K, and cell size in transformation and differentiation of hemopoietic cells.	10846175	J Biol Chem	2000
95	NR	Stat 5B, activated by insulin in a Jak-independent fashion, plays a role in glucokinase gene transcription.	10830280	Endocrinology	2000
95	NR	The juxtamembrane but not the carboxyl-terminal domain of the insulin receptor mediates insulin's metabolic functions in primary adipocytes and cultured hepatoma cells.	10828835	J Mol Endocrinol	2000
95	NR	Insulin-like growth factor I-mediated degradation of insulin receptor substrate-1 is inhibited by epidermal growth factor in prostate epithelial cells.	10811632	J Biol Chem	2000
95	NR	Hyperinsulinism and its interaction with hyperandrogenism in polycystic ovary syndrome.	10804539	Obstet Gynecol Surv	2000
95	NR	Evidence for an interaction between the insulin receptor and Grb7. A role for two of its binding domains, PIR and SH2.	10803466	Oncogene	2000
95	NR	Lycopene interferes with cell cycle progression and insulin-like growth factor I signaling in mammary cancer cells.	10798222	Nutr Cancer	2000
95	NR	Insulin receptor substrate-1 expression is regulated by estrogen in the MCF-7 human breast cancer cell line.	10777546	J Biol Chem	2000
95	NR	Selective attenuation of metabolic branch of insulin receptor down-signaling by high glucose in a hepatoma cell line, HepG2 cells.	10764799	J Biol Chem	2000
95	NR	Interleukin-4 mediates cell growth inhibition through activation of Stat1.	10744706	J Biol Chem	2000
95	NR	Multiple signaling pathways mediate interleukin-4-induced 3beta-hydroxysteroid dehydrogenase/delta5-delta4 isomerase type 1 gene expression in human breast cancer cells.	10674396	Mol Endocrinol	2000
95	NR	Insulin-like growth factor I-induced degradation of insulin receptor substrate 1 is mediated by the 26S proteasome and blocked by phosphatidylinositol 3'-kinase inhibition.	10669726	Mol Cell Biol	2000
95	NR	Differentiation and malignant transformation: two roads diverged in a wood.	10629105	J Cell Biochem	1999
95	NR	Human rhabdomyosarcoma cells retain insulin-regulated glucose transport activity through glucose transporter 1.	10620325	Arch Biochem Biophys	2000
95	NR	Insulin selectively activates STAT5b, but not STAT5a, via a JAK2-independent signalling pathway in Kym-1 rhabdomyosarcoma cells.	10618497	FEBS Lett	1999
95	NR	Insulin-like growth factor-I (IGF-I)-dependent activation of pp42/44 mitogen-activated protein kinase occurs independently of IGF-I receptor kinase activation and IRS-1 tyrosine phosphorylation.	10583412	Eur J Biochem	1999
95	NR	Increased activity and expression of MAP kinase in HCC model rats induced by 3'-methyl-4-dimethylamino-azobenzene.	10551398	J Hepatol	1999
95	NR	IRS-1 expression and activation are not sufficient to activate downstream pathways and enable IGF-I growth response in estrogen receptor negative breast cancer cells.	10543935	Growth Horm IGF Res	1999
95	NR	Selective insulin resistance in the polycystic ovary syndrome.	10487672	J Clin Endocrinol Metab	1999
95	NR	Insulin-like growth factor II signaling in neoplastic proliferation is blocked by transgenic expression of the metalloproteinase inhibitor TIMP-1.	10459021	J Cell Biol	1999
95	NR	Characterization of an antibody that can detect an activated IGF-I receptor in human cancers.	10438568	Exp Cell Res	1999
95	NR	The Gly972-->Arg amino acid polymorphism in IRS-1 impairs insulin secretion in pancreatic beta cells.	10430617	J Clin Invest	1999
95	NR	Insulin and insulin-like growth factor-I (IGF-I) receptor overexpression in breast cancers leads to insulin/IGF-I hybrid receptor overexpression: evidence for a second mechanism of IGF-I signaling.	10430101	Clin Cancer Res	1999
95	NR	Insulin/IGF-I hybrid receptors play a major role in IGF-I signaling in thyroid cancer.	10401676	Biochimie	1999
95	NR	The role of TNFalpha and TNF receptors in obesity and insulin resistance.	10395191	J Intern Med	1999
95	NR	The PTEN tumor suppressor homolog in Caenorhabditis elegans regulates longevity and dauer formation in an insulin receptor-like signaling pathway.	10377431	Proc Natl Acad Sci U S A	1999
95	NR	Insulin action in the polycystic ovary syndrome.	10352922	Endocrinol Metab Clin North Am	1999
95	NR	Enhancement of insulin-like growth factor signaling in human breast cancer: estrogen regulation of insulin receptor substrate-1 expression in vitro and in vivo.	10319328	Mol Endocrinol	1999
95	NR	Reversible change in thiol redox status of the insulin receptor alpha-subunit in intact cells.	10231542	Biochemistry	1999
95	NR	Human insulin receptor and insulin signaling proteins in hepatic disease.	10210639	J Surg Res	1999
95	NR	Regulation of dauer larva development in Caenorhabditis elegans by daf-18, a homologue of the tumour suppressor PTEN.	10209098	Curr Biol	1999
95	NR	Insulin receptor isoform A, a newly recognized, high-affinity insulin-like growth factor II receptor in fetal and cancer cells.	10207053	Mol Cell Biol	1999
95	NR	Insulin receptor substrate 1 is a target for the pure antiestrogen ICI 182,780 in breast cancer cells.	10188734	Int J Cancer	1999
95	NR	Modulation of insulin receptor signalling by pancreastatin in HTC hepatoma cells.	10096784	Diabetologia	1999
95	NR	Concerted activity of tyrosine phosphatase SHP-2 and focal adhesion kinase in regulation of cell motility.	10082579	Mol Cell Biol	1999
95	NR	Regulation of the insulin-like developmental pathway of Caenorhabditis elegans by a homolog of the PTEN tumor suppressor gene.	10077613	Proc Natl Acad Sci U S A	1999
95	NR	Insulin activates G alpha il,2 protein in rat hepatoma (HTC) cell membranes.	10065161	Cell Mol Life Sci	1999
95	NR	C-terminal Src kinase associates with ligand-stimulated insulin-like growth factor-I receptor.	10026153	J Biol Chem	1999
95	NR	Ethanol inhibition of insulin signaling in hepatocellular carcinoma cells.	9884156	Alcohol Clin Exp Res	1998
95	NR	Role of IRS-1 signaling in insulin-induced modulation of estrogen receptors in breast cancer cells.	9878535	Biochem Biophys Res Commun	1998
95	NR	Polycystic ovary syndrome and insulin resistance: thrifty genes struggling with over-feeding and sedentary life style?	9856413	J Endocrinol Invest	1998
95	NR	Insulin receptor substrate 2 and Shc play different roles in insulin-like growth factor I signaling.	9852124	J Biol Chem	1998
95	NR	Differential regulation of insulin receptor substrate-2 and mitogen-activated protein kinase tyrosine phosphorylation by phosphatidylinositol 3-kinase inhibitors in SH-SY5Y human neuroblastoma cells.	9832424	Endocrinology	1998
95	NR	Protein-tyrosine phosphatase alpha regulates Src family kinases and alters cell-substratum adhesion.	9822658	J Biol Chem	1998
95	NR	Effect of herbimycin A on tyrosine kinase receptors and platelet derived growth factor (PDGF)-induced signal transduction.	9821805	Biol Pharm Bull	1998
95	NR	4,5-bis(4-fluoroanilino)phthalimide: A selective inhibitor of the epidermal growth factor receptor signal transduction pathway with potent in vivo antitumor activity.	9816050	Clin Cancer Res	1995
95	NR	Overexpression of insulin receptor substrate 1 (IRS-1) in the human breast cancer cell line MCF-7 induces loss of estrogen requirements for growth and transformation.	9815941	Clin Cancer Res	1995
95	NR	Insulin-like growth factor binding protein-3 and insulin receptor substrate-1 in breast cancer: correlation with clinical parameters and disease-free survival.	9815544	Clin Cancer Res	1997
95	NR	Insulin action and insulin resistance: diseases involving defects in insulin receptors, signal transduction, and the glucose transport effector system.	9809695	Am J Med	1998
95	NR	Focal adhesion kinase and its potential involvement in tumor invasion and metastasis.	9790298	Head Neck	1998
95	NR	Enhanced expression of the insulin receptor substrate-2 docking protein in human pancreatic cancer.	9766646	Cancer Res	1998
95	NR	Lack of insulin resistance in fibroblasts from subjects with polycystic ovary syndrome.	9711989	Metabolism	1998
95	NR	Analysis of signaling protein kinases in human colon or colorectal carcinomas.	9690379	Dig Dis Sci	1998
95	NR	Insulin-stimulated cell growth in insulin receptor substrate-1-deficient ZR-75-1 cells is mediated by a phosphatidylinositol-3-kinase-independent pathway.	9671232	J Cell Biochem	1998
95	NR	B cell antigen receptor (BCR)-mediated formation of a SHP-2-pp120 complex and its inhibition by Fc gamma RIIB1-BCR coligation.	9670943	J Immunol	1998
95	NR	A specific increased expression of insulin receptor substrate 2 in pancreatic beta-cell lines is involved in mediating serum-stimulated beta-cell growth.	9648831	Diabetes	1998
95	NR	Divergent pathways regulate ligand-independent activation of ER alpha in SK-N-BE neuroblastoma and COS-1 renal carcinoma cells.	9626659	Mol Endocrinol	1998
95	NR	Insulin stimulates testosterone biosynthesis by human thecal cells from women with polycystic ovary syndrome by activating its own receptor and using inositolglycan mediators as the signal transduction system.	9626131	J Clin Endocrinol Metab	1998
95	NR	Insulin receptor substrate 1 antisense expression in an hepatoma cell line reduces cell proliferation and induces overexpression of the Src homology 2 domain and collagen protein (SHC).	9605520	Mol Cell Endocrinol	1998
95	NR	Insulin receptor substrate-1 is the predominant signaling molecule activated by insulin-like growth factor-I, insulin, and interleukin-4 in estrogen receptor-positive human breast cancer cells.	9545345	J Biol Chem	1998
95	NR	A role for the insulin-interleukin (IL)-4 receptor motif of the IL-4 receptor alpha-chain in regulating activation of the insulin receptor substrate 2 and signal transducer and activator of transcription 6 pathways. Analysis by mutagenesis.	9545332	J Biol Chem	1998
95	NR	Insulin-like growth factor-I-induced DNA synthesis in insulin-secreting cell line RINm5F is associated with phosphorylation of the insulin-like growth factor-I receptor and the insulin receptor substrate-2.	9582514	J Endocrinol	1998
95	NR	Guanosine triphosphatase-activating protein-associated protein, but not src-associated protein p68 in mitosis, is a part of insulin signaling complexes.	9564850	Endocrinology	1998
95	NR	Interactions between the oestrogen and insulin-like growth factor signalling pathways in the control of breast epithelial cell proliferation.	9513709	Biochem Soc Symp	1998
95	NR	Insulin receptor substrate-1 is expressed at high levels in all cells of the peri-implantation mouse embryo.	9508089	Mol Reprod Dev	1998
95	NR	Cytoskeletal and phosphoinositide requirements for muscarinic receptor signaling to focal adhesion kinase and paxillin.	9489713	J Neurochem	1998
95	NR	Overexpression of insulin receptor substrate-1 emerges early in hepatocarcinogenesis and elicits preneoplastic hepatic glycogenosis.	9466558	Am J Pathol	1998
95	NR	Early signaling events triggered by peroxovanadium [bpV(phen)] are insulin receptor kinase (IRK)-dependent: specificity of inhibition of IRK-associated protein tyrosine phosphatase(s) by bpV(phen).	9415395	Mol Endocrinol	1997
95	NR	The insulin-like growth factor-I receptor is required for EWS/FLI-1 transformation of fibroblasts.	9388225	J Biol Chem	1997
95	NR	Insulin resistance and the polycystic ovary syndrome: mechanism and implications for pathogenesis.	9408743	Endocr Rev	1997
95	NR	Insulin receptor expression and clinical outcome in node-negative breast cancer.	9394418	Proc Assoc Am Physicians	1997
95	NR	Cloning, chromosome localization, expression, and characterization of an Src homology 2 and pleckstrin homology domain-containing insulin receptor binding protein hGrb10gamma.	9360986	J Biol Chem	1997
95	NR	The IRS-pathway operates distinctively from the Stat-pathway in hematopoietic cells and transduces common and distinct signals during engagement of the insulin or interferon-alpha receptors.	9326223	Blood	1997
95	NR	Alphavbeta3 integrin associates with activated insulin and PDGFbeta receptors and potentiates the biological activity of PDGF.	9312019	EMBO J	1997
95	NR	Biological effects of human insulin receptor substrate-1 overexpression in hepatocytes.	9303488	Hepatology	1997
95	NR	Differential roles of IRS-1 and SHC signaling pathways in breast cancer cells.	9311601	Int J Cancer	1997
95	NR	Tyrosine phosphorylation of insulin receptor substrate-1 and activation of the PI-3-kinase pathway by glycine-extended gastrin precursors.	9245714	Biochem Biophys Res Commun	1997
95	NR	Mitogenic properties of insulin and insulin analogues mediated by the insulin receptor.	9248698	Diabetologia	1997
95	NR	Tyrosine residues in the C-terminal domain of the insulin-like growth factor-I receptor mediate mitogenic and tumorigenic signals.	9202243	Endocrinology	1997
95	NR	Insulin-like growth factor I receptor signaling in transformation by src oncogenes.	9199308	Mol Cell Biol	1997
95	NR	The protein tyrosine phosphatase LAR has a major impact on insulin receptor dephosphorylation.	9207225	Biochem Biophys Res Commun	1997
95	NR	Novel pathway of insulin signaling involving Stat1alpha in Hep3B cells.	9199189	Biochem Biophys Res Commun	1997
95	NR	alpha2,6-Sialyltransferase gene transfection into a human glioma cell line (U373 MG) results in decreased invasivity.	9166754	J Neurochem	1997
95	NR	Structures of the tyrosine kinase domain of fibroblast growth factor receptor in complex with inhibitors.	9139660	Science	1997
95	NR	Up-regulation of insulin/insulin-like growth factor-I hybrid receptors during differentiation of HT29-D4 human colonic carcinoma cells.	9112401	Endocrinology	1997
95	NR	Overexpressed IGF-I receptors reduce estrogen growth requirements, enhance survival, and promote E-cadherin-mediated cell-cell adhesion in human breast cancer cells.	9056422	Exp Cell Res	1997
95	NR	The IL-4-induced tyrosine phosphorylation of the insulin receptor substrate is dependent on JAK1 expression in human fibrosarcoma cells.	9013940	J Immunol	1997
95	NR	Human ovarian-carcinoma cell lines express IL-4 and IL-13 receptors: comparison between IL-4- and IL-13-induced signal transduction.	9009165	Int J Cancer	1997
95	NR	Comparison of IL-13- and IL-4-induced signaling in EBV-immortalized human B cells.	9015186	Cell Immunol	1997
95	NR	Effect of dimerization on signal transduction and biological function of oncogenic Ros, insulin, and insulin-like growth factor I receptors.	8995240	J Biol Chem	1997
95	NR	Effect of tumor necrosis factor-alpha on the phosphorylation of tyrosine kinase receptors is associated with dynamic alterations in specific protein-tyrosine phosphatases.	9015760	J Cell Biochem	1997
95	NR	Activation of estrogen receptor-mediated gene transcription by IGF-I in human breast cancer cells.	9014838	J Endocrinol	1997
95	NR	Transcriptional regulation of insulin receptor substrate 1 by protein kinase C.	8943287	J Biol Chem	1996
95	NR	Insulin receptor tyrosine kinase activity in colon carcinoma.	9222417	Braz J Med Biol Res	1996
95	NR	Suppression of insulin receptor activation by overexpression of the protein-tyrosine phosphatase LAR in hepatoma cells.	9023010	Cell Signal	1996
95	NR	A carboxy-terminal truncated insulin receptor substrate-1 dominant negative protein reverses the human hepatocellular carcinoma malignant phenotype.	8903330	J Clin Invest	1996
95	NR	A 100-kDa protein tyrosine phosphorylation is concurrent with beta 1 integrin-mediated morphological differentiation in neuroblastoma and small cell lung cancer cells.	8831561	Exp Cell Res	1996
95	NR	Insulin and secretagogues differentially regulate fluid-phase pinocytosis in insulin-secreting beta-cells.	8809056	Biochem J	1996
95	NR	Insulin receptor substrate 1 overexpression in human hepatocellular carcinoma cells prevents transforming growth factor beta1-induced apoptosis.	8758899	Cancer Res	1996
95	NR	Thrombin receptors modulate insulin-stimulated phosphatidylinositol 3,4,5-trisphosphate accumulation in 1321N1 astrocytoma cells.	8713057	Biochem J	1996
95	NR	A 60-kilodalton protein in rat hepatoma cells overexpressing insulin receptor was tyrosine phosphorylated and associated with Syp, phophatidylinositol 3-kinase, and Grb2 in an insulin-dependent manner.	8770882	Endocrinology	1996
95	NR	The focal adhesion kinase.	8708550	J Endocrinol	1996
95	NR	Neoplastic transformation induced by insulin receptor substrate-1 overexpression requires an interaction with both Grb2 and Syp signaling molecules.	8662827	J Biol Chem	1996
95	NR	Differential regulation of insulin-stimulated tyrosine phosphorylation of IRS-1 and SHC by Wortmannin in intact cells.	8660383	Biochem Biophys Res Commun	1996
95	NR	Motogenic and morphogenic activity of epithelial receptor tyrosine kinases.	8655582	J Cell Biol	1996
95	NR	Mitogenic signaling by Ret/ptc2 requires association with enigma via a LIM domain.	8662982	J Biol Chem	1996
95	NR	Cross-coupling between insulin and estrogen receptor in human neuroblastoma cells.	8732681	Mol Endocrinol	1996
95	NR	Sphingomyelinase and ceramide suppress insulin-induced tyrosine phosphorylation of the insulin receptor substrate-1.	8626623	J Biol Chem	1996
95	NR	Cell density-dependent changes in the insulin action pathway: evidence for involvement of protein-tyrosine phosphatases.	8726353	J Cell Biochem	1996
95	NR	The effect of purified extract of Fagopyrum esculentum (buckwheat) on protein kinases involved in signal transduction pathways.	8657738	Planta Med	1996
95	NR	Increased expression of insulin receptor substrate-1 in human pancreatic cancer.	8607861	Biochem Biophys Res Commun	1996
95	NR	Overexpression of human insulin receptor substrate 1 induces cellular transformation with activation of mitogen-activated protein kinases.	8622697	Mol Cell Biol	1996
95	NR	Role of insulin-like growth factors in autocrine growth of human retinoblastoma Y79 cells.	8612625	Eur J Biochem	1996
95	NR	A Grb2-associated docking protein in EGF- and insulin-receptor signalling.	8596638	Nature	1996
95	NR	Tumorigenic and mitogenic capacities are reduced in transfected fibroblasts expressing mutant insulin-like growth factor (IGF)-I receptors. The role of tyrosine residues 1250, 1251, and 1316 in the carboxy-terminus of the IGF-I receptor.	8593783	Endocrinology	1996
95	NR	The transmembrane protein-tyrosine phosphatase LAR modulates signaling by multiple receptor tyrosine kinases.	8557682	J Biol Chem	1996
95	NR	Effect of tyrosine mutations on the kinase activity and transforming potential of an oncogenic human insulin-like growth factor I receptor.	8550552	J Biol Chem	1996
95	NR	IGF-I receptor signalling: lessons from the somatotroph.	8701079	Recent Prog Horm Res	1996
95	NR	Receptors for interleukin (IL)-4 do not associate with the common gamma chain, and IL-4 induces the phosphorylation of JAK2 tyrosine kinase in human colon carcinoma cells.	8530527	J Biol Chem	1995
95	NR	Unique and selective mitogenic effects of vanadate on SV40-transformed cells.	8927049	Mol Cell Biochem	1995
95	NR	Mitogenic potential of insulin on lymphoma cells lacking IGF-1 receptor.	7486686	Ann N Y Acad Sci	1995
95	NR	The B isoform of the insulin receptor signals more efficiently than the A isoform in HepG2 cells.	7657666	J Biol Chem	1995
95	NR	Osmotic loading of neutralizing antibodies demonstrates a role for protein-tyrosine phosphatase 1B in negative regulation of the insulin action pathway.	7544790	J Biol Chem	1995
95	NR	UV activation of receptor tyrosine kinase activity.	7543196	Oncogene	1995
95	NR	Association of insulin receptor substrate 1 with simian virus 40 large T antigen.	7542742	Mol Cell Biol	1995
95	NR	Herbimycin A induces the 20 S proteasome- and ubiquitin-dependent degradation of receptor tyrosine kinases.	7622464	J Biol Chem	1995
95	NR	Differential pathways of insulin action upon the hepatitis B surface antigen gene expression and cell proliferation in human hepatoma cells.	7789317	Endocrinology	1995
95	NR	pp125FAK in human melanocytes and melanoma: expression and phosphorylation.	7543052	Exp Cell Res	1995
95	NR	Detection of a 60 kDa tyrosine-phosphorylated protein in insulin-stimulated hepatoma cells that associates with the SH2 domain of phosphatidylinositol 3-kinase.	7539611	Biochem J	1995
95	NR	Interleukin-13 signal transduction in lymphohemopoietic cells. Similarities and differences in signal transduction with interleukin-4 and insulin.	7744881	J Biol Chem	1995
95	NR	Transforming potential of the insulin receptor substrate 1.	7647039	Cell Growth Differ	1995
95	NR	Role of p85 subunit of phosphatidylinositol-3-kinase as an adaptor molecule linking the insulin receptor to insulin receptor substrate 1.	7659087	Mol Endocrinol	1995
95	NR	Effect of ethanol on p36 protein kinase substrate and insulin receptor substrate 1 expression and tyrosyl phosphorylation in human hepatocellular carcinoma cells.	7542850	Alcohol Clin Exp Res	1995
95	NR	Insulin-dependent tyrosine phosphorylation of the vav protooncogene product in cells of hematopoietic origin.	7535775	J Biol Chem	1995
95	NR	Selective inhibition of the platelet-derived growth factor signal transduction pathway by a protein-tyrosine kinase inhibitor of the 2-phenylaminopyrimidine class.	7708684	Proc Natl Acad Sci U S A	1995
95	NR	Mouse mammary tumors express elevated levels of RNA encoding the murine homology of SKY, a putative receptor tyrosine kinase.	7896835	J Biol Chem	1995
95	NR	Activation of protein kinase C stimulates the tyrosine phosphorylation and guanosine triphosphatase-activating protein association of p60 in rat hepatoma cells.	7835279	Endocrinology	1995
95	NR	Tyrosine phosphorylation of focal adhesion kinase at sites in the catalytic domain regulates kinase activity: a role for Src family kinases.	7529876	Mol Cell Biol	1995
95	NR	Insulin-induced differentiation and modulation of neuronal thread protein expression in primitive neuroectodermal tumor cells is linked to phosphorylation of insulin receptor substrate-1.	8746448	J Mol Neurosci	1995
95	NR	Modulatory effect of the transmembrane domain of the protein-tyrosine kinase encoded by oncogene ros: biological function and substrate interaction.	7526386	Proc Natl Acad Sci U S A	1994
95	NR	Ethanol inhibits insulin-like growth factor-1-mediated signalling and proliferation of C6 rat glioblastoma cells.	7526037	Lab Invest	1994
95	NR	Stimulation of glycogen synthesis by insulin in human erythroleukemia cells requires the synthesis of glycosyl-phosphatidylinositol.	7524086	Proc Natl Acad Sci U S A	1994
95	NR	Epidermal growth factor-dependent association of phosphatidylinositol 3-kinase with the erbB3 gene product.	7929151	J Biol Chem	1994
95	NR	Insulin and insulin-like growth factor signaling are defective in the MDA MB-468 human breast cancer cell line.	7848909	Cell Growth Differ	1994
95	NR	[Oncogenic activation of p21(ras) and pp60(c-src) in human colonic Caco-2 cells decreases insulin receptor function and expression through protein kinase C-dependent and independent pathways]	7734771	Bull Cancer	1994
95	NR	Reduced tyrosine kinase activity of the insulin receptor in obesity-diabetes. Central role of tumor necrosis factor-alpha.	7523453	J Clin Invest	1994
95	NR	Expression of insulin receptor substrate-1 in hepatocytes: an investigation using monoclonal antibodies.	8076365	Cancer Lett	1994
95	NR	PC12 cells overexpressing the insulin receptor undergo insulin-dependent neuronal differentiation.	7953556	Curr Biol	1994
95	NR	Reduced insulin receptor expression and function in human colonic Caco-2 cells by ras and polyoma middle T oncogenes.	8034618	J Biol Chem	1994
95	NR	Proximal enhancer of the human insulin receptor gene binds the transcription factor Sp1.	8013752	Diabetes	1994
95	NR	Functional insulin and insulin-like growth factor-1 receptors are preferentially expressed in multiple myeloma cell lines as compared to B-lymphoblastoid cell lines.	8205537	Cancer Res	1994
95	NR	Analysis of the adenylate cyclase signalling system, and alterations induced by culture with insulin, in a novel SV40-DNA-immortalized hepatocyte cell line (P9 cells).	8010967	Biochem J	1994
95	NR	NIH 3T3 cells transfected with a yeast H(+)-ATPase have altered sensitivity to insulin, insulin growth factor-I, and platelet-derived growth factor-AA.	8188769	J Cell Physiol	1994
95	NR	Tumor necrosis factor alpha inhibits signaling from the insulin receptor.	8197147	Proc Natl Acad Sci U S A	1994
95	NR	T-cell antigen CD28 interacts with the lipid kinase phosphatidylinositol 3-kinase by a cytoplasmic Tyr(P)-Met-Xaa-Met motif.	8146197	Proc Natl Acad Sci U S A	1994
95	NR	Fusion of a kinase gene, ALK, to a nucleolar protein gene, NPM, in non-Hodgkin's lymphoma.	8122112	Science	1994
95	NR	Differentiational regulation and phosphorylation of the fatty acid-binding protein from rat mammary epithelial cells.	8117746	Biochim Biophys Acta	1994
95	NR	Deletion of residues 485-599 from the human insulin receptor abolishes antireceptor antibody binding and influences tyrosine kinase activation.	8015549	Mol Endocrinol	1994
96	NR	Gene expression profile of butyrate-inhibited vascular smooth muscle cell proliferation.	14674679	Mol Cell Biochem	2003
96	NR	The in vitro reconstitution of nucleosome and its binding patterns with HMG1/2 and HMG14/17 proteins.	14672558	Cell Res	2003
96	NR	Antifungal activity of fluconazole in combination with lovastatin and their effects on gene expression in the ergosterol and prenylation pathways in Candida albicans.	14653518	Med Mycol	2003
96	NR	An octamer motif is required for activation of the inducible nitric oxide synthase promoter in pancreatic beta-cells.	14630716	Endocrinology	2004
96	NR	DNA-protein cross-linking by trans-[PtCl(2)(E-iminoether)(2)]. A concept for activation of the trans geometry in platinum antitumor complexes.	14602903	Nucleic Acids Res	2003
96	NR	Amphoterin induction in prostatic stromal cells by androgen deprivation is associated with metastatic prostate cancer.	14534709	Oncol Rep	2003
96	NR	Interaction of maize chromatin-associated HMG proteins with mononucleosomes: role of core and linker histones.	12956418	Biol Chem	2003
96	NR	Association of chromatin proteins high mobility group box (HMGB) 1 and HMGB2 with mitotic chromosomes.	12925773	Mol Biol Cell	2003
96	NR	Molecular genetic characterization of the distal NKC recombination hotspot and putative murine CMV resistance control locus.	12920489	Immunogenetics	2003
96	NR	Cloning and characterization of rice HMGB1 gene.	12909345	Gene	2003
96	NR	[The potential role of high mobility group-1 protein in the pathogenesis of sepsis-induced multiple organ dysfunction syndrome in rats]	12882679	Zhonghua Wai Ke Za Zhi	2003
96	NR	The acidic C-terminal domain and A-box of HMGB-1 regulates p53-mediated transcription.	12799451	Nucleic Acids Res	2003
96	NR	Drosophila DSP1 and rat HMGB1 have equivalent DNA binding properties and share a similar secondary fold.	12761302	J Biochem (Tokyo)	2003
96	NR	Retroposed copies of the HMG genes: a window to genome dynamics.	12727900	Genome Res	2003
96	NR	Phosphorylation of maize and Arabidopsis HMGB proteins by protein kinase CK2alpha.	12653554	Biochemistry	2003
96	NR	High mobility group-like proteins of the insect Plodia interpunctella.	12645872	Biochem Genet	2003
96	NR	Synthesis of signals for de novo DNA methylation in Neurospora crassa.	12640122	Mol Cell Biol	2003
96	NR	Increased susceptibility to LPS-induced endotoxin shock in secretory leukoprotease inhibitor (SLPI)-deficient mice.	12615907	J Exp Med	2003
96	NR	Nature of full-length HMGB1 binding to cisplatin-modified DNA.	12614161	Biochemistry	2003
96	NR	HMGB1 interacts differentially with members of the Rel family of transcription factors.	12604365	Biochem Biophys Res Commun	2003
96	NR	Rice HMGB1 protein recognizes DNA structures and bends DNA efficiently.	12590928	Arch Biochem Biophys	2003
96	NR	Cytokine therapeutics for the treatment of sepsis: why has nothing worked?	12570677	Curr Pharm Des	2003
96	NR	Erratum in:     Biochemistry. 2003 Apr 8;42(13):3996.	12564926	Biochemistry	2003
96	NR	Does high mobility group 1 protein function as a late mediator for LPS- or TNF-induced shock in galactosamine-sensitized mice? 	12537698	J Endotoxin Res	2002
96	DR	Autoantibodies to the transcriptional factor SOX13 in primary biliary cirrhosis compared with other diseases.	12473246	J Autoimmun	2002
96	NR	Metal-dependent stabilization of an active HMG protein.	12468716	Protein Eng	2002
96	NR	Two copies of mthmg1, encoding a novel mitochondrial HMG-like protein, delay accumulation of mitochondrial DNA deletions in Podospora anserina.	12455999	Eukaryot Cell	2002
96	NR	Erratum in:     Mol Cell Biol. 2003 Apr;23(8):3029.	12391148	Mol Cell Biol	2002
96	DR	Cytokine expression in three mouse models of experimental hepatitis.	12242077	Cytokine	2002
96	NR	Microheterogeneous Cytosolic High-Mobility Group Proteins from Broccoli Co-Purify with and Are Phosphorylated by Casein Kinase II.	12232253	Plant Physiol	1994
96	NR	Altered expression of novel genes in the cerebral cortex following experimental brain injury.	12225869	Brain Res Mol Brain Res	2002
96	NR	Efficient specific DNA binding by p53 requires both its central and C-terminal domains as revealed by studies with high-mobility group 1 protein.	12215537	Mol Cell Biol	2002
96	NR	HMGB1 B box increases the permeability of Caco-2 enterocytic monolayers and impairs intestinal barrier function in mice.	12198705	Gastroenterology	2002
96	NR	HMGB-1, a DNA-binding protein with cytokine activity, induces brain TNF and IL-6 production, and mediates anorexia and taste aversion.	12126646	Cytokine	2002
96	NR	Specificity of the stimulatory interaction between chromosomal HMGB proteins and the transcription factor Dof2 and its negative regulation by protein kinase CK2-mediated phosphorylation.	12065590	J Biol Chem	2002
96	NR	Plant chromosomal HMGB proteins efficiently promote the bacterial site-specific beta-mediated recombination in vitro and in vivo.	12056908	Biochemistry	2002
96	NR	Interactions between p53, hMSH2-hMSH6 and HMG I(Y) on Holliday junctions and bulged bases.	12034830	Nucleic Acids Res	2002
96	NR	Recognition of major DNA adducts of enantiomeric cisplatin analogs by HMG box proteins and nucleotide excision repair of these adducts.	12031669	Chem Biol	2002
96	NR	The DNA architectural protein HMGB1 displays two distinct modes of action that promote enhanceosome assembly.	12024049	Mol Cell Biol	2002
96	NR	Dynamics of reporter gene stimulation by HMG box proteins.	12015897	DNA Cell Biol	2002
96	NR	Conformational stability of six truncated cHMG1a proteins studied in their mixture by H/D exchange and electrospray ionization mass spectrometry.	11995979	Acta Biochim Pol	2001
96	NR	HMG-1 as regulatory trans-acting protein in the acute phase-induced expression of the rat liver haptoglobin gene.	11989650	Gen Physiol Biophys	2001
96	NR	The significance of changes in high mobility group-1 protein mRNA expression in rats after thermal injury.	11954836	Shock	2002
96	NR	Nucleolin is a calcium-binding protein.	11948683	J Cell Biochem	2002
96	NR	HMG2 interacts with the nucleosome assembly protein SET and is a target of the cytotoxic T-lymphocyte protease granzyme A.	11909973	Mol Cell Biol	2002
96	NR	Fine structure and activity of discrete RAG-HMG complexes on V(D)J recombination signals.	11839801	Mol Cell Biol	2002
96	NR	Interactions between HMG boxes.	11809932	Protein Eng	2001
96	NR	Molecular analysis of nonrandom 8q12 deletions in acute lymphoblastic leukemia: identification of two candidate genes.	11793444	Genes Chromosomes Cancer	2002
96	NR	The modulation of the biological activities of mitochondrial histone Abf2p by yeast PKA and its possible role in the regulation of mitochondrial DNA content during glucose repression.	11779632	Biochim Biophys Acta	2001
96	NR	HMGB1 and HMGB2 cell-specifically down-regulate the p53- and p73-dependent sequence-specific transactivation from the human Bax gene promoter.	11748232	J Biol Chem	2002
96	NR	HMGB1 interacts with many apparently unrelated proteins by recognizing short amino acid sequences.	11748221	J Biol Chem	2002
96	NR	The binding affinity of HMG1 protein to DNA modified by cis-platin and its analogs correlates with their antitumor activity.	11733188	Int J Biochem Cell Biol	2002
96	NR	Novel human HALR (MLL3) gene encodes a protein homologous to ALR and to ALL-1 involved in leukemia, and maps to chromosome 7q36 associated with leukemia and developmental defects.	11718452	Cancer Detect Prev	2001
96	NR	Protein kinase CK2 differentially phosphorylates maize chromosomal high mobility group B (HMGB) proteins modulating their stability and DNA interactions.	11694523	J Biol Chem	2002
96	PR	Recombination hot spot of hepatitis B virus genome binds to members of the HMG domain protein family and the Y box binding protein family; implication of these proteins in genomic instability.	11684893	Intervirology	2001
96	NR	Molecular archeology of an SP100 splice variant revisited: dating the retrotranscription and Alu insertion events.	11574059	Genome Biol	2001
96	NR	Thermodynamics of HMGB1 interaction with duplex DNA.	11513603	Biochemistry	2001
96	NR	Amphoterin includes a sequence motif which is homologous to the Alzheimer's beta-amyloid peptide (Abeta), forms amyloid fibrils in vitro, and binds avidly to Abeta.	11513581	Biochemistry	2001
96	NR	Borna disease virus phosphoprotein binds a neurite outgrowth factor, amphoterin/HMG-1.	11507219	J Virol	2001
96	NR	HMG1 and 2: architectural DNA-binding proteins.	11497996	Biochem Soc Trans	2001
96	NR	Structural requirements for cooperative binding of HMG1 to DNA minicircles.	11491303	J Mol Biol	2001
96	NR	Spt16-Pob3 and the HMG protein Nhp6 combine to form the nucleosome-binding factor SPN.	11432837	EMBO J	2001
96	NR	Differential chromatin association and nucleosome binding of the maize HMGA, HMGB, and SSRP1 proteins.	11425313	Biochemistry	2001
96	NR	Laser-induced photo-cross-linking of cisplatin-modified DNA to HMG-domain proteins.	11412107	Biochemistry	2001
96	NR	Molecular evolution of Sry and Sox gene.	11404013	Gene	2001
96	NR	Biochemical characterization of the structure-specific DNA-binding protein Cmb1 from Schizosaccharomyces pombe.	11399082	J Mol Biol	2001
96	NR	The binding interaction of HMG-1 with the TATA-binding protein/TATA complex.	11390376	J Biol Chem	2001
96	NR	HMG-1 enhances HMG-I/Y binding to an A/T-rich enhancer element from the pea plastocyanin gene.	11389716	Eur J Biochem	2001
96	NR	HMG-D complexed to a bulge DNA: an NMR model.	11344319	Protein Sci	2001
96	NR	HMG-1 rediscovered as a cytokine.	11303722	Shock	2001
96	NR	Two mutations of basic residues within the N-terminus of HMG-1 B domain with different effects on DNA supercoiling and binding to bent DNA.	11294645	Biochemistry	2001
96	NR	Identity of nuclear high-mobility-group protein, HMG-1, and sulfoglucuronyl carbohydrate-binding protein, SBP-1, in brain.	11279268	J Neurochem	2001
96	NR	New insights into host factor requirements for prokaryotic beta-recombinase-mediated reactions in mammalian cells.	11278972	J Biol Chem	2001
96	NR	HMG box A in HMG2 protein functions as a mediator of DNA structural alteration together with box B.	11275566	J Biochem (Tokyo)	2001
96	NR	The high mobility group (HMG) boxes of the nuclear protein HMG1 induce chemotaxis and cytoskeleton reorganization in rat smooth muscle cells.	11257120	J Cell Biol	2001
96	NR	Erratum in:     Trends Biochem Sci 2001 Apr;26(4):219.	11246022	Trends Biochem Sci	2001
96	NR	Gene expression patterns associated with the metastatic phenotype in rodent and human tumors.	11245467	Cancer Res	2001
96	NR	Detection of anti-neutrophil cytoplasmic antibodies in MRL/Mp-lpr/lpr mice and analysis of their target antigens.	11191287	Autoimmunity	2000
96	NR	Chromatin-mediated transcriptional regulation by the yeast architectural factors NHP6A and NHP6B.	11118215	EMBO J	2000
96	NR	Interaction with p53 enhances binding of cisplatin-modified DNA by high mobility group 1 protein.	11106654	J Biol Chem	2001
96	NR	Phage display screening reveals an association between germline-specific transcription factor Oct-4 and multiple cellular proteins.	11099378	J Mol Biol	2000
96	NR	Intercalating residues determine the mode of HMG1 domains A and B binding to cisplatin-modified DNA.	11087395	Biochemistry	2000
96	NR	The chromosomal protein HMG-D binds to the TAR and RBE RNA of HIV-1.	11086163	FEBS Lett	2000
96	NR	The effect of the acidic tail on the DNA-binding properties of the HMG1,2 class of proteins: insights from tail switching and tail removal.	11080451	J Mol Biol	2000
96	NR	Relationship between sex and antibodies to high mobility group proteins 1 and 2 in juvenile idiopathic arthritis.	11036848	J Rheumatol	2000
96	NR	FR900482 class of anti-tumor drugs cross-links oncoprotein HMG I/Y to DNA in vivo.	11033083	Chem Biol	2000
96	NR	DNA binding by single HMG box model proteins.	11024186	Nucleic Acids Res	2000
96	NR	HMG-domain protein recognition of cisplatin 1,2-intrastrand d(GpG) cross-links in purine-rich sequence contexts.	10995245	Biochemistry	2000
96	NR	HMG-1 as a mediator of acute lung inflammation.	10975801	J Immunol	2000
96	NR	A role of basic residues and the putative intercalating phenylalanine of the HMG-1 box B in DNA supercoiling and binding to four-way DNA junctions.	10962007	J Biol Chem	2000
96	NR	High mobility group 1 protein (HMG-1) stimulates proinflammatory cytokine synthesis in human monocytes.	10952726	J Exp Med	2000
96	NR	Comparative study of the coupling between topoisomerase I activity and high-mobility group proteins in E. coli and mammalian cells.	10945232	DNA Cell Biol	2000
96	NR	Molecular cloning and analysis of a group of genes differentially expressed in cells which overexpress the Hoxa-1 homeobox gene.	10942599	Exp Cell Res	2000
96	NR	High mobility group 1 and 2 proteins bind preferentially to DNA that contains bulky adducts induced by benzo[a]pyrene diol epoxide and N-acetoxy-acetylaminofluorene.	10940504	Cancer Lett	2000
96	NR	Stopped-flow fluorescence studies of HMG-domain protein binding to cisplatin-modified DNA.	10913248	Biochemistry	2000
96	NR	Influence of HMG-1 and adenovirus oncoprotein E1A on early stages of transcriptional preinitiation complex assembly.	10882737	J Biol Chem	2000
96	NR	HMG1 protein stimulates DNA end joining by promoting association of DNA molecules via their ends.	10866811	Eur J Biochem	2000
96	NR	Mechanism for specificity by HMG-1 in enhanceosome assembly.	10825199	Mol Cell Biol	2000
96	NR	Steroid hormones induce HMG1 overexpression and sensitize breast cancer cells to cisplatin and carboplatin.	10811891	Proc Natl Acad Sci U S A	2000
96	NR	Antisense oligodeoxynucleotide inhibition of vascular angiotensin-converting enzyme expression attenuates neointimal formation: evidence for tissue angiotensin-converting enzyme function.	10764654	Arterioscler Thromb Vasc Biol	2000
96	NR	Back to the roots of a new exon--the molecular archaeology of a SP100 splice variant.	10766566	Genomics	2000
96	NR	Sequence specificity, conformation, and recognition by HMG1 protein of major DNA interstrand cross-links of antitumor dinuclear platinum complexes.	10747955	J Biol Chem	2000
96	NR	Determining the DNA bending angle induced by non-specific high mobility group-1 (HMG-1) proteins: a novel method.	10715126	Biochemistry	2000
96	NR	Kinetic analysis of high-mobility-group proteins HMG-1 and HMG-I/Y binding to cholesterol-tagged DNA on a supported lipid monolayer.	10710428	Nucleic Acids Res	2000
96	NR	Regulation of cell migration by amphoterin.	10652254	J Cell Sci	2000
96	NR	Interactions of mammalian proteins with cisplatin-damaged DNA.	10626358	J Inorg Biochem	1999
96	NR	Structure-specific binding of the two tandem HMG boxes of HMG1 to four-way junction DNA is mediated by the A domain.	10610765	J Mol Biol	1999
96	NR	Mast cell and neuroendocrine cytoplasmic autoantigen(s) detected by monoclonal pANCA antibodies.	10607489	Clin Immunol	2000
96	NR	HMG boxes of DSP1 protein interact with the rel homology domain of transcription factors.	10606643	Nucleic Acids Res	2000
96	NR	The recognition of distorted DNA structures by HMG-D: a footprinting and molecular modelling study.	10556030	J Mol Biol	1999
96	NR	DNA bending induced by high mobility group proteins studied by fluorescence resonance energy transfer.	10508419	Biochemistry	1999
96	NR	Coregulatory proteins in steroid hormone receptor action: the role of chromatin high mobility group proteins HMG-1 and -2.	10503712	Steroids	1999
96	NR	The RAG1 homeodomain recruits HMG1 and HMG2 to facilitate recombination signal sequence binding and to enhance the intrinsic DNA-bending activity of RAG1-RAG2.	10490593	Mol Cell Biol	1999
96	NR	Interactions between an HMG-1 protein and members of the Rel family.	10485885	Proc Natl Acad Sci U S A	1999
96	NR	Toxicity of platinum(II) amino acid (N,O) complexes parallels their binding to DNA as measured in a new solid phase assay involving a fluorescent HMG1 protein construct readout.	10555574	J Biol Inorg Chem	1999
96	NR	Proinflammatory cytokines (tumor necrosis factor and interleukin 1) stimulate release of high mobility group protein-1 by pituicytes.	10455911	Surgery	1999
96	NR	HMG1 is not rearranged by 13q12 aberrations in lipomas.	10451712	Genes Chromosomes Cancer	1999
96	NR	High mobility group-like protein in bovine milk stimulates the proliferation of osteoblastic MC3T3-E1 cells.	10405332	Biochem Biophys Res Commun	1999
96	NR	Constitutive phosphorylation of the acidic tails of the high mobility group 1 proteins by casein kinase II alters their conformation, stability, and DNA binding specificity.	10400623	J Biol Chem	1999
96	NR	HMG-1 as a late mediator of endotoxin lethality in mice.	10398600	Science	1999
96	NR	Nucleosome structure completely inhibits in vitro cleavage by the V(D)J recombinase.	10393186	EMBO J	1999
96	NR	Basis for recognition of cisplatin-modified DNA by high-mobility-group proteins.	10385126	Nature	1999
96	NR	Reexamination of the high mobility group-1 protein for self-association and characterization of hydrodynamic properties.	10366723	Biochim Biophys Acta	1999
96	NR	The HMG-I(Y) A.T-hook peptide motif confers DNA-binding specificity to a structured chimeric protein.	10347218	J Biol Chem	1999
96	DR	Comment in:     Gut. 1999 Jun;44(6):776-7.	10323891	Gut	1999
96	NR	Solution structure of the HMG protein NHP6A and its interaction with DNA reveals the structural determinants for non-sequence-specific binding.	10228169	EMBO J	1999
96	NR	Directional binding of HMG-I(Y) on four-way junction DNA and the molecular basis for competitive binding with HMG-1 and histone H1.	10219086	Nucleic Acids Res	1999
96	NR	Structural and kinetic studies of a cisplatin-modified DNA icosamer binding to HMG1 domain B.	10212205	J Biol Chem	1999
96	NR	An HMG1-like protein facilitates Wnt signaling in Caenorhabditis elegans.	10197987	Genes Dev	1999
96	NR	HMG-1 stimulates estrogen response element binding by estrogen receptor from stably transfected HeLa cells.	10194768	Mol Endocrinol	1999
96	NR	Multiple layers of cooperativity regulate enhanceosome-responsive RNA polymerase II transcription complex assembly.	10082527	Mol Cell Biol	1999
96	NR	HMG protein family members stimulate human immunodeficiency virus type 1 and avian sarcoma virus concerted DNA integration in vitro.	10074149	J Virol	1999
96	NR	The stabilized structural array of two HMG1/2-boxes endowed by a linker sequence between them is requisite for the effective binding of HMG1 with DNA.	9990140	J Biochem (Tokyo)	1999
96	NR	Splice variants of the nuclear dot-associated Sp100 protein contain homologies to HMG-1 and a human nuclear phosphoprotein-box motif.	9973607	J Cell Sci	1999
96	NR	Selection of a cDNA clone for chicken high-mobility-group 1 (HMG1) protein through its unusually conserved 3'-untranslated region, and improved expression of recombinant HMG1 in Escherichia coli.	9931456	Gene	1998
96	NR	Differences in DNA recognition and conformational change activity between boxes A and B in HMG2 protein.	9888798	Biochemistry	1999
96	NR	DSP1 gene of Drosophila melanogaster encodes an HMG-domain protein that plays multiple roles in development.	9883584	Dev Genet	1998
96	NR	High mobility group protein 1 interacts specifically with the core domain of human TATA box-binding protein and interferes with transcription factor IIB within the pre-initiation complex.	9880542	J Biol Chem	1999
96	NR	Arachidonic acid alters tomato HMG expression and fruit growth and induces 3-hydroxy-3-methylglutaryl coenzyme A reductase-independent lycopene accumulation 	0009880344	Plant Physiol	1999
96	NR	High mobility group proteins 1 and 2 can function as DNA-binding regulatory components for DNA-dependent protein kinase in vitro.	9722660	J Biochem (Tokyo)	1998
96	NR	Four differently chromatin-associated maize HMG domain proteins modulate DNA structure and act as architectural elements in nucleoprotein complexes.	9675905	Plant J	1998
96	NR	High-mobility group chromatin proteins 1 and 2 functionally interact with steroid hormone receptors to enhance their DNA binding in vitro and transcriptional activity in mammalian cells.	9671457	Mol Cell Biol	1998
96	NR	DNA-binding properties of the tandem HMG boxes of high-mobility-group protein 1 (HMG1).	9654080	Eur J Biochem	1998
96	NR	Interaction of SP100 with HP1 proteins: a link between the promyelocytic leukemia-associated nuclear bodies and the chromatin compartment.	9636146	Proc Natl Acad Sci U S A	1998
96	NR	Human replication protein A preferentially binds cisplatin-damaged duplex DNA in vitro.	9628743	Biochemistry	1998
96	NR	Estrogen treatment induces elevated expression of HMG1 in MCF-7 cells.	9633537	Exp Cell Res	1998
96	NR	Abundance of mRNAs encoding HMG1/HMG2 class high-mobility-group DNA-binding proteins are differentially regulated in cotyledons of Pharbitis nil.	9617797	Plant Mol Biol	1998
96	NR	DNA bending by the chromosomal protein HMG1 and its high mobility group box domains. Effect of flanking sequences.	9553091	J Biol Chem	1998
96	NR	Non-histone chromosomal proteins HMG1 and 2 enhance ligation reaction of DNA double-strand breaks.	9600082	Biochem Biophys Res Commun	1998
96	NR	Hmg4, a new member of the Hmg1/2 gene family.	9598312	Genomics	1998
96	NR	Gene transduction for disseminated intraperitoneal tumor using cationic liposomes containing non-histone chromatin proteins: cationic liposomal gene therapy of carcinomatosa.	9578844	Gene Ther	1998
96	NR	The HVJ liposome method.	9567220	Exp Nephrol	1998
96	NR	Assembly, remodeling, and histone binding capabilities of yeast nucleosome assembly protein 1.	9497395	J Biol Chem	1998
96	NR	Isolation and characterization of a cDNA encoding a high mobility group protein HMG-1 from Canavalia gladiata D.C.	9524219	Biochim Biophys Acta	1998
96	NR	Decreased expression of the high-mobility group protein T160 by antisense RNA impairs the growth of mouse fibroblasts.	9523013	Biochimie	1997
96	NR	Basic and acidic regions flanking the HMG domain of maize HMGa modulate the interactions with DNA and the self-association of the protein.	9485418	Biochemistry	1998
96	NR	High mobility group protein-1 (HMG-1) is a unique activator of p53.	9472015	Genes Dev	1998
96	NR	Formation of large nucleoprotein complexes upon binding of the high-mobility-group (HMG) box B-domain of HMG1 protein to supercoiled DNA.	9492314	Eur J Biochem	1998
96	NR	Prevalence and characterization of perinuclear anti-neutrophil cytoplasmic antibodies (P-ANCA) directed against HMG1 and HMG2 in ulcerative colitis (UC).	9486411	Clin Exp Immunol	1998
96	NR	Enhancement of transcription factor, USF, binding to the adenovirus major late promoter: effect of dithiothreitol and high mobility group protein-1.	9473681	Biochim Biophys Acta	1998
96	NR	Variability in Arabidopsis thaliana chromosomal high-mobility-group-1-like proteins.	9461286	Eur J Biochem	1997
96	NR	Dof DNA-binding domains of plant transcription factors contribute to multiple protein-protein interactions.	9428691	Eur J Biochem	1997
96	NR	High-mobility group 1 protein inhibits helicase catalyzed displacement of cisplatin-damaged DNA.	9427537	Biochim Biophys Acta	1997
96	NR	A Drosophila kinesin-like protein, Klp38B, functions during meiosis, mitosis, and segmentation.	9398441	Dev Biol	1997
96	NR	DNA binding studies with cis-dichlorobis (5(6)-non/chlorosubstituted-2-hydroxymethyl-benzimidazole) platinum(II) complexes.	9379182	J Inorg Biochem	1997
96	NR	Difference in affinity for DNA between HMG proteins 1 and 2 determined by surface plasmon resonance measurements.	9348088	J Biochem (Tokyo)	1997
96	NR	Antibodies against a peptide sequence located in the linker region of the HMG-1/2 box domains in sera from patients with juvenile rheumatoid arthritis.	9336414	Arthritis Rheum	1997
96	NR	Difference in HMG1-induced DNA bending among microsatellites.	9330912	DNA Res	1997
96	NR	Erratum in:     Biochemistry 1997 Nov 11;36(45):13972.	9298962	Biochemistry	1997
96	NR	Competition between HMG-I(Y), HMG-1 and histone H1 on four-way junction DNA.	9254714	Nucleic Acids Res	1997
96	NR	Conformational changes of DNA induced by binding of Chironomus high mobility group protein 1a (cHMG1a). Regions flanking an HMG1 box domain do not influence the bend angle of the DNA.	9242635	J Biol Chem	1997
96	NR	Mechanism of repression of RNA polymerase I transcription by the retinoblastoma protein.	9234680	Mol Cell Biol	1997
96	NR	HMG1 protein inhibits the translesion synthesis of the major DNA cisplatin adduct by cell extracts.	9245584	J Mol Biol	1997
96	NR	High-mobility group (HMG) protein HMG-1 and TATA-binding protein-associated factor TAF(II)30 affect estrogen receptor-mediated transcriptional activation.	9212049	Mol Endocrinol	1997
96	NR	V(D)J recombination: modulation of RAG1 and RAG2 cleavage activity on 12/23 substrates by whole cell extract and DNA-bending proteins.	9166431	J Exp Med	1997
96	NR	Stimulation of V(D)J cleavage by high mobility group proteins.	9184213	EMBO J	1997
96	NR	Purification and cDNA cloning of maize HMGd reveal a novel plant chromosomal HMG-box protein with sequence similarity to HMGa.	9197548	Gene	1997
96	NR	Effect of nuclear protein HMG1 on in vitro slippage synthesis of the tandem repeat dTG x dCA.	9154923	Biochemistry	1997
96	NR	RAG1 and RAG2 form a stable postcleavage synaptic complex with DNA containing signal ends in V(D)J recombination.	9094713	Cell	1997
96	NR	High mobility group proteins HMG-1 and HMG-I/Y bind to a positive regulatory region of the pea plastocyanin gene promoter.	9161031	Plant J	1997
96	NR	Coactivation in vitro of the sigma54-dependent promoter Pu of the TOL plasmid of Pseudomonas putida by HU and the mammalian HMG-1 protein.	9098077	J Bacteriol	1997
96	NR	Suppression of high mobility group protein T160 expression impairs mouse cytomegalovirus replication.	9049420	J Gen Virol	1997
96	NR	Expression of high-mobility group-1 mRNA in human gastrointestinal adenocarcinoma and corresponding non-cancerous mucosa.	9036861	Int J Cancer	1997
96	NR	The acidic tail of the high mobility group protein HMG-D modulates the structural selectivity of DNA binding.	9054971	J Mol Biol	1997
96	NR	High mobility group proteins 1 and 2 recognize chromium-damaged DNA.	9054631	Carcinogenesis	1997
96	NR	The Drosophila DSP1 gene encoding an HMG 1-like protein: genomic organization, evolutionary conservation and expression.	9031641	Gene	1997
96	NR	Secretion and binding of HMG1 protein to the external surface of the membrane are required for murine erythroleukemia cell differentiation.	9009213	FEBS Lett	1997
96	NR	Cloning and analysis of an HMG gene from the lamprey Lampetra fluviatilis: gene duplication in vertebrate evolution.	9016958	Gene	1997
96	NR	Novel autoantigens of perinuclear anti-neutrophil cytoplasmic antibodies (P-ANCA) in ulcerative colitis: non-histone chromosomal proteins, HMG1 and HMG2.	9010268	Clin Exp Immunol	1997
96	NR	Maize chromosomal HMGc. Two closely related structure-specific DNA-binding proteins specify a second type of plant high mobility group box protein.	8955131	J Biol Chem	1996
96	NR	The transcriptional corepressor DSP1 inhibits activated transcription by disrupting TFIIA-TBP complex formation.	9003783	EMBO J	1996
96	NR	Differential binding of HMG1, HMG2, and a single HMG box to cisplatin-damaged DNA.	8975778	Toxicol Appl Pharmacol	1996
96	NR	A novel activity of HMG domains: promotion of the triple-stranded complex formation between DNA containing (GGA/TCC)11 and d(GGA)11 oligonucleotides.	8972860	Nucleic Acids Res	1996
96	NR	Enhanced coexpression of thioredoxin and high mobility group protein 1 genes in human hepatocellular carcinoma and the possible association with decreased sensitivity to cisplatin.	8968078	Cancer Res	1996
96	NR	PCR-based development of DNA substrates containing modified bases: an efficient system for investigating the role of the exocyclic groups in chemical and structural recognition by minor groove binding drugs and proteins.	8942984	Proc Natl Acad Sci U S A	1996
96	NR	Pure and highly purified follicle-stimulating hormone alone or in combination with human menopausal gonadotrophin for ovarian stimulation after pituitary suppression in in-vitro fertilization.	8981119	Hum Reprod	1996
96	NR	Primary pulmonary hypertension: immunogenetic response to high-mobility group (HMG) proteins and histone.	8918589	Clin Exp Immunol	1996
96	NR	The conserved lymphokine element-0 in the IL5 promoter binds to a high mobility group-1 protein.	9047378	Mol Immunol	1996
96	NR	[Development of non-viral gene delivery system and its applications]	8914452	Nippon Rinsho	1996
96	NR	HMG box proteins interact with multiple tandemly repeated (GCC)n (GGC)m DNA sequences.	8913860	J Biomol Struct Dyn	1996
97	DR	Cell surface expression of an endoplasmic reticulum resident heat shock protein gp96 triggers MyD88-dependent systemic autoimmune diseases.	14668429	Proc Natl Acad Sci U S A	2003
97	PR	Toll-like receptor 2 pathway drives streptococcal cell wall-induced joint inflammation: critical role of myeloid differentiation factor 88.	14634130	J Immunol	2003
97	NR	Inhibition of T helper 2-type responses, IgE production and eosinophilia by synthetic lipopeptides.	14515255	Eur J Immunol	2003
97	DR	Therapeutic targeting of Toll-like receptors for inflammatory and infectious diseases.	12901949	Curr Opin Pharmacol	2003
97	DR	Destruction of conditional insulinoma cell lines in NOD mice: a role for autoimmunity.	12739022	Diabetologia	2003
97	DR	Interleukin 1 receptor dependence of serum transferred arthritis can be circumvented by toll-like receptor 4 signaling.	12591910	J Exp Med	2003
97	DR	Role of the MyD88 transduction signaling pathway in endothelial activation by antiphospholipid antibodies.	12531807	Blood	2003
97	NR	The Ca2+-activated K+ channel of intermediate conductance:a possible target for immune suppression.	12472376	Expert Opin Ther Targets	2002
97	NR	Granulocyte/macrophage-colony-stimulating factor (GM-CSF) regulates lung innate immunity to lipopolysaccharide through Akt/Erk activation of NFkappa B and AP-1 in vivo.	12208854	J Biol Chem	2002
97	DR	Chromatin-IgG complexes activate B cells by dual engagement of IgM and Toll-like receptors.	11948342	Nature	2002
97	DR	Novel signal transduction pathway utilized by extracellular HSP70: role of toll-like receptor (TLR) 2 and TLR4.	11836257	J Biol Chem	2002
97	NR	Selective blockade of T lymphocyte K(+) channels ameliorates experimental autoimmune encephalomyelitis, a model for multiple sclerosis.	11717451	Proc Natl Acad Sci U S A	2001
97	NR	Liposomes as possible carriers for lactoferrin in the local treatment of inflammatory diseases.	11395926	Exp Biol Med (Maywood)	2001
97	DR	Dominant negative MyD88 proteins inhibit interleukin-1beta /interferon-gamma -mediated induction of nuclear factor kappa B-dependent nitrite production and apoptosis in beta cells.	10967106	J Biol Chem	2000
97	NR	Design of a potent and selective inhibitor of the intermediate-conductance Ca2+-activated K+ channel, IKCa1: a potential immunosuppressant.	10884437	Proc Natl Acad Sci U S A	2000
97	NR	The surgically delayed unipedicled TRAM flap for breast reconstruction.	8659945	Ann Plast Surg	1996
98	DR	Medullary thyroid carcinoma. Genetic screening and prophylactic thyroidectomies.	15179767	Acta Chir Iugosl	2003
98	DR	[Current opinion on the etiology of differentiated thyroid carcinoma]	15179755	Acta Chir Iugosl	2003
98	DR	Diagnostic procedures in the follow-up of patients affected by MEN type 2.	14870788	Tumori	2003
98	NR	Prophylactic thyroidectomy in MEN 2A syndrome.	14870785	Tumori	2003
98	DR	RETMEN2A and RETMEN2B oncoproteins are targets of PP1 inhibitor.	14870784	Tumori	2003
98	NR	Visual vignette. Multiple endocrine neoplasia type 2A (MEN2A) associated with cutaneous lichen amyloidosis.	14758805	Endocr Pract	2003
98	NR	Long-term follow up of a "sporadic" unilateral pheochromocytoma revealing multiple endocrine neoplasia MEN2A-2 in an elderly woman.	14739494	Endocr Pathol	2003
98	DR	Ret protein expression in adrenal medullary hyperplasia and pheochromocytoma.	14739491	Endocr Pathol	2003
98	DR	When should thyroidectomy be performed in familial medullary thyroid carcinoma gene carriers with non-cysteine RET mutations?	14668737	Surgery	2003
98	DR	RET tyrosine kinase and medullary thyroid cells are unaffected by clinical doses of STI571.	14666655	Anticancer Res	2003
98	DR	[Treatment of familial medullary thyroid carcinoma]	14663408	Minerva Chir	2003
98	DR	Molecular diagnosis of multiple endocrine neoplasia Type 2.	14628904	Expert Rev Mol Diagn	2003
98	DR	The newly detected mutations in the RET proto-oncogene in exon 16 as a cause of sporadic medullary thyroid carcinoma.	14618242	J Mol Med	2003
98	DR	[Multiple endocrine neoplasias. Recent advances in clinical and genetic diagnosis]	14604749	Rev Med Interne	2003
98	DR	A novel germ-line point mutation in RET exon 8 (Gly(533)Cys) in a large kindred with familial medullary thyroid carcinoma.	14602786	J Clin Endocrinol Metab	2003
98	DR	Concurrent lymph node metastases of medullary and papillary thyroid carcinoma in a case with RET oncogene germline mutation.	14586073	Endocr Pathol	2003
98	NR	Molecular mutations in thyroid carcinogenesis.	14569818	Am J Clin Pathol	2002
98	NR	Comment on:     N Engl J Med. 2003 Oct 16;349(16):1517-25.	14561800	N Engl J Med	2003
98	DR	Comment in:     N Engl J Med. 2003 Oct 16;349(16):1566-8.     N Engl J Med. 2004 Feb 26;350(9):943.	14561794	N Engl J Med	2003
98	DR	Germline succinate dehydrogenase subunit D mutation segregating with familial non-RET C cell hyperplasia.	14557476	J Clin Endocrinol Metab	2003
98	DR	Intronic single nucleotide polymorphisms in the RET protooncogene are associated with a subset of apparently sporadic pheochromocytoma and may modulate age of onset.	14557473	J Clin Endocrinol Metab	2003
98	DR	Comment in:     Surgery. 2004 Apr;135(4):447-8.	14555929	Surgery	2003
98	DR	Microsomal prostaglandin E2 synthase-1 is induced by conditional expression of RET/PTC in thyroid PCCL3 cells through the activation of the MEK-ERK pathway.	14555660	J Biol Chem	2003
98	NR	Detection of mutations in RET proto-oncogene codon 634 through double tandem hybridization.	14526122	Mol Biotechnol	2003
98	NR	[Association of deletions of the RET proto-oncogene wtih aggressive course of sporatic C-cell carcinoma]	14518256	Langenbecks Arch Chir Suppl Kongressbd	1998
98	DR	[Hereditary medullary thyroid carcinoma--genotype-phenotype characterization]	14508694	Dtsch Med Wochenschr	2003
98	DR	CEP-701 and CEP-751 inhibit constitutively activated RET tyrosine kinase activity and block medullary thyroid carcinoma cell growth.	14500395	Cancer Res	2003
98	NR	[Thyroid carcinomas of the follicular epithelium: tumor markers and oncogenes]	12975039	Med Clin (Barc)	2003
98	DR	Standard and molecular cytogenetics of endocrine tumors.	12951842	Am J Clin Pathol	2003
98	DR	Management of hereditary thyroid cancer in children.	12946481	Surg Oncol	2003
98	DR	Medullary thyroid carcinoma.	12943614	Curr Treat Options Oncol	2003
98	DR	[Medullary thyroid cancer: how tumor markers and genetics determine preventive measures]	12940128	Rev Med Liege	2003
98	DR	A RET C634R mutation in a Thai female with multiple endocrine neoplasia type 2A.	12930027	J Med Assoc Thai	2003
98	PR	C-cell hyperplasia and medullary thyroid carcinoma: clinicopathological and genetic correlations in 66 consecutive patients.	12920219	Mod Pathol	2003
98	PR	High prevalence of BRAF gene mutation in papillary thyroid carcinomas and thyroid tumor cell lines.	12907632	Cancer Res	2003
98	DR	[Analysis of mutations in the RET proto-oncogene in patients with medullary thyroid tumor]	12884527	Genetika	2003
98	DR	BRAF mutations and RET/PTC rearrangements are alternative events in the etiopathogenesis of PTC.	12881714	Oncogene	2003
98	NR	Tyrosine kinase oncoprotein, RET/PTC3, induces the secretion of myeloid growth and chemotactic factors.	12881713	Oncogene	2003
98	PR	[A familial form of medullary carcinoma of the thyroid gland]	12879602	Arkh Patol	2003
98	DR	Novel intronic polymorphisms in the RET proto-oncogene and their association with Hirschsprung disease.	12872262	Hum Mutat	2003
98	PR	The Ret proto-oncogene in the WAG/Rij rat strain: an animal model for inherited C-cell carcinoma?	12869284	Lab Anim	2003
98	DR	Antitumor capacity of a dominant-negative RET proto-oncogene mutant in a medullary thyroid carcinoma model.	12869215	Hum Gene Ther	2003
98	PR	Comment in:     Am J Clin Pathol. 2003 Nov;120(5):803; author reply 804.	12866375	Am J Clin Pathol	2003
98	DR	Frequent association between MEN 2A and cutaneous lichen amyloidosis.	12864791	Clin Endocrinol (Oxf)	2003
98	NR	Medullary thyroid carcinoma and multiple endocrine neoplasia type 2.	12858002	Endocr Pathol	2003
98	DR	Focal adhesions and associated proteins in medullary thyroid carcinoma cells.	12850460	J Surg Res	2003
98	DR	Comment on:     J Endocrinol Invest. 2002 Jan;25(1):25-31.	12841548	J Endocrinol Invest	2003
98	DR	Gene therapeutic approaches for medullary thyroid carcinoma treatment.	12811413	J Mol Med	2003
98	DR	RET codon 634 mutations in multiple endocrine neoplasia type 2: variable clinical features and clinical outcome.	12788868	J Clin Endocrinol Metab	2003
98	DR	Novel tumorigenic rearrangement, Delta rfp/ret, in a papillary thyroid carcinoma from externally irradiated patient.	12787916	Mutat Res	2003
98	DR	Surgical treatment of medullary thyroid carcinoma.	12755957	J Intern Med	2003
98	DR	Penetrance of inherited medullary thyroid carcinoma and genotype-phenotype correlation in a large multiple endocrine neoplasia type 2A family with C634Y RET mutation.	12746565	Endocr Pathol	2003
98	DR	Cys611Ser mutation in RET proto-oncogene in a kindred with medullary thyroid carcinoma and Hirschsprung's disease.	12734540	Eur J Hum Genet	2003
98	DR	Multiple endocrine neoplasias type 2A and thyroid medullary carcinoma: an interdisciplinary challenge.	12721726	Pediatr Surg Int	2003
98	DR	Acceptable age for prophylactic surgery in children with multiple endocrine neoplasia type 2a.	12711285	Eur J Surg Oncol	2003
98	PR	Genetic alterations in differentiated thyroid cancer: what can be expected for gene expression profiling of thyroid carcinomas.	12707638	Ann Endocrinol (Paris)	2003
98	DR	Polymorphisms G691S/S904S of RET as genetic modifiers of MEN 2A.	12702567	Cancer Res	2003
98	DR	Segregation of the V804L mutation and S836S polymorphism of exon 14 of the RET gene in an extended kindred with familial medullary thyroid cancer.	12694233	Clin Genet	2003
98	DR	Prophylactic thyroidectomy in multiple endocrine neoplasia: the impact of molecular mechanisms of RET proto-oncogene.	12690476	Langenbecks Arch Surg	2003
98	DR	Conditional expression of RET/PTC induces a weak oncogenic drive in thyroid PCCL3 cells and inhibits thyrotropin action at multiple levels.	12690093	Mol Endocrinol	2003
98	DR	Multiple endocrine neoplasia type 2: evaluation of the genotype-phenotype relationship.	12686527	Arch Surg	2003
98	DR	Efficient inhibition of RET/papillary thyroid carcinoma oncogenic kinases by 4-amino-5-(4-chloro-phenyl)-7-(t-butyl)pyrazolo[3,4-d]pyrimidine (PP2).	12679489	J Clin Endocrinol Metab	2003
98	DR	Genome-wide copy number imbalances identified in familial and sporadic medullary thyroid carcinoma.	12679485	J Clin Endocrinol Metab	2003
98	NR	Molecular genetics and management strategies in hereditary cancer syndromes.	12674901	J Ky Med Assoc	2003
98	DR	[Study of RET protooncogene in multiple endocrine neoplasm 2A and in familial medullary thyroid carcinoma. Clinical pathological findings in asymptomatic carriers]	12673960	Medicina (B Aires)	2003
98	DR	High prevalence of BRAF mutations in thyroid cancer: genetic evidence for constitutive activation of the RET/PTC-RAS-BRAF signaling pathway in papillary thyroid carcinoma.	12670889	Cancer Res	2003
98	DR	Loss of heterozygosity mutations of tumor suppressor genes in cytologically atypical areas in chronic lymphocytic thyroiditis.	12665650	Endocr Pathol	2002
98	DR	Etiology and significance of the optically clear nucleus.	12665647	Endocr Pathol	2002
98	DR	Molecular pathobiology of thyroid neoplasms.	12665646	Endocr Pathol	2002
98	DR	Pediatric medullary carcinoma of the thyroid with point mutation of RET proto-oncogene associated with multiple endocrine neoplasia and initially diagnosed by fine-needle aspiration biopsy.	12659362	South Med J	2003
98	DR	RET and NTRK1 proto-oncogenes in human diseases.	12652644	J Cell Physiol	2003
98	DR	Multiple endocrine neoplasia type 2A: an unusual clinical presentation and association with renal dysplasia.	12606135	Cancer Genet Cytogenet	2003
98	DR	RET oncogene mutations in medullary thyroid carcinoma in Mexican families.	12604374	Arch Med Res	2003
98	NR	Analysis of cancer/testis antigens in sporadic medullary thyroid carcinoma: expression and humoral response to NY-ESO-1.	12574209	J Clin Endocrinol Metab	2003
98	PR	Comment on:     Am J Surg Pathol. 2001 Oct;25(10):1245-51.	12548176	Am J Surg Pathol	2003
98	DR	Microscopic papillary thyroid carcinoma compared with clinical carcinomas by loss of heterozygosity mutational profile.	12548161	Am J Surg Pathol	2003
98	DR	Temporal trends and clinical correlates for the ret/PTC1 mutation in papillary thyroid carcinoma.	12534735	ANZ J Surg	2003
98	DR	Ras-mediated apoptosis of PC CL 3 rat thyroid cells induced by RET/PTC oncogenes.	12527893	Oncogene	2003
98	DR	Amplification and overexpression of mutant RET in multiple endocrine neoplasia type 2-associated medullary thyroid carcinoma.	12519890	J Clin Endocrinol Metab	2003
98	DR	[Genomic alterations in preneoplastic lesions]	12506466	Gan To Kagaku Ryoho	2002
98	DR	ZD6474, an orally available inhibitor of KDR tyrosine kinase activity, efficiently blocks oncogenic RET kinases.	12499271	Cancer Res	2002
98	DR	A new therapeutic approach in medullary thyroid cancer treatment: inhibition of oncogenic RET signaling by adenoviral vector-mediated expression of a dominant-negative RET mutant.	12490846	Surgery	2002
98	DR	Comment in:     Surgery. 2004 Feb;135(2):240-1; author reply 241.	12490842	Surgery	2002
98	NR	RET proto-oncogene mutations affecting codon 790/791: A mild form of multiple endocrine neoplasia type 2A syndrome?	12490841	Surgery	2002
98	DR	Evaluation of germline sequence variants of GFRA1, GFRA2, and GFRA3 genes in a cohort of Spanish patients with sporadic medullary thyroid cancer.	12490080	Thyroid	2002
98	DR	A founding locus within the RET proto-oncogene may account for a large proportion of apparently sporadic Hirschsprung disease and a subset of cases of sporadic medullary thyroid carcinoma.	12474140	Am J Hum Genet	2003
98	DR	Diagnostic and therapeutic approach to multiple endocrine neoplasia type 2B in pediatric patients.	12415360	Pediatr Surg Int	2002
98	DR	Primary hyperparathyroidism, C-cell hyperplasia and papillary thyroid carcinoma in a patient with RET germline polymorphism S836S.	12410354	Langenbecks Arch Surg	2002
98	NR	Various penetrance of familial medullary thyroid carcinoma in patients with RET protooncogene codon 790/791 germline mutations.	12409662	Ann Surg	2002
98	DR	New insights into the genetics of familial chromaffin cell tumors.	12381538	Ann N Y Acad Sci	2002
98	DR	[Polyadenomatoses: type 2 multiple endocrine neoplasms]	12212516	Presse Med	2002
98	DR	Surgical strategy in a kindred with a rare RET protooncogene mutation of variable penetrance with regard to multiple endocrine neoplasia.	12205548	World J Surg	2002
98	DR	Comparison of two provocative tests for calcitonin in medullary thyroid carcinoma: omeprazole vs pentagastrin.	12194927	Clin Chem	2002
98	DR	Papillary thyroid carcinoma in patients with RET proto-oncogene germline mutation.	12193298	Thyroid	2002
98	DR	[Proto-oncogene RET somatic mutations in medullary thyroid carcinoma]	12182058	Wiad Lek	2001
98	DR	[Consequences of clinical genetic analysis of RET proto-oncogene]	12182057	Wiad Lek	2001
98	DR	Prophylactic thyroidectomy in MEN 2A syndrome: experience in a single center.	12168961	J Am Coll Surg	2002
98	PR	Clinical characteristics and genetic screening of an extended family with MEN2A.	12150334	J Endocrinol Invest	2002
98	NR	[From the cytogenetics to the cytogenomics of thyroid tumors]	12135859	Bull Cancer	2002
98	DR	A novel germline point mutation, c.2304 G-->T, in codon 768 of the RET proto-oncogene in a patient with medullary thyroid carcinoma.	12116277	Am J Med Genet	2002
98	DR	Molecular Diagnosis of Multiple Endocrine Neoplasia (MEN) in Paraffin-Embedded Specimens.	12114809	Endocr Pathol	1995
98	DR	RET Proto-Oncogene and Thyroid Cancer.	12114728	Endocr Pathol	1997
98	DR	Molecular Screening for RET Proto-Oncogene Mutations in a German MEN2A Pedigree.	12114682	Endocr Pathol	1996
98	NR	Concurrent Pheochromocytoma, Paraganglioma, Papillary Thyroid Carcinoma, and Desmoid Tumor: A Case Report with Analyses at the Molecular Level.	12114665	Endocr Pathol	1998
98	DR	Characterization of gene expression induced by RET with MEN2A or MEN2B mutation.	12107109	Am J Pathol	2002
98	DR	Problem of prevalence of ret/PTC rearrangements in thyroid tumors.	12097207	Thyroid	2002
98	DR	Molecular mechanisms of RET activation in human cancer.	12095936	Ann N Y Acad Sci	2002
98	DR	[Thyroid carcinoma: genetics, diagnosis, clinical features, and surgical treatment]	12094702	Nippon Geka Gakkai Zasshi	2002
98	PR	Recommendations for reporting C cell pathology of the thyroid.	12089863	Wien Klin Wochenschr	2002
98	DR	Role of Dok1 in cell signaling mediated by RET tyrosine kinase.	12087092	J Biol Chem	2002
98	DR	A new identified germline mutation of the RET proto-oncogene responsible for familial medullary thyroid carcinoma in co-existence with a hyperfunctioning autonomous nodule.	12072055	Clin Endocrinol (Oxf)	2002
98	DR	Generation and characterization of novel monoclonal antibodies to the Ret receptor tyrosine kinase.	12061779	Biochem Biophys Res Commun	2002
98	DR	Medullary thyroid cancer.	12057161	Curr Treat Options Oncol	2000
98	PR	Activation of RET tyrosine kinase regulates interleukin-8 production by multiple signaling pathways.	12056817	Biochem Biophys Res Commun	2002
98	NR	Cortical-sparing laparoscopic adrenalectomy in a patient with multiple endocrine neoplasia type IIA.	12053093	Horm Res	2002
98	DR	The minisequencing method: a simple strategy for genetic screening of MEN 2 families.	12042015	BMC Genet	2002
98	DR	Multiple endocrine neoplasia 2A syndrome: Surgical management.	12037758	J Pediatr Surg	2002
98	NR	Recessive transmission of a multiple endocrine neoplasia syndrome in the rat.	12036912	Cancer Res	2002
98	DR	A PCR-mutagenesis strategy for rapid detection of mutations in codon 634 of the ret proto-oncogene related to MEN 2A.	12033991	BMC Med Genet	2002
98	DR	V804M RET mutation and familial medullary thyroid carcinoma: report of a large family with expression of the disease only in the homozygous gene carriers.	12019403	Surgery	2002
98	DR	Prospective trial of unilateral surgery for nonhereditary medullary thyroid carcinoma in patients without germline RET mutations.	12016484	World J Surg	2002
98	DR	Molecular and biochemical screening for the diagnosis and management of medullary thyroid carcinoma in multiple endocrine neoplasia type 2A.	11987030	Horm Metab Res	2002
98	PR	Comment in:     Endocr Pract. 2002 Jan-Feb;8(1):72-4.	11939755	Endocr Pract	2002
98	DR	[Prophylactic total thyroidectomy in children and adolescents with genetic mutations in the RET-protooncogene.]	11938683	Pediatr Med Chir	2002
98	DR	Comment in:     Surgery. 2002 Apr;131(4):382-3.	11935126	Surgery	2002
98	DR	Familial medullary thyroid carcinoma: clinical variability and low aggressiveness associated with RET mutation at codon 804.	11932300	J Clin Endocrinol Metab	2002
98	DR	C-cell hyperplasia and medullary thyroid microcarcinoma.	11914470	Endocr Pathol	2001
98	DR	Very early detection of RET proto-oncogene mutation is crucial for preventive thyroidectomy in multiple endocrine neoplasia type 2 children: presence of C-cell malignant disease in asymptomatic carriers.	11900218	Cancer	2002
98	DR	Functionally impaired TR mutants are present in thyroid papillary cancer.	11889175	J Clin Endocrinol Metab	2002
98	DR	Comment in:     J Endocrinol Invest. 2003 Apr;26(4):381-3.	11883863	J Endocrinol Invest	2002
98	DR	Erratum in:     Clin Endocrinol (Oxf) 2002 Apr;56(4):563.	11849247	Clin Endocrinol (Oxf)	2002
98	DR	Cancers connected with mutations in RET proto-oncogene.	11845976	Neoplasma	2001
98	DR	RET oligonucleotide microarray for the detection of RET mutations in multiple endocrine neoplasia type 2 syndromes.	11839664	Clin Cancer Res	2002
98	DR	Molecular changes in thyroid neoplasia.	11820615	Folia Histochem Cytobiol	2001
98	PR	Medullary thyroid cancer, papillary thyroid microcarcinoma and Graves' disease: an unusual clinical coexistence.	11817715	J Endocrinol Invest	2001
98	NR	Thyroid C-cell hyperplasia in an adolescent with neurofibromatosis type 1.	11815730	Horm Res	2001
98	DR	Atypical MEN type 2B associated with two germline RET mutations on the same allele not involving codon 918.	11788682	J Clin Endocrinol Metab	2002
98	NR	Multiple endocrine neoplasia.	11786689	Horm Res	2001
98	DR	RET(Men2B)-transgene produces sympathoadrenal tumors but does not prevent intestinal aganglionosis in gdnf-/- or gfr alpha-1(-/-) mice.	11779046	Pediatr Dev Pathol	2001
98	DR	Quality of life in patients at risk of medullary thyroid carcinoma and followed by a comprehensive medical network: trends for future evaluations.	11762820	Ann Oncol	2001
98	DR	Comment in:     Ned Tijdschr Geneeskd. 2001 Nov 17;145(46):2234-41.	11757244	Ned Tijdschr Geneeskd	2001
98	DR	Allelic imbalance of the mutant and wild-type RET allele in MEN 2A-associated medullary thyroid carcinoma.	11753660	Oncogene	2001
98	DR	Novel germline RET mutation segregating with papillary thyroid carcinomas.	11746981	Genes Chromosomes Cancer	2001
98	DR	Frequent RET rearrangements in thyroid papillary microcarcinoma detected by interphase fluorescence in situ hybridization.	11742034	Lab Invest	2001
98	DR	Familial medullary thyroid carcinoma and prominent corneal nerves associated with the germline V804M and V778I mutations on the same allele of RET.	11732489	J Med Genet	2001
98	DR	A case of multiple endocrine neoplasia type 2B undiagnosed for many years despite its typical phenotype.	11720239	Endocrine	2001
98	NR	Surgical treatment of medullary carcinoma of the thyroid.	11693822	Tumori	2001
98	DR	Three novel mutations in the RET proto-oncogene.	11692159	J Mol Med	2001
98	NR	Comment in:     Am J Surg Pathol. 2003 Feb;27(2):266-7.	11688458	Am J Surg Pathol	2001
98	DR	A novel chromosomal translocation t(3;5)(q12;p15.3) and loss of heterozygosity on chromosome 22 in a multifocal follicular variant of papillary thyroid carcinoma presenting with skin metastases.	11678839	Clin Endocrinol (Oxf)	2001
98	NR	Novel technique for scanning of codon 634 of the RET protooncogene with fluorescence resonance energy transfer and real-time PCR in patients with medullary thyroid carcinoma.	11673360	Clin Chem	2001
98	DR	Germline sequence variant S836S in the RET proto-oncogene is associated with low level predisposition to sporadic medullary thyroid carcinoma in the Spanish population.	11589684	Clin Endocrinol (Oxf)	2001
98	DR	The RET receptor: function in development and dysfunction in congenital malformation.	11585664	Trends Genet	2001
98	DR	[Phenotypic expression of a mutation in MEN 2A documented in a family in the western part of Sweden]	11577645	Lakartidningen	2001
98	DR	The sensitivity of activated Cys Ret mutants to glial cell line-derived neurotrophic factor is mandatory to rescue neuroectodermic cells from apoptosis.	11564857	Mol Cell Biol	2001
98	DR	Inhibition of Ret oncogene activity by the protein tyrosine phosphatase SHP1.	11564708	Endocrinology	2001
98	DR	[Germline mutations of the ret proto-oncogene in Chilean patients with hereditary and sporadic medullary thyroid carcinoma]	11552438	Rev Med Chil	2001
98	NR	The GDNF/RET signaling pathway and human diseases.	11544105	Cytokine Growth Factor Rev	2001
98	DR	Molecular genetic diagnostic program of multiple endocrine neoplasia type 2A and familial medullary thyroid carcinoma syndromes in Hungary.	11524247	J Endocrinol	2001
98	PR	Germline RET 634 mutation positive MEN 2A-related C-cell hyperplasias have genetic features consistent with intraepithelial neoplasia.	11502837	J Clin Endocrinol Metab	2001
98	DR	Familial medullary thyroid carcinoma with noncysteine ret mutations: phenotype-genotype relationship in a large series of patients.	11502806	J Clin Endocrinol Metab	2001
98	DR	C-cell and thyroid epithelial tumours and altered follicular development in transgenic mice expressing the long isoform of MEN 2A RET.	11494127	Oncogene	2001
98	NR	Typical ocular findings in a patient with multiple endocrine neoplasia type 2b syndrome.	11482345	Graefes Arch Clin Exp Ophthalmol	2001
98	PR	Total thyroidectomy for hereditary medullary thyroid carcinoma 12 years after correction of Hirschsprung's disease.	11471675	Eur J Surg	2001
98	DR	Receptor tyrosine kinases as therapeutic targets: the model of the MET oncogene.	11465538	Curr Drug Targets	2001
98	DR	[Hereditary thyroid cancer can be cured by prophylactic surgery]	11462876	Lakartidningen	2001
98	DR	Multiple endocrine neoplasia type 2 syndromes may be associated with renal malformations.	11454140	J Intern Med	2001
98	DR	Genetic markers in thyroid neoplasia.	11444172	Endocrinol Metab Clin North Am	2001
98	PR	Multiple endocrine neoplasia type 2: molecular aspects.	11443855	Front Horm Res	2001
98	PR	Multiple endocrine neoplasia type 2: clinical aspects.	11443849	Front Horm Res	2001
98	DR	RET/PTC rearrangements in thyroid nodules: studies in irradiated and not irradiated, malignant and benign thyroid lesions in children and adults.	11443191	J Clin Endocrinol Metab	2001
98	NR	Pseudohypoparathyroidism Ia and hypercalcitoninemia.	11443172	J Clin Endocrinol Metab	2001
98	DR	Multiple endocrine neoplasia type 2B.	11442663	Int J Urol	2001
98	DR	Large-scale analysis of mutations in RET exon 16 in sporadic medullary thyroid carcinomas in Japan.	11429053	Jpn J Cancer Res	2001
98	NR	[Medullary carcinoma of the thyroid gland]	11424598	Acta Biomed Ateneo Parmense	2000
98	PR	Altered gene expression in immunogenic poorly differentiated thyroid carcinomas from RET/PTC3p53-/- mice.	11423973	Oncogene	2001
98	DR	Clinical genetics of multiple endocrine neoplasias, Carney complex and related syndromes.	11407658	J Endocrinol Invest	2001
98	DR	Unusual clinical presentation of a patient with multiple endocrine neoplasia type 2A.	11395220	Neth J Med	2001
98	DR	Docking protein FRS2 links the protein tyrosine kinase RET and its oncogenic forms with the mitogen-activated protein kinase signaling cascade.	11390647	Mol Cell Biol	2001
98	DR	Nuclear factor-kappaB is constitutively active in C-cell carcinoma and required for RET-induced transformation.	11389085	Cancer Res	2001
98	NR	H4(D10S170), a gene frequently rearranged in papillary thyroid carcinoma, is fused to the platelet-derived growth factor receptor beta gene in atypical chronic myeloid leukemia with t(5;10)(q33;q22).	11389034	Blood	2001
98	NR	Comment in:     Ophthal Plast Reconstr Surg. 2002 Mar;18(2):163-4; author reply 164.	11388386	Ophthal Plast Reconstr Surg	2001
98	DR	A family of multiple endocrine neoplasia type 2A with the RET proto-oncogene mutation in codon 618 (Cys-->Arg).	11386462	Jpn J Clin Oncol	2001
98	DR	Importance of early screening and prophylactic thyroidectomy in asymptomatic nonindex RET germline carriers.	11376404	World J Surg	2001
98	DR	Diagnostic approach, genetic screening and prognostic factors of medullary thyroid carcinoma.	11370543	Rays	2000
98	NR	Molecular biology of thyroid neoplasms.	11370534	Rays	2000
98	DR	Over-representation of a germline variant in the gene encoding RET co-receptor GFRalpha-1 but not GFRalpha-2 or GFRalpha-3 in cases with sporadic medullary thyroid carcinoma.	11360200	Oncogene	2001
98	DR	Multiple endocrine neoplasia type 2B--genetic basis and clinical expression.	11356339	Surg Oncol	2000
98	DR	CGH alterations in medullary thyroid carcinomas in relation to the RET M918T mutation and clinical outcome.	11351254	Int J Oncol	2001
98	NR	Gene rearrangements in radiation-induced thyroid carcinogenesis.	11340615	Med Pediatr Oncol	2001
98	DR	[Molecular diagnosis of multiple type 2 endocrine neoplasia]	11338505	Vestn Ross Akad Med Nauk	2001
98	DR	Presentation of a kindred with familial medullary thyroid carcinoma and Cys611Phe mutation of the RET proto-oncogene demonstrating low grade malignancy.	11331212	Eur J Endocrinol	2001
98	DR	RET rearrangements in radiation-induced papillary thyroid carcinomas: high prevalence of topoisomerase I sites at breakpoints and microhomology-mediated end joining in ELE1 and RET chimeric genes.	11318605	Genomics	2001
98	DR	A rare variant, I852M, of the RET proto-oncogene in a patient with medullary thyroid carcinoma at age 20 years.	11295841	Hum Mutat	2001
98	NR	Chromosomal rearrangements in thyroid carcinomas: a recombination or death dilemma.	11295280	Cancer Lett	2001
98	NR	Familial medullary thyroid carcinoma (FMTC). Study of one family (treatment criteria).	11289752	Eur J Surg Oncol	2001
98	DR	Diagnosis and treatment of medullary thyroid cancer.	11289739	Baillieres Best Pract Res Clin Endocrinol Metab	2000
98	DR	Mutation analysis of NTRK2 and NTRK3, encoding 2 tyrosine kinase receptors, in sporadic human medullary thyroid carcinoma reveals novel sequence variants.	11279608	Int J Cancer	2001
98	DR	A large family with hereditary MTC: role of RET genetic analysis in differential diagnosis between MEN 2A and FMTC.	11280716	Horm Metab Res	2001
98	PR	Medullary thyroid carcinoma and lack of renal agenesis.	11272104	Thyroid	2001
98	DR	[Usefulness of RET proto-oncogene in the diagnosis of hereditary-type medullary carcinoma of the thyroid. Correlation with surgical findings]	11269881	Acta Otorrinolaringol Esp	2001
98	DR	How familial cancer genes and environmentally induced oncogenes have changed the endocrine landscape.	11266533	Mod Pathol	2001
98	DR	Multiple endocrine neoplasia type iia: report of a family with a study of three generations in qatar.	11250764	Endocr Pract	2001
98	DR	Increased in vivo phosphorylation of ret tyrosine 1062 is a potential pathogenetic mechanism of multiple endocrine neoplasia type 2B.	11245446	Cancer Res	2001
98	DR	Prognostic value of codon 918 (ATG-->ACG) RET proto-oncogene mutations in sporadic medullary thyroid carcinoma.	11241313	Int J Cancer	2001
98	DR	Genotype-phenotype correlations in hereditary medullary thyroid carcinoma: oncological features and biochemical properties.	11238493	J Clin Endocrinol Metab	2001
98	PR	Pathogenesis of thyroid nodules: histological classification?	11237284	Biomed Pharmacother	2001
98	DR	Thyroid carcinoma usually occurs in patients with familial adenomatous polyposis in the absence of biallelic inactivation of the adenomatous polyposis coli gene.	11232035	J Clin Endocrinol Metab	2001
98	DR	Estimation of risk of inherited medullary thyroid carcinoma in apparent sporadic patients.	11230481	J Clin Oncol	2001
98	DR	RET proto-oncogene mutation in a mixed medullary-follicular thyroid carcinoma.	11227733	J Endocrinol Invest	2001
98	DR	Multiple endocrine neoplasia (MEN)--an overview and case report--patient with sporadic bilateral pheochromocytoma, hyperparathyroidism and marfanoid habitus.	11205236	Anticancer Res	2000
98	DR	Prophylactic thyroidectomy in the treatment of thyroid medullary carcinoma. Age for surgery?	11194546	Eur J Pediatr Surg	2000
98	DR	[Prophylactic thyroidectomy in carriers of RET oncogene mutation carriers]	11187163	Tidsskr Nor Laegeforen	2000
98	NR	Comment on:     Science. 2000 Oct 6;290(5489):138-41.	11183150	Science	2000
98	NR	Pheochromocytoma in multiple endocrine neoplasia type 2: a prospective study.	11174835	Eur J Endocrinol	2001
98	DR	Thyroid cancer.	11165748	Cancer Lett	2001
98	NR	Sporadic and familial pheochromocytomas are associated with loss of at least two discrete intervals on chromosome 1p.	11156410	Cancer Res	2000
98	DR	A novel type of RET rearrangement (PTC8) in childhood papillary thyroid carcinomas and characterization of the involved gene (RFG8).	11156407	Cancer Res	2000
98	NR	Differential effects of leukocyte common antigen-related protein on biochemical and biological activities of RET-MEN2A and RET-MEN2B mutant proteins.	11121408	J Biol Chem	2001
98	DR	Medullary thyroid carcinoma (MTC)--clinical and molecular aspects on the basis of own experience.	11130252	Neoplasma	2000
98	NR	The TRK-T1 fusion protein induces neoplastic transformation of thyroid epithelium.	11126359	Oncogene	2000
98	NR	Human glial cell line-derived neurotrophic factor receptor alpha 4 is the receptor for persephin and is predominantly expressed in normal and malignant thyroid medullary cells.	11116144	J Biol Chem	2001
98	DR	The RET proto-oncogene in human cancers.	11114739	Oncogene	2000
98	DR	Update on the MEN 2A c804 RET mutation: is prophylactic thyroidectomy indicated?	11114642	Surgery	2000
98	DR	Multiple endocrine neoplasia type 2 and RET: from neoplasia to neurogenesis.	11073534	J Med Genet	2000
98	DR	Tyrosines 1015 and 1062 are in vivo autophosphorylation sites in ret and ret-derived oncoproteins.	11061555	J Clin Endocrinol Metab	2000
98	DR	Unilateral surgery supported by germline RET oncogene mutation analysis in patients with sporadic medullary thyroid carcinoma.	11038208	World J Surg	2000
98	DR	Regulation of proliferation and apoptosis in sporadic and hereditary medullary thyroid carcinomas and their putative precursor lesions.	11037345	Virchows Arch	2000
98	DR	Comment in:     Science. 2000 Oct 6;290(5489):62-3.	11021799	Science	2000
98	DR	Tissue-specific carcinogenesis in transgenic mice expressing the RET proto-oncogene with a multiple endocrine neoplasia type 2A mutation.	11016655	Cancer Res	2000
98	NR	Familial form of hirschsprung disease: nucleotide sequence studies reveal point mutations in the RET proto-oncogene in two of six families but not in other candidate genes.	10982477	Am J Med Genet	2000
98	DR	RET/PCM-1: a novel fusion gene in papillary thyroid carcinoma.	10980597	Oncogene	2000
98	DR	Incidence and clinical relevance of RET proto-oncogene germline mutations in pheochromocytoma patients.	10953992	J Hypertens	2000
98	DR	Is thyroidectomy necessary in RET mutations carriers of the familial medullary thyroid carcinoma syndrome?	10951350	Cancer	2000
98	DR	Glucocorticoids differentially inhibit expression of the RET proto-oncogene.	10947080	Gene Expr	1999
98	DR	Prevalence and distribution of ret/ptc 1, 2, and 3 in papillary thyroid carcinoma in New Caledonia and Australia.	10946873	J Clin Endocrinol Metab	2000
98	NR	Molecular genetics of neuroendocrine tumors.	10940682	Digestion	2000
98	DR	New breakpoints in both the H4 and RET genes create a variant of PTC-1 in a post-Chernobyl papillary thyroid carcinoma.	10931090	Clin Endocrinol (Oxf)	2000
98	DR	Tyrosine 1062 of RET-MEN2A mediates activation of Akt (protein kinase B) and mitogen-activated protein kinase pathways leading to PC12 cell survival.	10919641	Cancer Res	2000
98	DR	[Multiple endocrine neoplasia type 2; MEN 2]	10921320	Nippon Rinsho	2000
98	NR	Fusion of H4/D10S170 to the platelet-derived growth factor receptor beta in BCR-ABL-negative myeloproliferative disorders with a t(5;10)(q33;q21).	10910073	Cancer Res	2000
98	DR	RET proto-oncogene mutations in thyroid carcinomas: clinical relevance.	10882153	J Endocrinol Invest	2000
98	NR	RET is expressed but not mutated in extra-adrenal paragangliomas.	10878547	J Pathol	2000
98	DR	Variable expressivity of familial medullary thyroid carcinoma (FMTC) due to a RET V804M (GTG-->ATG) mutation.	10876191	Surgery	2000
98	PR	Tumorigenesis mediated by MET mutant M1268T is inhibited by dominant-negative Src.	10871851	Oncogene	2000
98	DR	Multiple endocrine neoplasia type 2B mutation in human RET oncogene induces medullary thyroid carcinoma in transgenic mice.	10871866	Oncogene	2000
98	DR	Medullary carcinoma of the thyroid gland.	10865039	World J Surg	2000
98	DR	Molecular genetics of thyroid tumors and surgical decision-making.	10865036	World J Surg	2000
98	NR	Expression and alternative splicing of mouse Gfra4 suggest roles in endocrine cell development.	10860579	Mol Cell Neurosci	2000
98	DR	Translocation t(10;14)(q11.2:q22.1) fusing the kinetin to the RET gene creates a novel rearranged form (PTC8) of the RET proto-oncogene in radiation-induced childhood papillary thyroid carcinoma.	10850414	Cancer Res	2000
98	DR	Sporadic endocrine tumours and their relationship to the hereditary endocrine neoplasia syndromes.	10849017	Eur J Clin Invest	2000
98	DR	Inherited medullary microcarcinoma of the thyroid: a study of 11 cases.	10843288	Am J Surg Pathol	2000
98	NR	Thyroid carcinomas with mixed follicular and C-cell differentiation patterns.	10839611	Semin Diagn Pathol	2000
98	NR	Papillary microcarcinoma of the thyroid: a clinico-pathologic and prognostic review.	10836212	In Vivo	2000
98	DR	Oncogenes and thyroid cancer.	10834397	Clin Chem Lab Med	2000
98	DR	Comment in:     Exp Clin Endocrinol Diabetes. 2000;108(8):493.	10826520	Exp Clin Endocrinol Diabetes	2000
98	DR	[Medullary carcinoma of the thyroid: diagnosis and therapy]	10822879	Clin Ter	2000
98	DR	Expression of RET and its ligand complexes, GDNF/GFRalpha-1 and NTN/GFRalpha-2, in medullary thyroid carcinomas.	10822229	Eur J Endocrinol	2000
98	NR	Somatic trinucleotide change encompassing codons 882 and 883 of the RET proto-oncogene in a patient with sporadic medullary thyroid carcinoma.	10822219	Eur J Endocrinol	2000
98	DR	The RET receptor tyrosine kinase: activation, signalling and significance in neural development and disease.	10812967	Pharm Acta Helv	2000
98	DR	Multiple endocrine neoplasias.	10805954	Semin Surg Oncol	2000
98	DR	The Chernobyl accident and its consequences: update at the millennium.	10787193	Semin Nucl Med	2000
98	DR	RET rearrangements in papillary thyroid carcinomas and adenomas detected by interphase FISH.	10773666	Cytogenet Cell Genet	2000
98	DR	Unilateral renal agenesis in a family with medullary thyroid carcinoma.	10777380	N Engl J Med	2000
98	DR	Absence of H- and K-ras oncogene mutations in sporadic medullary thyroid carcinoma.	10768832	Exp Clin Endocrinol Diabetes	2000
98	DR	Signaling through Ras is essential for ret oncogene-induced cell differentiation in PC12 cells.	10748077	J Biol Chem	2000
98	NR	Comment in:     Rev Port Cardiol. 2000 Jan;19(1):33-8.	10731788	Rev Port Cardiol	2000
98	DR	The ret/PTC mutations are common in sporadic papillary thyroid carcinoma of children and young adults.	10720057	J Clin Endocrinol Metab	2000
98	NR	Genomic organization and chromosomal mapping of ELKS, a gene rearranged in a papillary thyroid carcinoma.	10697956	J Hum Genet	2000
98	DR	Rapid MEN 2A gene carrier identification using primer-specific PCR amplification.	10691056	Scand J Clin Lab Invest	1999
98	PR	Translocations (X;10)(p22;q24) and (1;10)(q21;q11) in a follicular adenoma of the thyroid without apparent involvement of the RET protooncogene.	10686949	Cancer Genet Cytogenet	1999
98	DR	A two-hit model for development of multiple endocrine neoplasia type 2B by RET mutations.	10679286	Biochem Biophys Res Commun	2000
98	DR	C-cell hyperplasia, pheochromocytoma and sympathoadrenal malformation in a mouse model of multiple endocrine neoplasia type 2B.	10675330	EMBO J	2000
98	DR	Transforming ability of MEN2A-RET requires activation of the phosphatidylinositol 3-kinase/AKT signaling pathway.	10652352	J Biol Chem	2000
98	DR	Gene rearrangement and Chernobyl related thyroid cancers.	10646883	Br J Cancer	2000
98	NR	[Molecular genetic study of medullary thyroid cancer]	10628190	Orv Hetil	1999
98	DR	Thyroid consequences of the Chernobyl nuclear accident.	10626541	Acta Paediatr Suppl	1999
98	DR	Somatic mutations in RET exons 12 and 15 in sporadic medullary thyroid carcinomas: different spectrum of mutations in sporadic type from hereditary type.	10622534	Jpn J Cancer Res	1999
98	DR	A new germline mutation, R600Q, within the coding region of RET proto-oncogene: a rare polymorphism or a MEN 2 causing mutation?	10612852	Hum Mutat	2000
98	NR	Nmethyl-N-nitrosourea (MNU) induces papillary thyroid tumours which lack ras gene mutations in the hermaphroditic fish Rivulus marmoratus.	10607373	Teratog Carcinog Mutagen	2000
98	DR	Chromosomal breakpoint positions suggest a direct role for radiation in inducing illegitimate recombination between the ELE1 and RET genes in radiation-induced thyroid carcinomas.	10597232	Oncogene	1999
98	DR	De novo RET proto-oncogene mutation in a patient with multiple endocrine neoplasia type 2B.	10575840	J Formos Med Assoc	1999
98	NR	Mixed medullary-follicular thyroid carcinoma. Molecular evidence for a dual origin of tumor components.	10550306	Am J Pathol	1999
98	DR	Noncardiogenic pulmonary edema as the chief manifestation of a pheochromocytoma: a case report of MEN 2A with pedigree analysis of the RET proto-oncogene.	10526879	Tohoku J Exp Med	1999
98	DR	A novel case of multiple endocrine neoplasia type 2A associated with two de novo mutations of the RET protooncogene.	10522989	J Clin Endocrinol Metab	1999
98	NR	[Thyroidectomy and lymphadenectomy]	10501663	Chirurg	1999
98	DR	The Glu632-Leu633 deletion in cysteine rich domain of Ret induces constitutive dimerization and alters the processing of the receptor protein.	10490816	Oncogene	1999
98	DR	Presymptomatic detection and treatment of Japanese carriers of the multiple endocrine neoplasia type 2A gene.	10489126	Surg Today	1999
98	DR	Familial medullary thyroid carcinoma: presymptomatic diagnosis and management in children.	10484798	J Pediatr	1999
98	NR	Incidental detection of familial medullary thyroid carcinoma by calcitonin screening for nodular thyroid disease.	10474127	Eur J Endocrinol	1999
98	DR	Hammerhead ribozyme-mediated inactivation of mutant RET in medullary thyroid carcinoma.	10463581	Cancer Res	1999
98	DR	Age-Related Disease Penetrance in a Large Medullary Thyroid Cancer Family With a Codon 609 RET Gene Mutation.	10462620	Mol Diagn	1997
98	DR	RET proto-oncogene in the development of human cancer.	10458257	J Clin Oncol	1999
98	DR	Biological and biochemical properties of Ret with kinase domain mutations identified in multiple endocrine neoplasia type 2B and familial medullary thyroid carcinoma.	10445857	Oncogene	1999
98	PR	Mutation analysis reveals novel sequence variants in NTRK1 in sporadic human medullary thyroid carcinoma.	10443680	J Clin Endocrinol Metab	1999
98	DR	[A case of multiple endocrine neoplasia type 2A (MEN2A) with a mutation in the RET gene]	10442282	Hinyokika Kiyo	1999
98	DR	Infrequent detectable somatic mutations of the RET and glial cell line-derived neurotrophic factor (GDNF) genes in human pituitary adenomas.	10426588	Endocr J	1999
98	NR	Erratum in:     Rev Med Interne 2000 Jan;21(1):15.	10422141	Rev Med Interne	1999
98	DR	Different mutations of the RET gene cause different human tumoral diseases.	10401675	Biochimie	1999
98	PR	Genetics and clinicopathological findings in thyroid carcinomas associated with familial adenomatous polyposis.	10393829	Am J Pathol	1999
99	DR	[Relationship between single nucleotide polymorphisms in thiopurine methyltransferase gene and tolerance to thiopurines in acute leukemia]	14723818	Zhonghua Er Ke Za Zhi	2003
99	DR	Clinical relevance of pharmacogenetics.	14705861	Drug Metab Rev	2003
99	NR	Monitoring of azathioprine/6-mercaptopurine treatment in children with IBD is not necessary.	14671489	Inflamm Bowel Dis	2003
99	NR	Monitoring of AZA/6-MP treatment in children with IBD is necessary.	14671488	Inflamm Bowel Dis	2003
99	DR	Pyrosequencing of TPMT alleles in a general Swedish population and in patients with inflammatory bowel disease.	14656901	Clin Chem	2004
99	PR	Azathioprine as a treatment for severe atopic eczema in children with a partial thiopurine methyl transferase (TPMT) deficiency.	14651577	Pediatr Dermatol	2003
99	NR	Heavy metal tolerance and metal homeostasis in Pseudomonas putida as revealed by complete genome analysis.	14641571	Environ Microbiol	2003
99	DR	Pediatric acute lymphoblastic leukemia.	14633779	Hematology (Am Soc Hematol Educ Program)	2003
99	DR	Cat red blood cell thiopurine S-methyltransferase: companion animal pharmacogenetics.	14610243	J Pharmacol Exp Ther	2004
99	DR	Drug methylation in cancer therapy: lessons from the TPMT polymorphism.	14576848	Oncogene	2003
99	PR	With your genes? Take one of these, three times a day.	14574377	Nature	2003
99	DR	Relevance of thiopurine methyltransferase status in rheumatology patients receiving azathioprine.	14566029	Rheumatology (Oxford)	2004
99	PR	Tertiary structure of thiopurine methyltransferase from Pseudomonas syringae, a bacterial orthologue of a polymorphic, drug-metabolizing enzyme.	14556746	J Mol Biol	2003
99	DR	Phenotypic and genotypic analysis of thiopurine s-methyltransferase polymorphism in the bulgarian population.	14508387	Ther Drug Monit	2003
99	PR	Pharmacogenomics of azathioprine and 6-mercaptopurine in gastroenterologic therapy.	14502119	Rev Gastroenterol Disord	2003
99	DR	Thiopurine S-methyltransferase pharmacogenetics: chaperone protein association and allozyme degradation.	12972954	Pharmacogenetics	2003
99	PR	Thiopurine S-methyltransferase (TPMT) genotype does not predict adverse drug reactions to thiopurine drugs in patients with inflammatory bowel disease.	12940924	Aliment Pharmacol Ther	2003
99	DR	A novel TPMT missense mutation associated with TPMT deficiency in a 5-year-old boy with ALL.	12835738	Leukemia	2003
99	PR	Prospects and limits of pharmacogenetics: the thiopurine methyl transferase (TPMT) experience.	12814323	Am J Pharmacogenomics	2003
99	NR	Azathioprine: current status and future considerations.	12755967	Int J Dermatol	2003
99	NR	Pharmacogenetics of drug metabolising enzymes: importance for personalised medicine.	12747605	Clin Chem Lab Med	2003
99	PR	Optimization and individualization of thiopurine therapy in inflammatory bowel disease: the great variability among drug responses.	12746731	Pharmacogenomics J	2003
99	DR	Clinical use and practical application of TPMT enzyme and 6-mercaptopurine metabolite monitoring in IBD.	12684587	Rev Gastroenterol Disord	2003
99	DR	Cancer pharmacogenomics: current and future applications.	12618310	Biochim Biophys Acta	2003
99	PR	Pharmacogenetics of the major polymorphic metabolizing enzymes.	12588628	Fundam Clin Pharmacol	2003
99	DR	Pharmacogenetics in cancer treatment.	12525681	Annu Rev Med	2003
99	DR	Is thiopurine methyltransferase genetic polymorphism a major factor for withdrawal of azathioprine in rheumatoid arthritis patients?	12509611	Rheumatology (Oxford)	2003
99	DR	Practical pharmacogenetics: the cost effectiveness of screening for thiopurine s-methyltransferase polymorphisms in patients with rheumatological conditions treated with azathioprine.	12465143	J Rheumatol	2002
99	DR	Canine red blood cell thiopurine S-methyltransferase: companion animal pharmacogenetics.	12464800	Pharmacogenetics	2002
99	DR	Thiopurine methyltransferase activity and the use of azathioprine in inflammatory bowel disease.	12269967	Aliment Pharmacol Ther	2002
99	PR	Cefazolin administration and 2-methyl-1,3,4-thiadiazole-5-thiol in human tissue: possible relationship to hypoprothrombinemia.	12228189	Drug Metab Dispos	2002
99	DR	Thiopurine methyltransferase phenotype and genotype in relation to azathioprine therapy in autoimmune hepatitis.	12217596	J Hepatol	2002
99	DR	Azathioprine therapy and adverse drug reactions in patients with inflammatory bowel disease: impact of thiopurine S-methyltransferase polymorphism.	12172211	Pharmacogenetics	2002
99	DR	Thiopurine S-methyltransferase: a genetic polymorphism that affects a small number of drugs in a big way.	12172209	Pharmacogenetics	2002
99	DR	[Development of simplified and rapid detection assay for genetic polymorphisms influencing drug response and its clinical applications]	12136641	Yakugaku Zasshi	2002
99	PR	Pharmacogenomics.	12119546	Med Sci Monit	2002
99	PR	Pharmacogenetics of cytotoxic drugs.	12113035	Expert Rev Anticancer Ther	2001
99	PR	[New techniques for optimization of thiopurine therapy in leukemia and transplantation]	12043054	Tidsskr Nor Laegeforen	2002
99	DR	Differences between children and adults in thiopurine methyltransferase activity and metabolite formation during thiopurine therapy: possible role of concomitant methotrexate.	12021625	Ther Drug Monit	2002
99	NR	[Hypomethylation and multiple sclerosis, the susceptibility factor?]	11927101	Neurologia	2002
99	PR	Pharmacogenetics and cancer therapy.	11905809	Nat Rev Cancer	2001
99	PR	Elevated serum pancreatic enzyme activities in kidney transplant recipients and azathioprine drug therapy: is thiopurine methyltransferase polymorphism one missing link?	11834908	Urol Int	2002
99	DR	Polymorphisms of metabolizing enzymes and transporter proteins involved in the clearance of anticancer agents.	11822749	Ann Oncol	2001
99	DR	Thiopurine methyl transferase: activity and genotyping in patients with acute lymphoblastic leukemia.	11783509	Adv Exp Med Biol	2000
99	PR	Pharmacogenetic screening and therapeutic drugs.	11728416	Clin Chim Acta	2002
99	PR	Increasing relevance of pharmacogenetics of drug metabolism in clinical practice.	11720061	Intern Med J	2001
99	DR	Pharmacogenomics: the inherited basis for interindividual differences in drug response.	11701642	Annu Rev Genomics Hum Genet	2001
99	DR	Possible implication of thiopurine S-methyltransferase in occurrence of infectious episodes during maintenance therapy for childhood lymphoblastic leukemia with mercaptopurine.	11681411	Leukemia	2001
99	PR	Practical considerations for pharmacogenetic testing.	11569125	MLO Med Lab Obs	2001
99	PR	Differing contribution of thiopurine methyltransferase to mercaptopurine versus thioguanine effects in human leukemic cells.	11479220	Cancer Res	2001
99	DR	Genetic polymorphisms of thiopurine S-methyltransferase and 6-mercaptopurine toxicity in Japanese children with acute lymphoblastic leukaemia.	11337943	Pharmacogenetics	2001
99	DR	Preponderance of thiopurine S-methyltransferase deficiency and heterozygosity among patients intolerant to mercaptopurine or azathioprine.	11304783	J Clin Oncol	2001
99	DR	Thiopurine pharmacogenetics: clinical and molecular studies of thiopurine methyltransferase.	11259360	Drug Metab Dispos	2001
99	NR	[Targets of antileukemia agents: molecular mechanisms of mercaptopurine action]	11186004	Mol Biol (Mosk)	2000
99	DR	The use of denaturing high-pressure liquid chromatography for the detection of mutations in thiopurine methyltransferase.	11179762	J Biochem Biophys Methods	2001
99	DR	Clinical consequences of the polymorphism of azathioprine metabolism.	11134802	Transplant Proc	2000
99	PR	How to manage individualized drug therapy: application of pharmacogenetic knowledge of drug metabolism and transport.	11097342	Clin Chem Lab Med	2000
99	DR	[Aplasia after azathioprine administration: role of the thiopurine methyltransferase genetic polymorphism]	11093885	Med Clin (Barc)	2000
99	NR	High throughput detection of drug-metabolizing enzyme polymorphisms by allele-specific fluorogenic 5' nuclease chain reaction assay.	11041238	Biol Pharm Bull	2000
99	NR	Demonstration of thiopurine methyltransferase activity in the erythrocytes of cats.	11012121	J Vet Intern Med	2000
99	NR	A comparison of molecular and enzyme-based assays for the detection of thiopurine methyltransferase mutations.	10997970	Br J Haematol	2000
99	DR	Genetic polymorphism of thiopurine S-methyltransferase: molecular mechanisms and clinical importance.	10971199	Pharmacology	2000
99	DR	[Advances of research on the action of purinergic drugs and hereditary polymorphism of thiopurine methyltransferase]	10921112	Zhonghua Xue Ye Xue Za Zhi	1998
99	DR	Thiopurine S-methyltransferase gene polymorphism is predictive of azathioprine-induced myelosuppression in heart transplant recipients.	10798786	Transplantation	2000
99	DR	Genetic polymorphism of thiopurine methyltransferase and its clinical relevance for childhood acute lymphoblastic leukemia.	10764140	Leukemia	2000
99	PR	Screening for azathioprine toxicity: a pharmacoeconomic analysis based on a target case.	10727309	J Am Acad Dermatol	2000
99	PR	[Bone marrow depression after azathioprine. New discoveries on an old drug]	10707497	Lakartidningen	2000
99	NR	Pharmacogenetics in the practice of laboratory medicine.	10671647	Mol Diagn	1999
99	DR	Inherited variations in drug-metabolizing enzymes: significance in clinical oncology.	10671643	Mol Diagn	1999
99	DR	Thiopurine methyltransferase genotype and the toxicity of azathioprine in Japanese.	10628931	Intern Med	1999
99	DR	Mercaptopurine therapy intolerance and heterozygosity at the thiopurine S-methyltransferase gene locus.	10580024	J Natl Cancer Inst	1999
99	NR	Possible carcinogenic effect of 6-mercaptopurine on bone marrow stem cells: relation to thiopurine metabolism.	10491537	Cancer	1999
99	DR	Identification of thiopurine methyltransferase (TPMT) polymorphisms cannot predict myelosuppression in systemic lupus erythematosus patients taking azathioprine.	10461478	Rheumatology (Oxford)	1999
99	DR	Thiopurine methyltransferase pharmacogenetics: alternative molecular diagnosis and preliminary data from Northern Portugal.	10376773	Pharmacogenetics	1999
99	DR	Analysis of thiopurine methyltransferase variant alleles in childhood acute lymphoblastic leukaemia.	10354134	Br J Haematol	1999
99	PR	Methylation pharmacogenetics: catechol O-methyltransferase, thiopurine methyltransferase, and histamine N-methyltransferase.	10331075	Annu Rev Pharmacol Toxicol	1999
99	DR	Pharmacogenetics as a molecular basis for individualized drug therapy: the thiopurine S-methyltransferase paradigm.	10213363	Pharm Res	1999
99	PR	The frequency and distribution of thiopurine methyltransferase alleles in Caucasian and Asian populations.	10208641	Pharmacogenetics	1999
99	DR	Pharmacogenetics and cancer chemotherapy.	9893619	Eur J Cancer	1998
99	PR	The relationship between thiopurine methyltransferase activity and genotype in blasts from patients with acute leukemia.	9763570	Blood	1998
99	PR	Pharmacogenetics of cancer therapy: getting personal.	9634537	Am J Hum Genet	1998
99	PR	Thiopurine treatment in childhood leukemia. Metabolic aspects and sensitivity.	9598153	Adv Exp Med Biol	1998
99	PR	[Individualization of drug therapy and pharmacogenetics]	9549339	Nippon Rinsho	1998
99	PR	Thiopurine biology and pharmacology.	9114722	Trends Pharmacol Sci	1997
99	NR	Individualizing therapy with 6-mercaptopurine and 6-thioguanine related to the thiopurine methyltransferase genetic polymorphism.	8857546	Ther Drug Monit	1996
99	NR	Thiopurine methyltransferase: a review and a clinical pilot study.	8861653	J Chromatogr B Biomed Appl	1996
99	NR	Polymorphic thiopurine methyltransferase in erythrocytes is indicative of activity in leukemic blasts from children with acute lymphoblastic leukemia.	7703493	Blood	1995
99	NR	Thiopurine methyltransferase pharmacogenetics. Cloning of human liver cDNA and a processed pseudogene on human chromosome 18q21.1.	7628307	Drug Metab Dispos	1995
99	DR	A single point mutation leading to loss of catalytic activity in human thiopurine S-methyltransferase.	7862671	Proc Natl Acad Sci U S A	1995
99	DR	The role of genetic variation in thiopurine methyltransferase activity and the efficacy and/or side effects of azathioprine therapy in dermatologic patients.	7857117	Arch Dermatol	1995
99	PR	A pharmacogenetic basis for the safe and effective use of azathioprine and other thiopurine drugs in dermatologic patients.	7822499	J Am Acad Dermatol	1995
